Quiver News

$8,150,000 of GENERAL MOTORS COMPANY lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H.R. 906, REPAIR Act, H.R. 1707 SMART Act; S. 2934/HR 8684 SHOP SAFE Act, S. 2220 PREVAIL Act and autonomous vehicle technology, issues generally. Issues related to OECD Pillar 2 negotiations and agreements on the taxation of global income, IRA sections 30D, 45X, 45W, expiring provisions of the Tax Cut and Jobs Act. Defense authorization for Fiscal Year 2025, hybrid propulsion programs, infantry squad vehicle authorization; Armored vehicle procurement, provisions related to LIDAR Vehicle fuel economy; vehicle safety, autonomous vehicles, cybersecurity, connected vehicles, global competitiveness; S. 711, the Transportation Freedom Act, Protecting American Advanced Manufacturing Act; EV infrastructure and auto manufacturing supply chain; S. 154/H.R. 621, PART Act; Permitting Reform THUD Appropriations; Defense appropriations for Fiscal Year 2025; infantry squad vehicle funding, tactical electrification initiatives; Department of defense budget request for Fiscal Year 2025 Fuel economy/GHG rule/CAFE/ACC II; Safe II GHG reduction rule, Preserving Choice in Vehicle Purchases Act; calculation for EVs. Privacy and data breach, issues generally Tariffs, Non-tariff trade barriers, global market access Corporate governance and industrial loan charters, issues generally."

You can find more data on corporate lobbying on Quiver Quantitative.

GM Congressional Stock Trading

Members of Congress have traded $GM stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $GM stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 02/26.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

GM Insider Trading Activity

GM insiders have traded $GM stock on the open market 9 times in the past 6 months. Of those trades, 1 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $GM stock by insiders over the last 6 months:

• CRAIG B. GLIDDEN (Executive Vice President & GC) has made 0 purchases and 5 sales selling 383,142 shares for an estimated $21,696,752.
• MARY T BARRA (Chair & CEO) sold 206,824 shares for an estimated $11,913,062
• MARK L REUSS (President) sold 122,283 shares for an estimated $6,745,130
• ALFRED F JR KELLY purchased 12,000 shares for an estimated $607,920
• RORY HARVEY (Executive Vice President) sold 8,919 shares for an estimated $535,229

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

GM Hedge Fund Activity

We have seen 555 institutional investors add shares of GM stock to their portfolio, and 646 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL WORLD INVESTORS removed 22,218,452 shares (-46.0%) from their portfolio in Q4 2024, for an estimated $1,183,576,938
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 8,347,526 shares (-27.7%) from their portfolio in Q4 2024, for an estimated $444,672,710
• CAPITAL INTERNATIONAL INVESTORS removed 7,196,697 shares (-71.7%) from their portfolio in Q4 2024, for an estimated $383,368,049
• HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC removed 6,366,002 shares (-36.8%) from their portfolio in Q4 2024, for an estimated $339,116,926
• BLACKROCK, INC. removed 6,009,772 shares (-5.7%) from their portfolio in Q4 2024, for an estimated $320,140,554
• BARCLAYS PLC removed 5,419,215 shares (-70.0%) from their portfolio in Q4 2024, for an estimated $288,681,583
• FMR LLC removed 4,217,131 shares (-21.9%) from their portfolio in Q4 2024, for an estimated $224,646,568

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

GM Analyst Ratings

Wall Street analysts have issued reports on $GM in the last several months. We have seen 4 firms issue buy ratings on the stock, and 3 firms issue sell ratings.

Here are some recent analyst ratings:

• Barclays issued a "Negative" rating on 04/15/2025
• Bernstein issued a "Underperform" rating on 04/07/2025
• Cowen & Co. issued a "Buy" rating on 03/06/2025
• UBS issued a "Buy" rating on 02/03/2025
• Wells Fargo issued a "Underweight" rating on 02/03/2025
• Evercore ISI issued a "Outperform" rating on 12/13/2024
• Bank of America Securities issued a "Buy" rating on 12/04/2024

To track analyst ratings and price targets for GM, check out Quiver Quantitative's $GM forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Representative George Whitesides just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative George Whitesides and other politicians.

The trades in the new disclosure included a:

• Sale of $V stock (STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. C�������: TO AVOID ANY POSSIBLE CONFLICTS OF INTEREST WITH MY FUTURE CONGRESSIONAL WORK, I’M TRANSITIONING MY SINGLE STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. VISA INC.)
• Sale of $DIS stock (STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. C�������: TO AVOID ANY POSSIBLE CONFLICTS OF INTEREST WITH MY FUTURE CONGRESSIONAL WORK, I’M TRANSITIONING MY SINGLE STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. WALT DISNEY COMPANY)
• Sale of $KO stock (STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. C�������: TO AVOID ANY POSSIBLE CONFLICTS OF INTEREST WITH MY FUTURE CONGRESSIONAL WORK, I’M TRANSITIONING MY SINGLE STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. COCA-COLA COMPANY)
• Sale of $DEO stock (STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. C�������: TO AVOID ANY POSSIBLE CONFLICTS OF INTEREST WITH MY FUTURE CONGRESSIONAL WORK, I’M TRANSITIONING MY SINGLE STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. DIAGEO PLC COMMON STOCK)
• Sale of $INVA stock (STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. C�������: TO AVOID ANY POSSIBLE CONFLICTS OF INTEREST WITH MY FUTURE CONGRESSIONAL WORK, I’M TRANSITIONING MY SINGLE STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. SP INNOVIVA, INC. - COMMON STOCK)
• Sale of $JPM stock (STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. C�������: TO AVOID ANY POSSIBLE CONFLICTS OF INTEREST WITH MY FUTURE CONGRESSIONAL WORK, I’M TRANSITIONING MY SINGLE STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. JP MORGAN CHASE & CO. COMMON STOCK)
• Sale of $MMC stock (STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. C�������: TO AVOID ANY POSSIBLE CONFLICTS OF INTEREST WITH MY FUTURE CONGRESSIONAL WORK, I’M TRANSITIONING MY SINGLE STOCK, COMPANY-SPECIFIC HOLDINGS INTO PASSIVE ETFS AND MUTUAL FUNDS, PER BEST PRACTICES. MARSH & MCLENNAN COMPANIES, INC. COMMON STOCK)

To see all the trades, and to see details on the trade sizes and dates, see Quiver Quantitative's politician page for Representative George Whitesides

Senator David McCormick just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Senator David McCormick and other politicians.

The trades in the new disclosure included a:

• Purchase of $BITB stock (Bitwise Bitcoin ETF)

To see all the trades, and to see details on the trade sizes and dates, see Quiver Quantitative's politician page for Senator David McCormick

Representative Thomas R. Suozzi just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Thomas R. Suozzi and other politicians.

The trades in the new disclosure included a:

• Sale of $GIC stock (GLOBAL INDUSTRIAL COMPANY COMMON STOCK)

To see all the trades, and to see details on the trade sizes and dates, see Quiver Quantitative's politician page for Representative Thomas R. Suozzi

Senator John W. Hickenlooper just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Senator John W. Hickenlooper and other politicians.

The trades in the new disclosure included a:

• Sale of $FWONK stock (Liberty Media Formula One Sr C)

To see all the trades, and to see details on the trade sizes and dates, see Quiver Quantitative's politician page for Senator John W. Hickenlooper

Senator John Boozman just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Senator John Boozman and other politicians.

The trades in the new disclosure included a:

• Sale of $IVW stock (iShares S&P 500 Growth ETF)
• Sale of $DTE stock (Dte Energy Company)
• Purchase of $AMAT stock (Applied Materials)
• Purchase of $TBLL stock (Invesco Short Term Treasury ETF)

To see all the trades, and to see details on the trade sizes and dates, see Quiver Quantitative's politician page for Senator John Boozman

Representative Robert Bresnahan just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Robert Bresnahan and other politicians.

The trades in the new disclosure included a:

• Purchase of $TXN stock (TEXAS INSTRUMENTS INCORPORATED - COMMON STOCK)
• Sale of $RDDT stock (REDDIT, INC. CLASS A COMMON STOCK)
• Purchase of $IBM stock (INTERNATIONAL BUSINESS MACHINES CORPORATION COMMON STOCK)
• Sale of $HOOD stock (ROBINHOOD MARKETS, INC. - CLASS A COMMON STOCK)
• Sale of $META stock (META PLATFORMS, INC. - CLASS A COMMON STOCK)
• Sale of $TSLA stock (TESLA, INC. - COMMON STOCK)
• Sale of $NET stock (CLOUDFLARE, INC. CLASS A COMMON STOCK)

To see all the trades, and to see details on the trade sizes and dates, see Quiver Quantitative's politician page for Representative Robert Bresnahan

$3,080,000 of SOUTHERN COMPANY lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Climate change issues, generally; Environmental regulation, generally (Effluent Limitations Guidelines; Good Neighbor Ozone Transport; CAA Sec. 111 rulemaking) S.J.Res. 4, tankless water heater CRA; H.J.Res. 20, tankless water heater CRA; DOE Distribution Transformer Rule; Grid enhancing technologies, generally; Issues related to FERCs transmission planning and cost allocation rule (Order 1920); Issues related to FERCs regional transmission organizations, generally; Issues related to deregulation, generally; DOE Loan Program Office issues, generally (1706); Issues related to Transmission legislation, generally; Issues related to Grid enhancing technologies, generally; Issues related to Natural gas infrastructure development, generally; Issues related to Energy infrastructure development, generally; Issues related to FERC nominations, generally; Issues related to S.2651, the SITE Act; Issues related to Building American Energy Security Act of 2023; Issues related to regional transmission organizations, generally; Issues related to deregulation generally; Issues related to interconnection, generally; H.R. 7624, Advancing Grid-Enhancing Technologies Act of 2024; H.R. 4476, PURPA Modernization Act of 2017; H.R. 1897, ESA Amendments of 2025; S.1449 RESTART Act; Issues related to HR 1, generally; Issues related to NEPA and permitting reform, generally; Issues related to Yucca Mountain used fuel repository; Issues related to used fuel management; Issues related to consent-based siting generally; Issues related to AP1000 technology generally; Issues related to Accident Tolerant Fuel program; Issues related to advanced nuclear technology; Issues related to DOE Advanced Reactor Development Program, generally; Issues related to small modular reactors (SMRs) in general; Issues related to natural gas stoves; Issues related to DOE energy efficiency standards for electric distribution transformers; DOE new nuclear R&D programs, generally; NRC fee issues, generally; Issues related to NRC nominees in general; Issues related to the NRC decision on Subsequent License Renewal; Issues related to Subsequent License Renewal, generally; Issues related to nuclear uprates, generally; Issues related to nuclear fuels; Issues related to HAELU fuel; Issues related to distribution transformers, generally; The ADVANCE Act, P.L. 118-67; None. Budget reconciliation, generally; Energy R&D funding; Low Income Home Energy Assistance Program (LIHEAP) funding; FY2025 Energy and Water Development and Related Agencies Appropriations bills, generally; Issues related to the Department of Government Efficiency, generally; Climate change issues, generally; Environmental regulation, generally; Clean Water Act, generally; Nationwide Permit Program, generally (Clean Water Act Section 404); NEPA Phase II Proposed Rule and NEPA issues, generally; ESA regulations, generally; Issues related to wildfires, generally; Tax Cuts and Jobs Act issues; generally; Inflation Reduction Act Implementation, generally; None. Drone/UAV issues, generally; None. Middle-mile broadband infrastructure issues, generally; Spectrum issues, generally, including the FCC's 6 GHz spectrum proposal and Cruz-Thune spectrum pipeline bill; Pole attachment issues, generally; None."

You can find more data on corporate lobbying on Quiver Quantitative.

SO Congressional Stock Trading

Members of Congress have traded $SO stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $SO stock by members of Congress over the last 6 months:

• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 2 times. They made 2 purchases worth up to $30,000 on 04/03, 11/07 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

SO Insider Trading Activity

SO insiders have traded $SO stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $SO stock by insiders over the last 6 months:

• CHRISTOPHER C WOMACK (Chairman, President & CEO) has made 0 purchases and 3 sales selling 40,000 shares for an estimated $3,549,692.
• KIMBERLY S, GREENE (Chairman, President & CEO, GPC) sold 32,190 shares for an estimated $2,997,532
• JAMES JEFFREY PEOPLES (Chairman, President & CEO, APC) sold 14,540 shares for an estimated $1,250,440
• STAN W CONNALLY (EVP & COO) sold 12,500 shares for an estimated $1,153,000
• MARTIN BERNARD DAVIS (EVP & CIO) has made 0 purchases and 2 sales selling 2,295 shares for an estimated $201,314.
• STERLING A JR. SPAINHOUR (EVP, Chief Legal Officer & CCO) sold 793 shares for an estimated $70,212
• CHRISTOPHER CUMMISKEY (EVP & CCO) sold 837 shares for an estimated $69,738

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

SO Hedge Fund Activity

We have seen 982 institutional investors add shares of SO stock to their portfolio, and 817 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• MIZUHO SECURITIES USA LLC removed 14,543,154 shares (-99.3%) from their portfolio in Q4 2024, for an estimated $1,197,192,437
• MARSHALL WACE, LLP added 3,307,527 shares (+325.7%) to their portfolio in Q4 2024, for an estimated $272,275,622
• BLACKROCK, INC. added 3,252,999 shares (+4.0%) to their portfolio in Q4 2024, for an estimated $267,786,877
• MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 3,245,816 shares (-12.9%) from their portfolio in Q4 2024, for an estimated $267,195,573
• CAPITAL RESEARCH GLOBAL INVESTORS removed 2,308,980 shares (-97.1%) from their portfolio in Q4 2024, for an estimated $190,075,233
• PRICE T ROWE ASSOCIATES INC /MD/ removed 2,147,937 shares (-11.9%) from their portfolio in Q4 2024, for an estimated $176,818,173
• QUBE RESEARCH & TECHNOLOGIES LTD added 2,137,749 shares (+430.1%) to their portfolio in Q4 2024, for an estimated $175,979,497

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

SO Analyst Ratings

Wall Street analysts have issued reports on $SO in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Morgan Stanley issued a "Outperform" rating on 03/20/2025
• Scotiabank issued a "Outperform" rating on 12/12/2024

To track analyst ratings and price targets for SO, check out Quiver Quantitative's $SO forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,480,000 of OCCIDENTAL PETROLEUM CORPORATION lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Carbon Capture and Storage Enhanced Oil Recovery Energy Infrastructure Financing Zero Carbon Power Vessel crewing and manning Federal lands - oil and gas leasing and permitting Merchant Marine Act (Jones Act) Risk management and financial assurance Incidental Take Regulation Permitting reform Endangered Species Act LCV grants Enhanced Oil Recovery Carbon Capture and Storage - pore space Federal lands - oil and gas leasing and permitting Enhanced Oil Recovery (CO2) 45Q Tax Credit for Sequestered CO2 Superfund Tax Corporate Tax Policy Implementation International Tax Policy Exploration and Production Waste Regulation Permitting reform legislation Reciprocal switching Rail customer service Oil and gas vessel restrictions in the Gulf of America Rice's whale Certificate of compliance Crude export vessels Transportation Security Administration authority for security and efficiency crude oil export terminals Diamond Alkali Superfund site Rail safety Tank car safety Carbon Capture and Storage Greenhouse Gas Reporting CO2 Enhanced Oil Recovery Methane Emissions Regulation Permitting reform NESHAP for the Synthetic Organic Chemical Manufacturing Industry Risk Management & Reporting TSCA Advanced Recycling ARBAN S.4244 Rail safety Tank car safety Reciprocal switching Rail customer service Oil and gas vessel restrictions in the Gulf of America Rice's whale Certificate of compliance Crude export vessels Maritime issues Shipping issues Export terminals Reauthorization of the Chemical Facility Anti-Terrorism Standards (CFATS) Transportation Security Administration authority for security and efficiency crude oil export terminals Antidumping duties Proposed tariffs on imported goods"

You can find more data on corporate lobbying on Quiver Quantitative.

OXY Congressional Stock Trading

Members of Congress have traded $OXY stock 5 times in the past 6 months. Of those trades, 5 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $OXY stock by members of Congress over the last 6 months:

• REPRESENTATIVE ROBERT BRESNAHAN purchased up to $50,000 on 02/25.
• REPRESENTATIVE JEFFERSON SHREVE purchased up to $50,000 on 02/24.
• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 2 times. They made 2 purchases worth up to $30,000 on 01/21, 11/20 and 0 sales.
• REPRESENTATIVE MARIA ELVIRA SALAZAR purchased up to $50,000 on 10/25.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

OXY Insider Trading Activity

OXY insiders have traded $OXY stock on the open market 6 times in the past 6 months. Of those trades, 6 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $OXY stock by insiders over the last 6 months:

• HATHAWAY INC BERKSHIRE has made 6 purchases buying 9,659,907 shares for an estimated $444,877,222 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

OXY Hedge Fund Activity

We have seen 501 institutional investors add shares of OXY stock to their portfolio, and 626 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• EAGLE CAPITAL MANAGEMENT LLC removed 10,722,236 shares (-94.1%) from their portfolio in Q4 2024, for an estimated $529,785,680
• VANGUARD GROUP INC added 10,434,098 shares (+18.1%) to their portfolio in Q4 2024, for an estimated $515,548,782
• BERKSHIRE HATHAWAY INC added 8,896,890 shares (+3.5%) to their portfolio in Q4 2024, for an estimated $439,595,334
• DODGE & COX removed 8,008,546 shares (-10.3%) from their portfolio in Q4 2024, for an estimated $395,702,257
• FMR LLC removed 4,421,415 shares (-51.6%) from their portfolio in Q4 2024, for an estimated $218,462,115
• MORGAN STANLEY added 2,847,704 shares (+25.1%) to their portfolio in Q4 2024, for an estimated $140,705,054
• BANK OF AMERICA CORP /DE/ removed 2,361,651 shares (-32.0%) from their portfolio in Q4 2024, for an estimated $116,689,175

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

OXY Analyst Ratings

Wall Street analysts have issued reports on $OXY in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Morgan Stanley issued a "Overweight" rating on 03/26/2025
• Goldman Sachs issued a "Sell" rating on 02/21/2025
• Wolfe Research issued a "Outperform" rating on 01/03/2025

To track analyst ratings and price targets for OXY, check out Quiver Quantitative's $OXY forecast page.

OXY Price Targets

Multiple analysts have issued price targets for $OXY recently. We have seen 3 analysts offer price targets for $OXY in the last 6 months, with a median target of $54.0.

Here are some recent targets:

• Devin McDermott from Morgan Stanley set a target price of $58.0 on 03/26/2025
• Leo Mariani from Roth Capital set a target price of $54.0 on 01/23/2025
• Ryan Todd from Piper Sandler set a target price of $51.0 on 12/19/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,790,000 of DUKE ENERGY CORPORATION lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H.R. 1968, Full Year Continuing Appropriations and Extensions Act, 2025 H.R. 8997, S 4927, Energy & Water Development and Related Agencies Appropriations from the 118th Congress (specifically advanced nuclear, SMR, grid resiliency, and loan guarantee funding) for inclusion in FY-25 Continuing Resolution or Omnibus Appropriations bills. H.R.9027, S.4690, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025 from the 118th Congress (specifically funding for renewable gas, waste energy programs & U.S. forest service permitting staff) for inclusion in FY-25 Continuing Resolution or Omnibus Appropriations bills. H.R.8998, S. 4802, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2025 from the 118th Congress (specifically funding for national parks, national forests & support for permitting staff at U.S. Fish & Wildlife and BOEM) for inclusion in FY-25 Continuing Resolution or Omnibus Appropriations bills. H.R.8774, S. 4921 - Department of Defense Appropriations Act, 2025 from the 118th Congress (specifically funding for energy programs and base resiliency) for inclusion in FY-25 Continuing Resolution or Omnibus Appropriations bills. H.R. 9029, S. 4942 Departments of Labor, Health and Human Services, and Education, and Related Agencies Act, 2025 from the 118th Congress (specifically funding for LIHEAP) for inclusion in FY-25 Continuing Resolution or Omnibus Appropriations bills. H.R. 8580, S. 4677, Military Construction, Veterans Affairs, and Related Agencies Act, 2025 from the 118th Congress (specifically to support VA hospital, storm hardening and resiliency efforts) for inclusion in FY-25 Continuing Resolution or Omnibus Appropriations bills. H.R. 9028, Transportation, Housing and Urban Development, and Related Agencies Act, 2025 from the 118th Congress (specifically to support pipeline safety funding and permitting) for inclusion in FY-25 Continuing Resolution or Omnibus Appropriations bills. H.R. 8773, S. 4928, Financial Services and General Government Act, 2025 from the 118th Congress (specifically disaster general business credit acceleration) for inclusion in FY-25 Continuing Resolution or Omnibus Appropriations bills. H.R. 8772, S. 4678, Legislative Branch Appropriations Act, 2025 from the 118th Congress (specifically for JTC and Congressional budget office scoring of Federal energy tax policy) for inclusion in FY-25 Continuing Resolution or Omnibus Appropriations bills. H.R. 9026, S. 4795, Commerce, Justice, Science, and Related Agencies Act, 2025 from the 118th Congress (specifically for energy support for federal facilities) for inclusion in FY-25 Continuing Resolution or Omnibus Appropriations bills. Energy R&D funding - advanced nuclear, small modular reactors, domestic nuclear fuel production, and transmission infrastructure; LIHEAP Issues generally; Disaster supplemental funding general - storm recovery Draft legislation on transmission - permitting reform; Artificial intelligence resource adequacy; Load growth; Data center issues; Energy security issues; Resiliency; Transmission and distribution issues; E.O. 14241 Coal Executive Order E.O. 14154 Unleashing American Energy E.O. 14156 Declaring a National Energy Emergency E.O. 14179 Removing Barriers to American Leadership in Artificial Intelligence E.O. 14213 Establishing the National Energy Dominance Council. H.R. 471- the Fix Our Forest Act; Wildfires and other natural disasters; EPA regulations on Clean Air Act Section 111 d and b; Guidance on EPA regulations; Good Neighbor Rule; Coal combustion residuals; Effluent Limitation Guidelines; Draft legislation related to the Federal Permitting Improvement - rights-of-way and siting and permitting; National Environmental Policy Act - categorical exclusions; Clean Water Act; Endangered Species Act; Power demand resource adequacy; Clean Air Act; P.L. 117-169 - Inflation Reduction Act Clean Energy Credits Implementation; Budget reconciliation to be introduced: issues including interest deductibility, 45U, 48E, 48Y, transferability; General business credit carryforwards generally (S. 5457 from 118th and HR 10380 from 118th) Issues related to energy grid supply chain; Cyber and physical security draft legislation; Counter UAS legislation"

You can find more data on corporate lobbying on Quiver Quantitative.

DUK Congressional Stock Trading

Members of Congress have traded $DUK stock 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $DUK stock by members of Congress over the last 6 months:

• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 3 times. They made 3 purchases worth up to $45,000 on 12/24, 11/25, 11/01 and 0 sales.
• REPRESENTATIVE VIRGINIA FOXX purchased up to $15,000 on 12/06.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

DUK Insider Trading Activity

DUK insiders have traded $DUK stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $DUK stock by insiders over the last 6 months:

• ROBERT ALEXANDER GLENN (EVP & CEO DEF & Midwest) has made 0 purchases and 2 sales selling 15,002 shares for an estimated $1,646,245.
• JULIA S JANSON (EVP&CEO, Duke Energy Carolinas) sold 10,000 shares for an estimated $1,160,866
• KODWO GHARTEY-TAGOE (EVP, CLO & Corp Sec) sold 9,007 shares for an estimated $1,054,719
• LOUIS E. RENJEL (EVP, Chief Corporate Affairs) has made 0 purchases and 4 sales selling 5,270 shares for an estimated $587,560.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

DUK Hedge Fund Activity

We have seen 986 institutional investors add shares of DUK stock to their portfolio, and 857 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PATHWAY FINANCIAL ADVISERS, LLC removed 6,719,670 shares (-99.1%) from their portfolio in Q4 2024, for an estimated $723,977,245
• CAPITAL RESEARCH GLOBAL INVESTORS removed 4,617,276 shares (-45.1%) from their portfolio in Q4 2024, for an estimated $497,465,316
• GQG PARTNERS LLC removed 4,336,659 shares (-98.7%) from their portfolio in Q4 2024, for an estimated $467,231,640
• FMR LLC added 4,115,001 shares (+55.7%) to their portfolio in Q4 2024, for an estimated $443,350,207
• BLACKROCK, INC. added 2,096,096 shares (+3.5%) to their portfolio in Q4 2024, for an estimated $225,833,383
• WELLINGTON MANAGEMENT GROUP LLP removed 1,731,160 shares (-9.7%) from their portfolio in Q4 2024, for an estimated $186,515,178
• MILLENNIUM MANAGEMENT LLC added 1,556,155 shares (+2418.2%) to their portfolio in Q4 2024, for an estimated $167,660,139

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

DUK Analyst Ratings

Wall Street analysts have issued reports on $DUK in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Guggenheim issued a "Buy" rating on 03/05/2025

To track analyst ratings and price targets for DUK, check out Quiver Quantitative's $DUK forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,240,000 of ASTRAZENECA PHARMACEUTICALS LP lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H.R.946 - Optimizing Research Progress Hope and New Cures (ORPHAN Cures) Act HR 1262/ S 932, Give Kids A Chance Act Implementation of the Inflation Reduction Act (IRA) -- with specific focus on drug negotiation (orphan drug exemption language) Issues related to Inflation Reduction Act (IRA) consideration of small molecule drugs, biologics, and genetically targeted technologies Issues related to expanding/amending the orphan drug exclusion in IRA Issues related to pharmacy benefit manager (PBM) reform Issues related to e-labeling Issues related to the price and manufacture of inhaled medicines Issues related to the IRAs drug price negotiation program Issues related to drug pricing Issues related to the US manufacturing of pharmaceuticals Issues related to importation of drugs Issues related to FDA Orange Book patent listings Issues related to environmental sustainability Issues related to FDA modernization Policies related to international reference pricing for pharmaceuticals Policies related to 340B rebate model for IRA compliance Policies related to the definition of a qualifying single source drug under the IRA Pediatric rare disease priority review voucher Reauthorization of the pediatric priority review voucher program Company sustainability policy issues General issues related to health equity in rare disease and clinical trials General issues related to vaccine safety, efficacy, and access General issues related to rare disease and orphan drugs General issues related to ACIP recommendations Education to Hill staff on next generation propellant and PFAS FDA modernization policy issues Tariffs/trade policies related to tariffs on pharmaceuticals Definition of Qualified Single Source Drug (QSSD) for purposes of Medicare drug price negotiation E-labeling - allowing FDA to finalize a rule to allow digital versions of prescriptions Medicare patient access to rare disease therapies Centers for Medicare and Medicaid Innovation (CMMI) policy issues Value-based payment arrangements Efforts to improve coding, coverage, and access for rare disease therapies Medicare drug price negotiation Part B and Part D drugs Medicare Part D reform and inflation penalties Medicaid Drug Rebate Program proposed rule Issues related to the digital communication of prescribing information for drugs General issues related to diagnostic reimbursement e-labeling- allowing health care providers to receive prescribing information for drugs electronically rather than in paper form from manufacturers Issues related to PBM reform US manufacturing of pharmaceuticals H.R.591 - Defending American Jobs and Investment Act HR 1414 - Cameron's Law, to restore orphan drug research tax credit H.R.1990 - American Innovation and R&D Competitiveness Act of 2025 H.R.4695 - Unfair Tax Prevention Act Expiring provisions of the Tax Cut and Jobs Act law Tax reform in budget reconciliation Trade and tariffs (general education, country-specific tariffs, sector-specific tariffs) pharmaceutical manufacturing (general education) Issues related to tariffs Issues related to the deduction of research and development expenditures Education on tax in preparation for 2025 tax legislation Issues related to IP and patents Issues related to FDA Orange Book patent listings"

You can find more data on corporate lobbying on Quiver Quantitative.

AZN Congressional Stock Trading

Members of Congress have traded $AZN stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $AZN stock by members of Congress over the last 6 months:

• REPRESENTATIVE BRUCE WESTERMAN purchased up to $15,000 on 03/03.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

AZN Hedge Fund Activity

We have seen 546 institutional investors add shares of AZN stock to their portfolio, and 567 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BANK OF AMERICA CORP /DE/ added 15,722,197 shares (+189.3%) to their portfolio in Q4 2024, for an estimated $1,030,118,347
• CAPITAL WORLD INVESTORS removed 6,111,652 shares (-97.7%) from their portfolio in Q4 2024, for an estimated $400,435,439
• MORGAN STANLEY added 4,476,178 shares (+34.9%) to their portfolio in Q4 2024, for an estimated $293,279,182
• HOLOCENE ADVISORS, LP added 4,300,401 shares (+inf%) to their portfolio in Q4 2024, for an estimated $281,762,273
• MARSHALL WACE, LLP added 3,876,961 shares (+inf%) to their portfolio in Q4 2024, for an estimated $254,018,484
• CITADEL ADVISORS LLC added 3,774,365 shares (+841.6%) to their portfolio in Q4 2024, for an estimated $247,296,394
• BOSTON PARTNERS added 3,670,719 shares (+9985.6%) to their portfolio in Q4 2024, for an estimated $240,505,508

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AZN Analyst Ratings

Wall Street analysts have issued reports on $AZN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• BMO Capital issued a "Outperform" rating on 11/13/2024

To track analyst ratings and price targets for AZN, check out Quiver Quantitative's $AZN forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,040,000 of INTERNATIONAL BUSINESS MACHINES CORPORATION (IBM) lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Legislative & Regulatory Issues Related to Budget & Appropriations Matters: FY2026 appropriations provisions relating to technology modernization, quantum computing, the U.S. Artificial Intelligence Safety Institute, and the National Artificial Intelligence Research Resource. Legislative & Regulatory Issues Related to Technology Policy, including R&D, Cybersecurity, Privacy, Health IT & Technology Procurement: Artificial Intelligence (AI), general purpose AI and foundation models, open source AI, AI regulatory guidance, AI security, AI bias, AI and the workforce, AI use and implementation by federal agencies; cloud computing, secure cloud policy; encryption policy, post quantum cryptography; quantum computing; national data privacy standards; federal agency IT modernization; National Quantum Initiative Reauthorization Act; S. 579, Department of Energy Quantum Leadership Act of 2024; implementation of Public Law no. 115-368, the National Quantum Initiative Act; implementation and issues related to Public Law no. 117-167, CHIPS and Science Act; National AI Research Resource Task Force; NIST AI Risk Management Framework; Interim Final Rule on Framework for Artificial Intelligence Diffusion. Legislative & Regulatory Issues Related to Education, Workforce Training & Related Matters: Modernizing apprenticeships; creating multiple career pathways; advancing skills-based hiring including federal contracts; increasing federal support for Historically Black Colleges & Universities (HBCUs); cybersecurity workforce/skills development policy; quantum computing workforce/skills development policy; artificial intelligence and the future of work; S. 383, Jumpstart Our Businesses By Supporting Students Act. Legislative & Regulatory Issues Related to Labor, Workplace & Benefits Policy: Paid family and medical leave. Antitrust policy; 2023 merger guidelines; Final Rule on Premerger Notification, Reporting and Waiting Period Requirements. Legislative & Regulatory Issues Related to Domestic and International Tax, including Tax Treaties: Tax proposals related to Global Intangible Low-Taxed Income, or GILTI Minimum Tax, and proposed Section 163(n) on interest deductibility; H.Con.Res. 14, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. 559, American Interest in Manufacturing and Main Street Act; H.R. 7024, Tax Relief for American Families and Workers Act of 2024; America First Trade Policy Executive Order; OECD Global Tax Deal Executive Order; Public Law no. 117-169, Inflation Reduction Act, implementation and regulations. Global Digital Taxes, e.g. DSTs; U.S. Treasury guidelines and related regulations on OECD, Addressing Tax Challenges of Digitalization, and BEPS 2.0. T.D. 9959, Final Regulations on foreign tax credits; REG-120653-22, CHIPS Act advanced manufacturing tax credit; Notice 2023-63 and Notice 2024-12 on application of Section 174 on R&D expenses. H.R. 33, U.S.-Taiwan Expedited Double Tax Relief Act. Legislative & Regulatory Issues Related to International Trade Including Multilateral & Bilateral Trade Agreements: Provisions related to tariffs, cross-border data transfers, digital trade, and new trade agreements. Legislative & Regulatory Issues Related to Government Issues: Federal government adoption of AI. Legislative & Regulatory Issues Related to copyright/patent/trademark: Artificial intelligence and intellectual property; H.R. 2794, S. 1367, NO FAKES Act."

You can find more data on corporate lobbying on Quiver Quantitative.

IBM Congressional Stock Trading

Members of Congress have traded $IBM stock 6 times in the past 6 months. Of those trades, 6 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $IBM stock by members of Congress over the last 6 months:

• REPRESENTATIVE DWIGHT EVANS purchased up to $15,000 on 04/03.
• REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 2 purchases worth up to $30,000 on 03/11, 03/10 and 0 sales.
• REPRESENTATIVE LLOYD DOGGETT has traded it 2 times. They made 2 purchases worth up to $30,000 on 03/10, 12/10 and 0 sales.
• REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 03/10.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

IBM Insider Trading Activity

IBM insiders have traded $IBM stock on the open market 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $IBM stock by insiders over the last 6 months:

• ROBERT DAVID THOMAS (Senior Vice President) sold 26,543 shares for an estimated $6,715,639
• NICKLE JACLYN LAMOREAUX (Senior Vice President) sold 3,600 shares for an estimated $774,727
• ALFRED W ZOLLAR purchased 936 shares for an estimated $197,138

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

IBM Hedge Fund Activity

We have seen 1,310 institutional investors add shares of IBM stock to their portfolio, and 1,298 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL WORLD INVESTORS added 9,650,534 shares (+413.5%) to their portfolio in Q4 2024, for an estimated $2,121,476,889
• HOLOCENE ADVISORS, LP removed 2,593,208 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $570,064,914
• LEGAL & GENERAL GROUP PLC removed 2,235,612 shares (-24.7%) from their portfolio in Q4 2024, for an estimated $491,454,585
• NORTHERN TRUST CORP added 1,704,209 shares (+18.6%) to their portfolio in Q4 2024, for an estimated $374,636,264
• BARCLAYS PLC removed 1,587,342 shares (-34.5%) from their portfolio in Q4 2024, for an estimated $348,945,391
• VANGUARD GROUP INC added 1,539,888 shares (+1.7%) to their portfolio in Q4 2024, for an estimated $338,513,579
• AMERIPRISE FINANCIAL INC removed 1,501,333 shares (-21.6%) from their portfolio in Q4 2024, for an estimated $330,038,033

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

IBM Analyst Ratings

Wall Street analysts have issued reports on $IBM in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Goldman Sachs issued a "Buy" rating on 02/05/2025
• UBS issued a "Sell" rating on 01/14/2025
• Evercore ISI issued a "Outperform" rating on 12/03/2024
• Bank of America Securities issued a "Buy" rating on 10/24/2024

To track analyst ratings and price targets for IBM, check out Quiver Quantitative's $IBM forecast page.

IBM Price Targets

Multiple analysts have issued price targets for $IBM recently. We have seen 5 analysts offer price targets for $IBM in the last 6 months, with a median target of $250.0.

Here are some recent targets:

• Matthew Swanson from RBC Capital set a target price of $250.0 on 10/24/2024
• Keith Bachman from Loop Capital Markets set a target price of $260.0 on 10/24/2024
• Wamsi Mohan from Bank of America Securities set a target price of $250.0 on 10/24/2024
• Keith Bachman from BMO Capital set a target price of $260.0 on 10/24/2024
• James Schneider from Goldman Sachs set a target price of $250.0 on 10/24/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,170,000 of HOME DEPOT lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Monitored draft legislation related to credit card security and competition; monitored draft legislation related to online marketplace payments. Monitored draft legislation and appropriations related to organized retail crime. S. 852/H.R. 20 Richard L. Trumka Protecting the Right to Organize Act of 2025, provisions regarding right-to-work, privacy, and eliminating private ballot elections; H.R. 6655 Stronger Workforce for America Act; H.R. 6585 Bipartisan Workforce Pell Act Monitored the application of tariff-related measures, including: Section 301 tariffs; Section 232 steel and aluminum tariffs; Reciprocal tariffs; IEEPA tariffs; maritime vessels. Exclusions for impacted products and tariffs on imports under applicable categories. Implementation of P.L. 117-167, the Inflation Reduction Act of 2022, related to the High-Efficiency Electric Home Rebate Program; Monitor activity related to House and Senate Tax Teams. Monitored draft legislation on the budget resolution related to tax policy. Monitored issues related to port congestion; Issues related to global supply chain security. Monitored international trade issues, the Administrations trade agenda and related draft legislation; Generalized System of Preferences; de minimis Issues related to skilled trade careers for veterans. S. 127 Whole-Home Repairs Act of 2025; monitored housing matters related to zoning, permitting, and supply"

You can find more data on corporate lobbying on Quiver Quantitative.

HD Congressional Stock Trading

Members of Congress have traded $HD stock 15 times in the past 6 months. Of those trades, 12 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $HD stock by members of Congress over the last 6 months:

• REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 2 purchases worth up to $100,000 on 03/31, 02/24 and 0 sales.
• REPRESENTATIVE LLOYD DOGGETT has traded it 2 times. They made 2 purchases worth up to $30,000 on 03/27, 12/12 and 0 sales.
• REPRESENTATIVE GREG LANDSMAN sold up to $15,000 on 03/27.
• REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 03/19, 02/24.
• REPRESENTATIVE BRUCE WESTERMAN purchased up to $15,000 on 03/03.
• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 3 times. They made 3 purchases worth up to $45,000 on 01/08, 11/25, 10/21 and 0 sales.
• REPRESENTATIVE JAMES COMER has traded it 2 times. They made 2 purchases worth up to $30,000 on 01/02 and 0 sales.
• REPRESENTATIVE KEVIN HERN purchased up to $15,000 on 12/12.
• REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 11/08.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

HD Insider Trading Activity

HD insiders have traded $HD stock on the open market 13 times in the past 6 months. Of those trades, 2 have been purchases and 11 have been sales.

Here’s a breakdown of recent trading of $HD stock by insiders over the last 6 months:

• ANN MARIE CAMPBELL (Senior EVP) has made 0 purchases and 3 sales selling 30,068 shares for an estimated $12,279,334.
• TERESA WYNN ROSEBOROUGH (EVP, Gen. Counsel & Corp. Sec.) has made 0 purchases and 3 sales selling 22,084 shares for an estimated $9,030,416.
• TIMOTHY A. HOURIGAN (EVP - Human Resources) sold 16,004 shares for an estimated $6,553,958
• RICHARD V MCPHAIL (EVP & CFO) sold 6,500 shares for an estimated $2,654,925
• HECTOR A PADILLA (EVP - US Sales and Operations) has made 0 purchases and 2 sales selling 3,626 shares for an estimated $1,482,904.
• WILLIAM D BASTEK (EVP, Merchandising) sold 2,969 shares for an estimated $1,236,915
• GREGORY D BRENNEMAN has made 2 purchases buying 2,884 shares for an estimated $999,767 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

HD Hedge Fund Activity

We have seen 1,678 institutional investors add shares of HD stock to their portfolio, and 1,670 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL WORLD INVESTORS removed 4,148,985 shares (-17.4%) from their portfolio in Q4 2024, for an estimated $1,613,913,675
• BLACKROCK, INC. added 3,478,356 shares (+5.0%) to their portfolio in Q4 2024, for an estimated $1,353,045,700
• LEGAL & GENERAL GROUP PLC removed 2,209,041 shares (-26.6%) from their portfolio in Q4 2024, for an estimated $859,294,858
• PROFICIO CAPITAL PARTNERS LLC added 2,030,372 shares (+21394.9%) to their portfolio in Q4 2024, for an estimated $789,794,404
• WELLINGTON MANAGEMENT GROUP LLP removed 1,594,980 shares (-18.9%) from their portfolio in Q4 2024, for an estimated $620,431,270
• NORTHERN TRUST CORP added 1,424,857 shares (+13.3%) to their portfolio in Q4 2024, for an estimated $554,255,124
• CASTLEKEEP INVESTMENT ADVISORS LLC added 1,207,993 shares (+36363.4%) to their portfolio in Q4 2024, for an estimated $469,897,197

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

HD Analyst Ratings

Wall Street analysts have issued reports on $HD in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Evercore ISI issued a "Outperform" rating on 11/13/2024
• Loop Capital Markets issued a "Buy" rating on 11/13/2024

To track analyst ratings and price targets for HD, check out Quiver Quantitative's $HD forecast page.

HD Price Targets

Multiple analysts have issued price targets for $HD recently. We have seen 6 analysts offer price targets for $HD in the last 6 months, with a median target of $447.5.

Here are some recent targets:

• Zhihan Ma from Bernstein set a target price of $421.0 on 01/07/2025
• Greg Melich from Evercore ISI set a target price of $430.0 on 11/13/2024
• Laura Champine from Loop Capital Markets set a target price of $465.0 on 11/13/2024
• David Bellinger from Mizuho Securities set a target price of $440.0 on 11/13/2024
• Scot Ciccarelli from Truist Financial set a target price of $465.0 on 11/12/2024
• Joseph Feldman from Telsey Advisory set a target price of $455.0 on 11/08/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,303,000 of BECTON DICKINSON AND COMPANY lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to corporate taxation Tax incentives for domestic manufacturing Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization Issues related to medical device supply chain"

You can find more data on corporate lobbying on Quiver Quantitative.

BDX Congressional Stock Trading

Members of Congress have traded $BDX stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $BDX stock by members of Congress over the last 6 months:

• REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 03/05.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

BDX Insider Trading Activity

BDX insiders have traded $BDX stock on the open market 14 times in the past 6 months. Of those trades, 1 have been purchases and 13 have been sales.

Here’s a breakdown of recent trading of $BDX stock by insiders over the last 6 months:

• ROLAND GOETTE (EVP and President, EMEA) has made 0 purchases and 2 sales selling 5,121 shares for an estimated $1,130,528.
• MICHAEL DAVID GARRISON (EVP & President, Medical) has made 0 purchases and 3 sales selling 3,914 shares for an estimated $869,504.
• SHANA CAROL NEAL (EVP and Chief People Officer) has made 0 purchases and 3 sales selling 2,575 shares for an estimated $594,550.
• RICHARD BYRD (EVP & President Interventional) has made 0 purchases and 2 sales selling 2,399 shares for an estimated $541,895.
• DAVID SHAN (EVP and Chief ISC Officer) has made 0 purchases and 2 sales selling 2,000 shares for an estimated $450,375.
• JEFFREY WILLIAM HENDERSON purchased 1,500 shares for an estimated $350,430
• BERTRAM L SCOTT sold 700 shares for an estimated $159,593

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

BDX Hedge Fund Activity

We have seen 664 institutional investors add shares of BDX stock to their portfolio, and 747 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 3,219,317 shares (+36.1%) to their portfolio in Q4 2024, for an estimated $730,366,447
• KOVITZ INVESTMENT GROUP PARTNERS, LLC added 2,722,829 shares (+392.4%) to their portfolio in Q4 2024, for an estimated $617,728,215
• BLACKROCK, INC. added 1,711,450 shares (+7.7%) to their portfolio in Q4 2024, for an estimated $388,276,661
• CITADEL ADVISORS LLC added 1,398,984 shares (+376.2%) to their portfolio in Q4 2024, for an estimated $317,387,500
• BANK OF NEW YORK MELLON CORP removed 1,308,118 shares (-28.6%) from their portfolio in Q4 2024, for an estimated $296,772,730
• PRICE T ROWE ASSOCIATES INC /MD/ removed 1,251,742 shares (-9.2%) from their portfolio in Q4 2024, for an estimated $283,982,707
• BANK OF AMERICA CORP /DE/ added 1,098,633 shares (+77.8%) to their portfolio in Q4 2024, for an estimated $249,246,868

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

BDX Analyst Ratings

Wall Street analysts have issued reports on $BDX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• UBS issued a "Buy" rating on 12/18/2024

To track analyst ratings and price targets for BDX, check out Quiver Quantitative's $BDX forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$4,240,000 of PFIZER INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H. Con. Res. 14 - Establishing the congressional budget for the US Government for FY 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034 Budget Reconciliation S 526 - Pharmacy Benefit Manager Transparency Act of 2025 S 527 - Prescription Pricing for the People Act of 2025 S 832 - EPIC Act of 2025 S 864 - HELP Copays Act S 882 - Patients Before Middlemen Act S 1040 - Drug Competition Enhancement Act HR 946 - ORPHAN Cures Act HR 1492 - EPIC Act Biosimilars Access & Reimbursement 340B Reform 340B Access Act Inflation Reduction Act (IRA) Biosimilar Pause Inflation Reduction Act (IRA) Pill Penalty Vaccine Coverage Intellectual Property Protections PBM Reform Lower Cost More Transparency Act Bayh-Dole Act March-In Rights Cancer Policies Drug Pricing/Foreign Reference Pricing Digital Therapeutics Access & Reimbursement Patient Out of Pocket Costs S 526 - Pharmacy Benefit Manager Transparency Act of 2025 S 527 - Prescription Pricing for the People Act of 2025 S 832 - Epic Act of 2025 S 864 - HELP Copays Act S 882 - Patients Before Middlemen Act HR 946 - ORPHAN Cures Act PBM Reform Medicaid Prescription Drug Access H. Con. Res. 14 - Establishing the congressional budget for the US Government for FY 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034 VICP Reform and Excise Tax Tax Cuts and Jobs Act (TCJA) Comprehensive Corporate Tax Reform HR 2213 - Authorize the President to Enter Into Trade Agreements for the Reciprocal Elimination of Duties or Other Import Restrictions with Respect to Medical Goods Medical Supply Chain Resiliency Act International Supply Chain Tariffs Non-Tariff Trade Barriers"

You can find more data on corporate lobbying on Quiver Quantitative.

PFE Congressional Stock Trading

Members of Congress have traded $PFE stock 11 times in the past 6 months. Of those trades, 5 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $PFE stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 1 purchase worth up to $15,000 on 02/26 and 2 sales worth up to $65,000 on 03/31, 01/24.
• REPRESENTATIVE CAROL D. MILLER sold up to $15,000 on 03/10.
• REPRESENTATIVE BRUCE WESTERMAN purchased up to $15,000 on 03/03.
• REPRESENTATIVE ROBERT BRESNAHAN purchased up to $50,000 on 02/25.
• REPRESENTATIVE JEFFERSON SHREVE purchased up to $50,000 on 02/24.
• SENATOR JOHN BOOZMAN sold up to $15,000 on 02/13.
• REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 02/12, 01/15.
• REPRESENTATIVE LAUREL M. LEE purchased up to $50,000 on 10/21.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

PFE Insider Trading Activity

PFE insiders have traded $PFE stock on the open market 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $PFE stock by insiders over the last 6 months:

• RONALD E BLAYLOCK purchased 19,457 shares for an estimated $499,072
• JENNIFER B. DAMICO (SVP & Controller) sold 2,500 shares for an estimated $64,825
• SCOTT GOTTLIEB purchased 1,000 shares for an estimated $28,240

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

PFE Hedge Fund Activity

We have seen 1,107 institutional investors add shares of PFE stock to their portfolio, and 1,637 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 25,315,159 shares (+19.5%) to their portfolio in Q4 2024, for an estimated $671,611,168
• WELLINGTON MANAGEMENT GROUP LLP removed 23,736,431 shares (-14.5%) from their portfolio in Q4 2024, for an estimated $629,727,514
• BLACKROCK, INC. added 15,738,757 shares (+3.6%) to their portfolio in Q4 2024, for an estimated $417,549,223
• STARBOARD VALUE LP added 15,368,658 shares (+inf%) to their portfolio in Q4 2024, for an estimated $407,730,496
• MILLENNIUM MANAGEMENT LLC removed 12,434,525 shares (-80.4%) from their portfolio in Q4 2024, for an estimated $329,887,948
• AMUNDI removed 10,800,352 shares (-22.9%) from their portfolio in Q4 2024, for an estimated $286,533,338
• BARCLAYS PLC removed 10,203,305 shares (-37.7%) from their portfolio in Q4 2024, for an estimated $270,693,681

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

PFE Analyst Ratings

Wall Street analysts have issued reports on $PFE in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Goldman Sachs issued a "Buy" rating on 10/30/2024

To track analyst ratings and price targets for PFE, check out Quiver Quantitative's $PFE forecast page.

PFE Price Targets

Multiple analysts have issued price targets for $PFE recently. We have seen 2 analysts offer price targets for $PFE in the last 6 months, with a median target of $32.5.

Here are some recent targets:

• Robyn Karnauskas from Truist Financial set a target price of $32.0 on 12/18/2024
• Chris Shibutani from Goldman Sachs set a target price of $33.0 on 10/30/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,220,000 of MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Equitable Community Access to Pharmacist Services Act; Clinical trial diversity, health equity; Emergency preparedness and response. PAHPA Reauthorization; Healthcare innovation, ARPA-H, oncology research; Community Health Center Reauthorization; Benefit cost and transparency, real time benefit tools and patient APIs - S. 1339; Controlled Substance Reporting; Pharmaceutical Manufacturing and Supply Chain Shortage; Alleviating Drug Shortages; Telehealth Modernization Act of 2024; H.R.4011 Timely Access to Cancer Treatment Act; H.R.2630, S.652 The Safe Step Act; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3561, PATIENT Act; H.R. 4473, Medicare Patient Access to Cancer Treatment Act; HR 2484 Seniors Access to Critical Medications Act. Equitable Community Access to Pharmacist Services Act; Healthcare innovation and oncology research; H.R.3173, S.3018 The Improving Seniors Timely Access to Care Act; Medically integrated physician dispensing regulations; HR 2484 Seniors Access to Critical Medications Act Equitable Community Access to Pharmacist Services Act; H.R. 4011 Timely Access to Cancer Treatment; Medically integrated physician dispensing regulations; S.127, PBM Transparency Act; Drug price transparency and cost savings opportunities. Last-in, first-out (LIFO) Inventory Accounting Method; H.R.5376 The Inflation Reduction Act H.R.5376 The Inflation Reduction Act"

You can find more data on corporate lobbying on Quiver Quantitative.

MCK Congressional Stock Trading

Members of Congress have traded $MCK stock 4 times in the past 6 months. Of those trades, 3 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $MCK stock by members of Congress over the last 6 months:

• REPRESENTATIVE JONATHAN L. JACKSON purchased up to $15,000 on 03/04.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 01/24.
• REPRESENTATIVE JARED MOSKOWITZ has traded it 2 times. They made 2 purchases worth up to $30,000 on 01/15 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

MCK Insider Trading Activity

MCK insiders have traded $MCK stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $MCK stock by insiders over the last 6 months:

• BRIAN S. TYLER (Chief Executive Officer) has made 0 purchases and 4 sales selling 35,845 shares for an estimated $22,016,825.
• LEANN B SMITH (EVP & Chief HR Officer) has made 0 purchases and 3 sales selling 1,346 shares for an estimated $795,275.
• MICHELE LAU (EVP and Chief Legal Officer) sold 312 shares for an estimated $188,760

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MCK Hedge Fund Activity

We have seen 696 institutional investors add shares of MCK stock to their portfolio, and 727 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BLACKROCK, INC. removed 685,005 shares (-6.2%) from their portfolio in Q4 2024, for an estimated $390,391,199
• FARALLON CAPITAL MANAGEMENT LLC added 610,700 shares (+inf%) to their portfolio in Q4 2024, for an estimated $348,044,037
• APPLIED FINANCE CAPITAL MANAGEMENT, LLC removed 576,268 shares (-91.2%) from their portfolio in Q4 2024, for an estimated $328,420,895
• MANUFACTURERS LIFE INSURANCE COMPANY, THE removed 565,132 shares (-47.5%) from their portfolio in Q4 2024, for an estimated $322,074,378
• FRANKLIN RESOURCES INC removed 432,901 shares (-14.2%) from their portfolio in Q4 2024, for an estimated $246,714,608
• FMR LLC removed 423,400 shares (-14.3%) from their portfolio in Q4 2024, for an estimated $241,299,894
• JPMORGAN CHASE & CO added 384,205 shares (+9.7%) to their portfolio in Q4 2024, for an estimated $218,962,271

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MCK Analyst Ratings

Wall Street analysts have issued reports on $MCK in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Jefferies issued a "Buy" rating on 11/19/2024

To track analyst ratings and price targets for MCK, check out Quiver Quantitative's $MCK forecast page.

MCK Price Targets

Multiple analysts have issued price targets for $MCK recently. We have seen 2 analysts offer price targets for $MCK in the last 6 months, with a median target of $701.5.

Here are some recent targets:

• Rob Dickerson from Jefferies set a target price of $715.0 on 11/19/2024
• Eric Coldwell from Robert W. Baird set a target price of $688.0 on 11/07/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,499,800 of CATERPILLAR INC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"General discussions and briefings on ocean shipping, port operations, and logistical environment (no bill number). Discussions regarding automotive right to repair efforts (H.R.1566 - Right to Equitable and Professional Auto Industry Repair Act; entire bill) Discussions re: implementation of the Infrastructure Investment and Jobs Act (issues related to surface transportation funding and infrastructure investments; PL: 117-58). General discussions about Highway Trust Fund and surface transportation reauthorization (no specific bill). Discussions regarding workforce challenges in the manufacturing and construction industries (HR1151, Freedom to Invest in Tomorrow's Workforce Act) (entire bill). General discussions regarding ongoing industry issue of product theft from shipping containers on railroads (no specific bill). General discussions related to U.S. trade policy, market access issues and digital trade policy (no bill number). Discussions regarding extension of the Investment Tax Credit for combined heat and power system property (Sec 48 ITC) and implementation of tax credits related to combined heat and power systems and waste heat recovery, including qualifying combined heat and power systems under the section 45Y and 48E tax credits. (Section 13001; P.L. 117-169) General discussions around energy tax credits (no bill number). Issues related to interest deductibility (No bill number). General discussions related to corporate and international tax issues and OECD negotiations on the taxation of global income including IRC 11, 951A, 250 on the taxation of domestic and global income. (No bill number) Issues related to bonus depreciation (no bill number) Issues related to IRC 174 and full expensing of R&E expenditures (HR 1990 - American Innovation and R&D Competitiveness Act of 2025 (entire bill)) Issues related to the deductibility of state and local taxes and IRC 164(a) (no bill number) General discussions around permitting reform (no bill number). General discussions around oil and gas leasing (no bill number). Research and development for gas turbine technology; Funding for DOE programs related to gas turbine technology (no bill number)."

You can find more data on corporate lobbying on Quiver Quantitative.

CAT Congressional Stock Trading

Members of Congress have traded $CAT stock 11 times in the past 6 months. Of those trades, 8 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $CAT stock by members of Congress over the last 6 months:

• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 7 times. They made 7 purchases worth up to $105,000 on 04/04, 03/17, 01/08, 12/24, 10/21 and 0 sales.
• REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 0 purchases and 2 sales worth up to $150,000 on 03/13, 02/24.
• REPRESENTATIVE BRUCE WESTERMAN purchased up to $15,000 on 03/03.
• REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 02/25.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

CAT Insider Trading Activity

CAT insiders have traded $CAT stock on the open market 17 times in the past 6 months. Of those trades, 2 have been purchases and 15 have been sales.

Here’s a breakdown of recent trading of $CAT stock by insiders over the last 6 months:

• ANDREW R J BONFIELD (Chief Financial Officer) has made 0 purchases and 5 sales selling 20,000 shares for an estimated $7,854,459.
• LANGE BOB DE (Group President) has made 0 purchases and 3 sales selling 12,657 shares for an estimated $5,192,561.
• ANTHONY D. FASSINO (Group President) has made 0 purchases and 2 sales selling 11,788 shares for an estimated $4,823,345.
• CHERYL H JOHNSON (Chief Human Resources Officer) sold 2,664 shares for an estimated $1,009,229
• JASON KAISER (Group President) sold 2,425 shares for an estimated $860,147
• DANIEL M DICKINSON sold 1,300 shares for an estimated $543,400
• WILLIAM E SCHAUPP (Chief Accounting Officer) sold 968 shares for an estimated $368,788
• GERALD JOHNSON has made 2 purchases buying 200 shares for an estimated $76,414 and 0 sales.
• SUSAN C SCHWAB sold 2 shares for an estimated $766

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CAT Hedge Fund Activity

We have seen 1,188 institutional investors add shares of CAT stock to their portfolio, and 1,245 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CITIGROUP INC removed 1,946,599 shares (-73.6%) from their portfolio in Q4 2024, for an estimated $706,148,253
• BANK OF AMERICA CORP /DE/ removed 1,228,570 shares (-20.6%) from their portfolio in Q4 2024, for an estimated $445,676,053
• CAPITAL RESEARCH GLOBAL INVESTORS added 1,196,861 shares (+69.3%) to their portfolio in Q4 2024, for an estimated $434,173,296
• CAPITAL WORLD INVESTORS removed 1,086,756 shares (-6.2%) from their portfolio in Q4 2024, for an estimated $394,231,606
• LEGAL & GENERAL GROUP PLC removed 900,218 shares (-25.8%) from their portfolio in Q4 2024, for an estimated $326,563,081
• D. E. SHAW & CO., INC. removed 892,910 shares (-65.7%) from their portfolio in Q4 2024, for an estimated $323,912,031
• PROFICIO CAPITAL PARTNERS LLC added 803,166 shares (+50072.7%) to their portfolio in Q4 2024, for an estimated $291,356,498

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CAT Analyst Ratings

Wall Street analysts have issued reports on $CAT in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Raymond James issued a "Outperform" rating on 02/03/2025
• Wedbush issued a "Outperform" rating on 02/03/2025
• Morgan Stanley issued a "Underweight" rating on 01/31/2025
• Citigroup issued a "Buy" rating on 01/31/2025

To track analyst ratings and price targets for CAT, check out Quiver Quantitative's $CAT forecast page.

CAT Price Targets

Multiple analysts have issued price targets for $CAT recently. We have seen 3 analysts offer price targets for $CAT in the last 6 months, with a median target of $365.0.

Here are some recent targets:

• Angel Castillo from Morgan Stanley set a target price of $283.0 on 04/16/2025
• David Raso from Evercore ISI set a target price of $365.0 on 01/13/2025
• Jamie Cook from Truist Financial set a target price of $471.0 on 12/19/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,360,000 of CORTEVA AGRISCIENCE LLC (FKA E I DU PONT DE NEMOURS AND COMPANY) lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Implementation and oversight of the Agriculture Marketing Act of 1946 to require the Secretary of Proposed update to plant incorporated protectant rule and proposed update to guidance clarifying the regulatory approach for food from plantsdeveloped with the newest tools of genome editing. 7CFR Part 340 Pesticide Matters Seed Matters Climate change matters 2024 Farm Bill Endangered Species Act and Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) Biostimulant regulatory matters Pesticide matters Farm Bill 2024 Endangered Species Act and Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) Pesticide matters Climate change matters Trade Intellectual property rights and protection Agriculture trade Trade and international relations Tariff matters Seed trade matters Issues related to Mexico's regulation of agricultural biotechnology and pesticides Corporate taxation matters Taxation matters impacting US farmers 2025 NDAA Intellectual property rights and protection Technology access"

You can find more data on corporate lobbying on Quiver Quantitative.

CTVA Congressional Stock Trading

Members of Congress have traded $CTVA stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $CTVA stock by members of Congress over the last 6 months:

• SENATOR TOMMY TUBERVILLE sold up to $15,000 on 10/29.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

CTVA Insider Trading Activity

CTVA insiders have traded $CTVA stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $CTVA stock by insiders over the last 6 months:

• CHARLES V. MAGRO (Chief Executive Officer) sold 46,905 shares for an estimated $2,993,477
• CORNEL B FUERER (SVP, Gen Counsel and Secretary) sold 37,672 shares for an estimated $2,388,367
• BRIAN TITUS (See Remarks) sold 26,560 shares for an estimated $1,692,934

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CTVA Hedge Fund Activity

We have seen 533 institutional investors add shares of CTVA stock to their portfolio, and 518 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL WORLD INVESTORS added 12,381,436 shares (+2874.6%) to their portfolio in Q4 2024, for an estimated $705,246,594
• INDEPENDENT FRANCHISE PARTNERS LLP added 5,604,838 shares (+51.5%) to their portfolio in Q4 2024, for an estimated $319,251,572
• NUVEEN ASSET MANAGEMENT, LLC removed 3,466,156 shares (-24.6%) from their portfolio in Q4 2024, for an estimated $197,432,245
• GLENVIEW CAPITAL MANAGEMENT, LLC removed 3,187,473 shares (-60.8%) from their portfolio in Q4 2024, for an estimated $181,558,462
• VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. removed 2,731,022 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $171,863,214
• BOSTON PARTNERS removed 2,447,663 shares (-72.3%) from their portfolio in Q4 2024, for an estimated $139,418,884
• DUPONT CAPITAL MANAGEMENT CORP removed 1,949,165 shares (-45.8%) from their portfolio in Q4 2024, for an estimated $111,024,438

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CTVA Analyst Ratings

Wall Street analysts have issued reports on $CTVA in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• KeyBanc issued a "Overweight" rating on 04/14/2025
• RBC Capital issued a "Outperform" rating on 12/19/2024

To track analyst ratings and price targets for CTVA, check out Quiver Quantitative's $CTVA forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,160,000 of COINBASE INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Matters affecting digital currency Matters affecting Securities and Exchange Commission budget request/appropriations Regulatory matters impacting digital currency Matters affecting digital asset regulation Matters affecting Broker DeFi CRA, Stablecoins and market structure legislation"

You can find more data on corporate lobbying on Quiver Quantitative.

COIN Congressional Stock Trading

Members of Congress have traded $COIN stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $COIN stock by members of Congress over the last 6 months:

• REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 03/31.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

COIN Insider Trading Activity

COIN insiders have traded $COIN stock on the open market 359 times in the past 6 months. Of those trades, 0 have been purchases and 359 have been sales.

Here’s a breakdown of recent trading of $COIN stock by insiders over the last 6 months:

• BRIAN ARMSTRONG (Chairman and CEO) has made 0 purchases and 93 sales selling 1,605,000 shares for an estimated $479,009,611.
• EMILIE CHOI (President & COO) has made 0 purchases and 35 sales selling 360,480 shares for an estimated $113,813,199.
• FREDERICK ERNEST III EHRSAM has made 0 purchases and 38 sales selling 177,724 shares for an estimated $53,901,980.
• LAWRENCE J BROCK (Chief People Officer) has made 0 purchases and 40 sales selling 59,624 shares for an estimated $18,666,841.
• FREDERICK R WILSON has made 0 purchases and 15 sales selling 50,000 shares for an estimated $14,548,948.
• ALESIA J HAAS (Chief Financial Officer) has made 0 purchases and 42 sales selling 51,626 shares for an estimated $14,167,833.
• PAUL GREWAL (Chief Legal Officer) has made 0 purchases and 77 sales selling 49,988 shares for an estimated $13,446,337.
• JENNIFER N. JONES (Chief Accounting Officer) has made 0 purchases and 19 sales selling 17,323 shares for an estimated $5,497,007.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

COIN Hedge Fund Activity

We have seen 549 institutional investors add shares of COIN stock to their portfolio, and 365 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JANE STREET GROUP, LLC added 3,470,318 shares (+112.1%) to their portfolio in Q4 2024, for an estimated $861,679,959
• A16Z PERENNIAL MANAGEMENT, L.P. added 1,640,962 shares (+inf%) to their portfolio in Q4 2024, for an estimated $407,450,864
• TORONTO DOMINION BANK added 1,407,476 shares (+4604.6%) to their portfolio in Q4 2024, for an estimated $349,476,290
• SOZO VENTURES GP II, L.P. removed 1,085,040 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $269,415,432
• SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 1,073,957 shares (-52.4%) from their portfolio in Q4 2024, for an estimated $266,663,523
• FMR LLC added 1,023,617 shares (+15.2%) to their portfolio in Q4 2024, for an estimated $254,164,101
• BLACKROCK, INC. added 1,012,652 shares (+8.9%) to their portfolio in Q4 2024, for an estimated $251,441,491

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

COIN Analyst Ratings

Wall Street analysts have issued reports on $COIN in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Needham issued a "Buy" rating on 02/10/2025
• Oppenheimer issued a "Outperform" rating on 02/10/2025
• Monness issued a "Buy" rating on 12/19/2024
• UBS issued a "Buy" rating on 10/31/2024
• H.C. Wainwright issued a "Buy" rating on 10/29/2024

To track analyst ratings and price targets for COIN, check out Quiver Quantitative's $COIN forecast page.

COIN Price Targets

Multiple analysts have issued price targets for $COIN recently. We have seen 4 analysts offer price targets for $COIN in the last 6 months, with a median target of $292.5.

Here are some recent targets:

• An analyst from Monness set a target price of $420.0 on 02/18/2025
• John Todaro from Needham set a target price of $290.0 on 10/31/2024
• Mike Colonnese from H.C. Wainwright set a target price of $295.0 on 10/29/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,070,000 of CARDINAL HEALTH INC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, behavioral health, food is medicine, acute hospital care at home waiver; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, pandemic preparedness, and product shortages. Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation bottlenecks. Issues related to tax reform and 2017 Tax Cuts and Jobs Act. Issues related to tariffs, trade, and U.S. trade policy. Issues related to tariffs, trade, and U.S. trade policy."

You can find more data on corporate lobbying on Quiver Quantitative.

CAH Congressional Stock Trading

Members of Congress have traded $CAH stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $CAH stock by members of Congress over the last 6 months:

• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 2 times. They made 2 purchases worth up to $30,000 on 03/17, 01/21 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

CAH Insider Trading Activity

CAH insiders have traded $CAH stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $CAH stock by insiders over the last 6 months:

• MARY C. SCHERER (Chief Accounting Officer) sold 3,504 shares for an estimated $432,919

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CAH Hedge Fund Activity

We have seen 494 institutional investors add shares of CAH stock to their portfolio, and 461 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PACER ADVISORS, INC. removed 4,254,464 shares (-99.2%) from their portfolio in Q4 2024, for an estimated $503,175,457
• MILLENNIUM MANAGEMENT LLC added 2,608,333 shares (+331.1%) to their portfolio in Q4 2024, for an estimated $308,487,543
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 2,382,566 shares (-77.4%) from their portfolio in Q4 2024, for an estimated $281,786,080
• ELLIOTT INVESTMENT MANAGEMENT L.P. removed 2,000,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $236,540,000
• MARSHALL WACE, LLP added 1,913,892 shares (+154.6%) to their portfolio in Q4 2024, for an estimated $226,356,006
• CITADEL ADVISORS LLC added 1,530,044 shares (+92.0%) to their portfolio in Q4 2024, for an estimated $180,958,303
• AMERIPRISE FINANCIAL INC removed 1,298,199 shares (-44.2%) from their portfolio in Q4 2024, for an estimated $153,537,995

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CAH Analyst Ratings

Wall Street analysts have issued reports on $CAH in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Cowen & Co. issued a "Buy" rating on 01/31/2025
• Evercore ISI issued a "Outperform" rating on 01/07/2025

To track analyst ratings and price targets for CAH, check out Quiver Quantitative's $CAH forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,235,360 of TOYOTA MOTOR NORTH AMERICA INC (TMA) lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"International tax matters related to inbound and outbound investments and a global minimum tax; taxation matters related to the corporate tax rate. The Build It in America Act (H.R. 3938) The Defending American Jobs and Investment Act (H.R. 3665) The Unfair Tax Prevention Act (H.R. 4695) REPAIR Act - H.R. 1566 INFORM Consumers Act SHOP Safe Act - S. 2934 S.2140 - Patent Eligibility Restoration Act (PERA) S. 2220 - The PREVAIL Act She Drives Act (S.161) Issues related to motor vehicle right to repair (House, Senate) Issues related to vehicle data access Issues related to cybersecurity Issues related to artificial intelligence Issues related to semiconductor research and development Issues related to vehicle privacy To create feasible federal rules for regulating vehicle tailpipe emissions and fuel economy: U.S. EPAs Multi-Pollutant Emissions Standards for Model Years 2027 through 2032 for Light-Duty and Medium-Duty Vehicles U.S. DOT NHTSAs Corporate Average Fuel Economy Standard for Model Years 2027 through 2032 for Light-Duty and Medium-duty Vehicles To limit U.S. EPAs use of CAA and EPCA to implement a ban on ICE vehicles and create a BEV mandate through rulemaking: FY24 Interior, Environment, and Related Agencies Appropriations Act (H.R. 4821) and (S. 2605) To end the BEV mandate and rescind CAs Waiver under the CAA granted by the Biden era EPA: Supporting a Congressional Review Act measure to remove the ability of EPA under the CAA Sec. 172 to grant the state of CA or any other state (preempt) the right to regulate GHG and tailpipe emissions outside of the EPA federal multi-pollutant emissions standards. To support the creation one national standard. H.J. Res 88 S.J. Res 45 To advance permitting reform and access to critical minerals for EV battery production: Energy Permitting Reform Act (EPRA) (S. 4753), Lower Energy Costs Act (LECA) (H.R. 1) To ensure equitable and feasible standards for implementation of IRA Tax credits: U.S. Treasury implementation and preservation of IRA Section 45X (batteries) To ensure feasible rules for managing forever chemicals in manufacturing: U.S. EPAs implementation of PFAS restrictions as part of the Comprehensive Environmental Response, Compensation and Liability Act (CERCLA) PFAS Accountability Act of 2024 (H.R. 7194) / (S. 3725) To increase the availability of Hydrogen fuel for light, medium and heavy-duty vehicles: U.S. Treasury Implementation and preservation of Inflation Reduction Act of 2022, Clean Hydrogen Production Credit (45V) (H2 production) PART Act (H.R. 621 and S. 154) CARS Act (H.R. 2948) Safe Vehicle Access for Survivors Act - HR 2110 AM Radio - S. 315 and HR 979 S. 5189 Close the Shadow Banking Loophole Act H.R. 170 SMART Act Draft PARTS Act S. 2891 Restoring America Invents Act HR 5184 Advancing Americas Interests Act Customs Modernization Act Ocean Shipping Reform Implementation Act HR 1836 SHIP IT Act HR 471 USMCA Implementation Congressional Trade Authority Act HR 5188 H.R. 6655, A Stronger Workforce for America Act"

You can find more data on corporate lobbying on Quiver Quantitative.

TM Congressional Stock Trading

Members of Congress have traded $TM stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $TM stock by members of Congress over the last 6 months:

• REPRESENTATIVE BRUCE WESTERMAN purchased up to $15,000 on 03/03.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

TM Hedge Fund Activity

We have seen 297 institutional investors add shares of TM stock to their portfolio, and 233 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BANK OF AMERICA CORP /DE/ removed 393,831 shares (-41.5%) from their portfolio in Q4 2024, for an estimated $76,643,450
• NORTHERN TRUST CORP added 384,149 shares (+66.5%) to their portfolio in Q4 2024, for an estimated $74,759,236
• MEDIOLANUM INTERNATIONAL FUNDS LTD removed 328,500 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $63,929,385
• CAPTRUST FINANCIAL ADVISORS added 234,078 shares (+166.3%) to their portfolio in Q4 2024, for an estimated $45,553,919
• UBS GROUP AG added 217,338 shares (+285.7%) to their portfolio in Q4 2024, for an estimated $42,296,148
• MILLENNIUM MANAGEMENT LLC added 158,036 shares (+286.0%) to their portfolio in Q4 2024, for an estimated $30,755,385
• FISHER ASSET MANAGEMENT, LLC added 129,560 shares (+1.9%) to their portfolio in Q4 2024, for an estimated $25,213,671

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

TM Analyst Ratings

Wall Street analysts have issued reports on $TM in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Macquarie issued a "Outperform" rating on 02/04/2025

To track analyst ratings and price targets for TM, check out Quiver Quantitative's $TM forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,140,000 of MARATHON PETROLEUM COMPANY LP lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Renewable Fuel Standard - Renewable Volume Obligations (No bill) - 2024-2025 Cellulosic Waivers (No bill) - Renewable Natural Gas Pathways (No bill) - Lifecycle Analysis (No bill) Reid Vapor Pressure Waiver for E10 Gasoline - H.R. 1346 and S. 593, Nationwide Consumer and Fuel Retailer Choice Act of 2025 Inflation Reduction Act - Clean fuel production credit - Sustainable aviation fuel Last-In, First-Out Accounting Method Corporate Rate Master Limited Partnerships (MLPs) - S.510, Financing Our Energy Future Act Permitting Reform Feedstock tariffs or restrictions (No Bill) Transportation logistics - Pipeline safety reauthorization - Freight Rail Safety & Competition EPA Tailpipe Emissions Proposals - Heavy Duty, Light and Medium Duty - H.R. 346, the Preserving Choice in Vehicle Purchases Act H.J.Res.35 and S.J.Res.12, Congressional Disapproval to Waste Emissions Charge for Petroleum and Natural Gas systems Per- and Polyfluoroalkyl substances (PFAS)"

You can find more data on corporate lobbying on Quiver Quantitative.

MPC Congressional Stock Trading

Members of Congress have traded $MPC stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $MPC stock by members of Congress over the last 6 months:

• REPRESENTATIVE JEFFERSON SHREVE purchased up to $50,000 on 03/05.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

MPC Insider Trading Activity

MPC insiders have traded $MPC stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $MPC stock by insiders over the last 6 months:

• JEFFREY C CAMPBELL purchased 6,000 shares for an estimated $897,644
• RICKY D. HESSLING (Chief Commercial Officer) purchased 2,000 shares for an estimated $269,440
• EVAN BAYH purchased 1,000 shares for an estimated $133,700

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MPC Hedge Fund Activity

We have seen 530 institutional investors add shares of MPC stock to their portfolio, and 802 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• WELLINGTON MANAGEMENT GROUP LLP added 4,367,774 shares (+78.1%) to their portfolio in Q4 2024, for an estimated $609,304,473
• FMR LLC removed 2,352,128 shares (-41.5%) from their portfolio in Q4 2024, for an estimated $328,121,856
• STATE STREET CORP removed 1,749,276 shares (-7.8%) from their portfolio in Q4 2024, for an estimated $244,024,002
• NOMURA HOLDINGS INC removed 1,262,158 shares (-97.2%) from their portfolio in Q4 2024, for an estimated $176,071,041
• VANGUARD GROUP INC removed 1,029,852 shares (-3.2%) from their portfolio in Q4 2024, for an estimated $143,664,354
• LEGAL & GENERAL GROUP PLC removed 960,765 shares (-33.1%) from their portfolio in Q4 2024, for an estimated $134,026,717
• BOSTON PARTNERS added 935,042 shares (+37.4%) to their portfolio in Q4 2024, for an estimated $130,438,359

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MPC Analyst Ratings

Wall Street analysts have issued reports on $MPC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Raymond James issued a "Strong Buy" rating on 03/27/2025
• Morgan Stanley issued a "Overweight" rating on 12/19/2024

To track analyst ratings and price targets for MPC, check out Quiver Quantitative's $MPC forecast page.

MPC Price Targets

Multiple analysts have issued price targets for $MPC recently. We have seen 3 analysts offer price targets for $MPC in the last 6 months, with a median target of $174.0.

Here are some recent targets:

• An analyst from Raymond James set a target price of $193.0 on 03/27/2025
• An analyst from Barclays set a target price of $161.0 on 03/14/2025
• Joe Laetsch from Morgan Stanley set a target price of $174.0 on 12/19/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,080,000 of IHEARTMEDIA INC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"HR 979/S.315,the "AM Radio for Every Vehicle Act." Congressional oversight and legislative proposals regarding data privacy. Congressional oversight and legislative proposals regarding the FCCs proceeding on new FM station power levels and classes (MB Docket No. 24-183). H. Con. Res. 12/S. Con. Res. 8, "Supporting the Local Radio Freedom Act." HR.861/S.326, "American Music Fairness Act." Congressional oversight and legislative proposals regarding Copyright Royalty Board rate setting. Congressional oversight and legislative proposals regarding copyright-related concerns with artificial intelligence. Preserving the deductibility of advertising expenses Preserving the R&D tax credit"

You can find more data on corporate lobbying on Quiver Quantitative.

IHRT Insider Trading Activity

IHRT insiders have traded $IHRT stock on the open market 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $IHRT stock by insiders over the last 6 months:

• ROBERT W PITTMAN (Chairman and CEO) purchased 200,000 shares for an estimated $320,040
• RICHARD J BRESSLER (SEE REMARKS) purchased 100,000 shares for an estimated $178,820
• JAMES A RASULO sold 40,223 shares for an estimated $96,406

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

IHRT Hedge Fund Activity

We have seen 69 institutional investors add shares of IHRT stock to their portfolio, and 44 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• ACADIAN ASSET MANAGEMENT LLC added 1,095,425 shares (+126.6%) to their portfolio in Q4 2024, for an estimated $2,168,941
• AQR CAPITAL MANAGEMENT LLC removed 1,062,596 shares (-48.9%) from their portfolio in Q4 2024, for an estimated $2,103,940
• BRACEBRIDGE CAPITAL, LLC removed 1,008,456 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $1,996,742
• WELLS FARGO & COMPANY/MN removed 943,029 shares (-93.9%) from their portfolio in Q4 2024, for an estimated $1,867,197
• CHARLES SCHWAB INVESTMENT MANAGEMENT INC removed 890,499 shares (-32.5%) from their portfolio in Q4 2024, for an estimated $1,763,188
• DEUTSCHE BANK AG\ added 789,170 shares (+25.9%) to their portfolio in Q4 2024, for an estimated $1,562,556
• MORGAN STANLEY added 523,937 shares (+156.3%) to their portfolio in Q4 2024, for an estimated $1,037,395

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

IHRT Analyst Ratings

Wall Street analysts have issued reports on $IHRT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Guggenheim issued a "Buy" rating on 11/18/2024

To track analyst ratings and price targets for IHRT, check out Quiver Quantitative's $IHRT forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,050,000 of DAVITA INC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to Veterans Affairs and dialysis Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026, provisions related to dialysis (no bill number) H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options ESRD facilities serving as originating sites for telehealth services under the Medicare program H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act Issues related to End Stage Renal Disease (ESRD) Perspective Payment System (PPS) Issues related to nursing shortages CMS regulations pertaining to the Medicare Advantage Program Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options ESRD facilities serving as originating sites for telehealth services under the Medicare program"

You can find more data on corporate lobbying on Quiver Quantitative.

DVA Insider Trading Activity

DVA insiders have traded $DVA stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.

Here’s a breakdown of recent trading of $DVA stock by insiders over the last 6 months:

• HATHAWAY INC BERKSHIRE has made 0 purchases and 19 sales selling 953,091 shares for an estimated $147,740,046.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

DVA Hedge Fund Activity

We have seen 219 institutional investors add shares of DVA stock to their portfolio, and 316 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS GROUP AG added 607,396 shares (+409.9%) to their portfolio in Q4 2024, for an estimated $90,836,071
• BLACKROCK, INC. removed 465,288 shares (-9.9%) from their portfolio in Q4 2024, for an estimated $69,583,820
• BANK OF AMERICA CORP /DE/ removed 431,630 shares (-69.0%) from their portfolio in Q4 2024, for an estimated $64,550,266
• EPOCH INVESTMENT PARTNERS, INC. added 368,436 shares (+inf%) to their portfolio in Q4 2024, for an estimated $55,099,603
• JPMORGAN CHASE & CO removed 332,508 shares (-59.2%) from their portfolio in Q4 2024, for an estimated $49,726,571
• CITADEL ADVISORS LLC removed 332,336 shares (-76.6%) from their portfolio in Q4 2024, for an estimated $49,700,848
• HOLOCENE ADVISORS, LP added 302,154 shares (+inf%) to their portfolio in Q4 2024, for an estimated $45,187,130

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,043,920 of CARRIER GLOBAL CORPORATION lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Monitor energy efficiency tax incentives in P.L. 117-169, Inflation Reduction Act; monitor international tax provisions in P.L. 117-169, Inflation Reduction Act. Support and provide feedback on the implementation of 25C in P.L. 117-169, Inflation Reduction Act. Monitor research and development portions in H.R. 7024, the Tax Relief for American Families and Workers Act, and engagement related to qualifying Carrier technologies for clean energy tax incentives. Educate policymakers about Carrier's work on building and energy efficiency. Monitor implementation of P.L. 117-58, the Infrastructure Investment and Jobs Act. Advocate for investments into technologies that leverage energy storage to enable load flexibility and provide grid resilience in the fiscal year (FY) 2025 Energy and Water Appropriations Bill. Advocate for the use of cold chain technologies aimed at hunger prevention in developing agricultural markets and the implementation of P.L.117-195, the Global Food Security Act in the fiscal year (FY) 2025 Energy and Water Appropriations Bill, and the fiscal year (FY) 2025 Agriculture Appropriations Bill. Monitor EPA implementation of HFC refrigerant transition for HVAC systems. Monitor Trade Policy"

You can find more data on corporate lobbying on Quiver Quantitative.

CARR Congressional Stock Trading

Members of Congress have traded $CARR stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $CARR stock by members of Congress over the last 6 months:

• SENATOR TOMMY TUBERVILLE sold up to $15,000 on 01/10.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

CARR Insider Trading Activity

CARR insiders have traded $CARR stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $CARR stock by insiders over the last 6 months:

• KEVIN J. O'CONNOR (Senior VP & CLO) sold 167,183 shares for an estimated $12,281,697
• KYLE CROCKETT (VP, Controller & CAO) has made 0 purchases and 2 sales selling 30,592 shares for an estimated $2,123,966.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CARR Hedge Fund Activity

We have seen 574 institutional investors add shares of CARR stock to their portfolio, and 712 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL RESEARCH GLOBAL INVESTORS removed 19,710,212 shares (-20.7%) from their portfolio in Q4 2024, for an estimated $1,345,419,071
• CAPITAL INTERNATIONAL INVESTORS removed 9,913,189 shares (-11.7%) from their portfolio in Q4 2024, for an estimated $676,674,281
• WEALTHFRONT ADVISERS LLC added 4,915,826 shares (+5840.1%) to their portfolio in Q4 2024, for an estimated $335,554,282
• BROWN ADVISORY INC added 3,080,984 shares (+139.1%) to their portfolio in Q4 2024, for an estimated $210,307,967
• CAPITAL WORLD INVESTORS removed 2,696,104 shares (-5.7%) from their portfolio in Q4 2024, for an estimated $184,036,059
• MORGAN STANLEY added 2,522,360 shares (+23.4%) to their portfolio in Q4 2024, for an estimated $172,176,293
• ARTISAN PARTNERS LIMITED PARTNERSHIP added 2,432,778 shares (+inf%) to their portfolio in Q4 2024, for an estimated $166,061,426

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CARR Analyst Ratings

Wall Street analysts have issued reports on $CARR in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Wells Fargo issued a "Negative" rating on 01/07/2025

To track analyst ratings and price targets for CARR, check out Quiver Quantitative's $CARR forecast page.

CARR Price Targets

Multiple analysts have issued price targets for $CARR recently. We have seen 2 analysts offer price targets for $CARR in the last 6 months, with a median target of $76.5.

Here are some recent targets:

• Joseph O'Dea from Wells Fargo set a target price of $75.0 on 01/07/2025
• Brett Linzey from Mizuho Securities set a target price of $78.0 on 10/28/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,250,000 of UNION PACIFIC CORPORATION lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to Rail Safety Issues related to Railroad Retirement Board Issues related to the Surface Transportation Board Issues related to Automated Track Inspections Issues related to Passenger Rail Operations on Freight-Owned Corridors Issues related to third party access to rail rights of way Issues related to Grade Crossing Safety Issues related to Close Call Reporting Issues related to Surface Transportation Reauthorization Issues related to Executive Branch Nominees Issues related to truck size and weight Issues related to cargo theft Issues related to trade and tariffs Issues related to USTR investigations into Chinese shipbuilding industry FY 2026 Homeland Security Appropriations FY 2026 Commerce-Justice-Science Appropriations FY 2026 Transportation, Housing and Urban Development Appropriations Issues related to crew consist Issues related to veterans hiring for supply chain jobs S. 1072 - Stop CARB Act of 2025 Issues related to locomotive emissions Issues related to CARB regulations for locomotive emissions and EPA waiver Issues related to rail infrastructure on US military bases HR 2243/S.679 LEOSA Reform Act of 2025 Issues related to staffing and operations at rail ports of entry to the United States along the Southern Border Issues related to non-intrusive inspection technology and infrastructure Issues related to the Customs Trade Partnership Against Terrorism (CTPAT) program Issues related to Cybersecurity Issues related to corporate taxes considered under reconciliation"

You can find more data on corporate lobbying on Quiver Quantitative.

UNP Congressional Stock Trading

Members of Congress have traded $UNP stock 7 times in the past 6 months. Of those trades, 6 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $UNP stock by members of Congress over the last 6 months:

• REPRESENTATIVE BRUCE WESTERMAN purchased up to $15,000 on 03/04.
• REPRESENTATIVE JULIE JOHNSON purchased up to $15,000 on 02/25.
• REPRESENTATIVE JEFFERSON SHREVE purchased up to $50,000 on 02/24.
• REPRESENTATIVE JOSH GOTTHEIMER has traded it 3 times. They made 3 purchases worth up to $45,000 on 02/03, 01/29, 12/13 and 0 sales.
• REPRESENTATIVE MIKE KELLY sold up to $50,000 on 11/08.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

UNP Insider Trading Activity

UNP insiders have traded $UNP stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $UNP stock by insiders over the last 6 months:

• ELIZABETH F WHITED (PRESIDENT) sold 7,500 shares for an estimated $1,875,000
• CRAIG V RICHARDSON (EVP CHIEF LEGAL OFFICER & CORP) has made 0 purchases and 2 sales selling 6,495 shares for an estimated $1,636,740.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

UNP Hedge Fund Activity

We have seen 1,091 institutional investors add shares of UNP stock to their portfolio, and 1,159 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 3,059,010 shares (-73.8%) from their portfolio in Q4 2024, for an estimated $697,576,640
• JPMORGAN CHASE & CO added 2,163,404 shares (+25.3%) to their portfolio in Q4 2024, for an estimated $493,342,648
• BANK OF AMERICA CORP /DE/ removed 1,632,268 shares (-13.8%) from their portfolio in Q4 2024, for an estimated $372,222,394
• GEODE CAPITAL MANAGEMENT, LLC added 1,616,895 shares (+12.6%) to their portfolio in Q4 2024, for an estimated $368,716,735
• CAPITAL INTERNATIONAL INVESTORS removed 1,616,851 shares (-15.7%) from their portfolio in Q4 2024, for an estimated $368,706,702
• BLACKROCK, INC. added 1,605,645 shares (+3.7%) to their portfolio in Q4 2024, for an estimated $366,151,285
• CAPITAL RESEARCH GLOBAL INVESTORS added 1,298,178 shares (+14.3%) to their portfolio in Q4 2024, for an estimated $296,036,511

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

UNP Analyst Ratings

Wall Street analysts have issued reports on $UNP in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Loop Capital Markets issued a "Sell" rating on 02/03/2025
• Goldman Sachs issued a "Buy" rating on 01/23/2025
• Raymond James issued a "Strong Buy" rating on 01/10/2025
• Wells Fargo issued a "Overweight" rating on 01/07/2025

To track analyst ratings and price targets for UNP, check out Quiver Quantitative's $UNP forecast page.

UNP Price Targets

Multiple analysts have issued price targets for $UNP recently. We have seen 4 analysts offer price targets for $UNP in the last 6 months, with a median target of $265.0.

Here are some recent targets:

• An analyst from Deutsche Bank set a target price of $295.0 on 03/07/2025
• Rick Paterson from Loop Capital Markets set a target price of $200.0 on 02/03/2025
• Patrick Tyler Brown from Raymond James set a target price of $265.0 on 01/10/2025
• Christian Wetherbee from Wells Fargo set a target price of $265.0 on 01/07/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$3,620,000 of NORTHROP GRUMMAN CORPORATION lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"FY25 Defense Appropriations Act (H.R. 8774; S. 4921); FY25 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act (H.R. 8580; S. 4677); National Security Space Programs; Microelectronics; FY25 Servicemember Quality of Life Improvement and National Defense Authorization Act (H.R. 8070; S. 4638); Establishing the Congressional Budget for the United States Government for FY2025 and Setting Forth the Appropriate Budgetary Levels for FY2026 through FY2034 (H.Con.Res. 14); Full-Year Continuing Appropriations and Extensions Act, 2025 (H.R. 1968) FY25 Defense Appropriations Act (H.R. 8774; S. 4921); FY25 Servicemember Quality of Life Improvement and National Defense Authorization Act (H.R. 8070; S. 4638); Full-Year Continuing Appropriations and Extensions Act, 2025 (H.R. 1968); Establishing the Congressional Budget for the United States Government for Fiscal Year 2025 and Setting Forth the Appropriate Budgetary Levels for Fiscal Years 2026 through 2034 (H.Con.Res. 14) Amortization of Qualified Research and Experimentation Expenses; Additional First-year ("Bonus") Depreciation Deduction; Corporate Statutory Rate; Establishing the Congressional Budget for the United States Government for Fiscal 2025 and Setting Forth the Appropriate Budgetary Levels for Fiscal Years 2026 through 2034 (H.Con.Res. 14) Export Control Reform, Foreign Military Sales, Defense Trade, International Sales FY25 Servicemember Quality of Life Improvement and National Defense Authorization Act (H.R. 8070; S. 4638); Intelligence Authorization Act for Fiscal Year 2025 (H.R. 8512; S. 4443) Reprogrammings; Establishing the Congressional Budget for the United States Government for Fiscal Year 2025 and Setting Forth the Appropriate Budgetary Levels for Fiscal Years 2026 through 2034 (H.Con.Res. 14) FY25 Commerce, Justice, Science Appropriations Act (H.R. 9026; S. 4795); Full-Year Continuing Appropriations and Extensions Act, 2025 (H.R. 1968); NASA Transition Authorization Act of 2025 (S. 933); Orbits Act of 2023 (S. 447); Space Research and Continuing Exploration (RACE) Act (H.R. 529)"

You can find more data on corporate lobbying on Quiver Quantitative.

NOC Insider Trading Activity

NOC insiders have traded $NOC stock on the open market 64 times in the past 6 months. Of those trades, 0 have been purchases and 64 have been sales.

Here’s a breakdown of recent trading of $NOC stock by insiders over the last 6 months:

• KATHY J WARDEN (Chair, CEO and President) sold 3,750 shares for an estimated $1,783,687
• BENJAMIN R. DAVIES (CVP & Pres. Defense Systems) has made 0 purchases and 4 sales selling 2,105 shares for an estimated $1,042,725.
• MICHAEL A HARDESTY (Corp VP, Controller & CAO) sold 1,931 shares for an estimated $875,872
• KATHRYN G SIMPSON (Corp VP & General Counsel) has made 0 purchases and 2 sales selling 1,924 shares for an estimated $840,013.
• MARK A III WELSH has made 0 purchases and 56 sales selling 198 shares for an estimated $95,114.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

NOC Hedge Fund Activity

We have seen 685 institutional investors add shares of NOC stock to their portfolio, and 661 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• MORGAN STANLEY removed 805,949 shares (-16.2%) from their portfolio in Q4 2024, for an estimated $378,223,806
• CAPITAL INTERNATIONAL INVESTORS added 461,307 shares (+5.9%) to their portfolio in Q4 2024, for an estimated $216,486,762
• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 457,927 shares (-87.5%) from their portfolio in Q4 2024, for an estimated $214,900,561
• PRICE T ROWE ASSOCIATES INC /MD/ added 450,858 shares (+28.5%) to their portfolio in Q4 2024, for an estimated $211,583,150
• BALYASNY ASSET MANAGEMENT L.P. removed 429,796 shares (-98.9%) from their portfolio in Q4 2024, for an estimated $201,698,964
• FIRST TRUST ADVISORS LP added 371,814 shares (+337.1%) to their portfolio in Q4 2024, for an estimated $174,488,592
• INVESCO LTD. added 343,018 shares (+24.7%) to their portfolio in Q4 2024, for an estimated $160,974,917

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

NOC Analyst Ratings

Wall Street analysts have issued reports on $NOC in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Morgan Stanley issued a "Overweight" rating on 04/16/2025
• Wells Fargo issued a "Overweight" rating on 03/07/2025
• Susquehanna issued a "Positive" rating on 01/08/2025

To track analyst ratings and price targets for NOC, check out Quiver Quantitative's $NOC forecast page.

NOC Price Targets

Multiple analysts have issued price targets for $NOC recently. We have seen 3 analysts offer price targets for $NOC in the last 6 months, with a median target of $550.0.

Here are some recent targets:

• Charles Minervino from Susquehanna set a target price of $557.0 on 01/08/2025
• Sheila Kahyaoglu from Jefferies set a target price of $550.0 on 10/30/2024
• David Strauss from Barclays set a target price of $550.0 on 10/29/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,420,000 of DELL TECHNOLOGIES INC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues relating to domestic and international corporate tax; H.R. 1990, American Innovation and R&D Competitiveness Act of 2025 (and Senate companion, when introduced); implementation of 2017 Tax Cuts and Jobs Act (P.L. No. 115-97). Issues relating to DOD technology enhancements and modernization, DOD procurement and service contract requirements, and funding for DOD IT programs, including cybersecurity, artificial intelligence (AI), 5G, and cloud computing programs; issues relating to annual National Defense Authorization Act; implementation of Pub. L. No. 118-31, James M. Inhofe National Defense Authorization Act for Fiscal Year 2024. Issues relating to patent litigation and processes, protecting and modernizing intellectual property rights, and USPTO policies and operations; issues relating to "PREVAIL" Act (Senate and House), Patent Eligibility Restoration Act of 2023, and Advancing Americas Interests Act (118th Congress); S.708/H.R. 1574, the RESTORE Patent Rights Act of 2025. Issues relating to increasing access to technology, connectivity, and STEM education programs (no specific legislation). Issues relating to efficient government operations, procurement practices, and IT modernization (no specific legislation). Issues relating to supply chain security, information technology programs, cybersecurity procurement, data breach notification, and cybersecurity resiliency (no specific legislation). Issues relating to artificial intelligence, semiconductor supply chain requirements, telecom infrastructure, data privacy protections, cloud computing, emerging technology, and the National Institute of Standards and Technology (NIST) and cryptographic module validation program (no specific legislation); implementation of National Defense Authorization Act for Fiscal Year 2021 (CHIPS Act). Issues regarding international trade, trade agreements, tariffs, export controls and licensing, AI Diffusion, and supply chain (no specific legislation). Issues regarding regulation and reporting of carbon emissions, grid infrastructure modernization, IT energy efficiency requirements, and circular economy (no specific legislation)."

You can find more data on corporate lobbying on Quiver Quantitative.

DELL Congressional Stock Trading

Members of Congress have traded $DELL stock 6 times in the past 6 months. Of those trades, 5 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $DELL stock by members of Congress over the last 6 months:

• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 2 times. They made 2 purchases worth up to $30,000 on 04/04, 11/07 and 0 sales.
• SENATOR MARKWAYNE MULLIN has traded it 3 times. They made 3 purchases worth up to $115,000 on 02/03, 01/02 and 0 sales.
• REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 01/28.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

DELL Insider Trading Activity

DELL insiders have traded $DELL stock on the open market 164 times in the past 6 months. Of those trades, 0 have been purchases and 164 have been sales.

Here’s a breakdown of recent trading of $DELL stock by insiders over the last 6 months:

• V (GP), L.L.C. SLTA has made 0 purchases and 75 sales selling 2,954,775 shares for an estimated $364,748,433.
• IV (GP), L.L.C. SLTA has made 0 purchases and 75 sales selling 2,954,775 shares for an estimated $364,748,433.
• YVONNE MCGILL (Chief Financial Officer) has made 0 purchases and 7 sales selling 16,000 shares for an estimated $2,152,535.
• LAKE GROUP, L.L.C. SILVER has made 0 purchases and 2 sales selling 7,496 shares for an estimated $885,727.
• RADAKOVICH LYNN VOJVODICH has made 0 purchases and 4 sales selling 2,900 shares for an estimated $356,903.
• BRUNILDA RIOS (Chief Accounting Officer) sold 926 shares for an estimated $86,386

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

DELL Hedge Fund Activity

We have seen 657 institutional investors add shares of DELL stock to their portfolio, and 518 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JANE STREET GROUP, LLC removed 5,565,515 shares (-80.5%) from their portfolio in Q4 2024, for an estimated $641,369,948
• NORGES BANK added 3,690,256 shares (+1428.8%) to their portfolio in Q4 2024, for an estimated $425,265,101
• VANGUARD GROUP INC added 2,662,407 shares (+10.5%) to their portfolio in Q4 2024, for an estimated $306,815,782
• MICHAEL & SUSAN DELL FOUNDATION added 2,300,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $265,052,000
• FMR LLC removed 1,949,489 shares (-16.4%) from their portfolio in Q4 2024, for an estimated $224,659,112
• DEUTSCHE BANK AG\ added 1,872,262 shares (+163.1%) to their portfolio in Q4 2024, for an estimated $215,759,472
• JANUS HENDERSON GROUP PLC added 1,865,013 shares (+160.5%) to their portfolio in Q4 2024, for an estimated $214,924,098

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

DELL Analyst Ratings

Wall Street analysts have issued reports on $DELL in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Bank of America Securities issued a "Buy" rating on 11/22/2024
• Wells Fargo issued a "Overweight" rating on 11/18/2024

To track analyst ratings and price targets for DELL, check out Quiver Quantitative's $DELL forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$3,290,000 of UNITEDHEALTH GROUP INC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Drug Pricing PBM and Drug Pricing Reforms Inflation Reduction Act Veterans Health Issues Data Privacy Paperless / Digital Healthcare Communications Value-Based Care No Surprises Act Healthcare Modernization Policies Medicaid and Commercial Market Coverage Policy Medicare Advantage Program Medicare Home Health System Payments Medicare Modernization Proposals"

You can find more data on corporate lobbying on Quiver Quantitative.

UNH Congressional Stock Trading

Members of Congress have traded $UNH stock 11 times in the past 6 months. Of those trades, 4 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $UNH stock by members of Congress over the last 6 months:

• REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 1 purchase worth up to $50,000 on 03/31 and 1 sale worth up to $50,000 on 02/24.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $100,000 on 03/31, 01/24 and 1 sale worth up to $50,000 on 02/26.
• REPRESENTATIVE GREG LANDSMAN sold up to $50,000 on 03/27.
• REPRESENTATIVE BRUCE WESTERMAN purchased up to $15,000 on 03/03.
• REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 0 purchases and 2 sales worth up to $65,000 on 02/25, 01/13.
• REPRESENTATIVE RICK LARSEN sold up to $15,000 on 01/07.
• SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 12/20.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

UNH Insider Trading Activity

UNH insiders have traded $UNH stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $UNH stock by insiders over the last 6 months:

• TIMOTHY PATRICK FLYNN purchased 1,000 shares for an estimated $511,575
• ERIN MCSWEENEY (EVP & Chief People Officer) sold 701 shares for an estimated $438,987

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

UNH Hedge Fund Activity

We have seen 1,504 institutional investors add shares of UNH stock to their portfolio, and 1,698 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL WORLD INVESTORS removed 4,725,017 shares (-18.0%) from their portfolio in Q4 2024, for an estimated $2,390,197,099
• DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 3,799,364 shares (-74.8%) from their portfolio in Q4 2024, for an estimated $1,921,946,273
• PRICE T ROWE ASSOCIATES INC /MD/ removed 3,621,799 shares (-14.5%) from their portfolio in Q4 2024, for an estimated $1,832,123,242
• AMUNDI added 2,991,470 shares (+97.2%) to their portfolio in Q4 2024, for an estimated $1,513,265,014
• FMR LLC removed 2,380,516 shares (-7.3%) from their portfolio in Q4 2024, for an estimated $1,204,207,823
• UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,301,010 shares (+36.6%) to their portfolio in Q4 2024, for an estimated $1,163,988,918
• LEGAL & GENERAL GROUP PLC removed 2,251,253 shares (-27.3%) from their portfolio in Q4 2024, for an estimated $1,138,818,842

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

UNH Analyst Ratings

Wall Street analysts have issued reports on $UNH in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Morgan Stanley issued a "Overweight" rating on 04/15/2025
• Bernstein issued a "Outperform" rating on 04/15/2025
• Stephens issued a "Overweight" rating on 03/03/2025
• Jefferies issued a "Buy" rating on 12/09/2024

To track analyst ratings and price targets for UNH, check out Quiver Quantitative's $UNH forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,100,000 of GOLDMAN SACHS GROUP INC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Implementation of P.L. 111-203 Dodd-Frank Wall Street Reform and Consumer Protection Act, securitization, market structure, issues related to capital and resolution, issues related to digital assets legislation, and other issues related to the financial services industry. Issues related to US economic competitiveness, housing and global economic issues. Issues related to tax policy. Issues related to US trade policy. Review of P.L. 85-511 Bank Holding Company Act of 1956 and issues related to global banking policy."

You can find more data on corporate lobbying on Quiver Quantitative.

GS Congressional Stock Trading

Members of Congress have traded $GS stock 18 times in the past 6 months. Of those trades, 14 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $GS stock by members of Congress over the last 6 months:

• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 3 times. They made 3 purchases worth up to $45,000 on 03/07, 02/12, 11/07 and 0 sales.
• REPRESENTATIVE JEFFERSON SHREVE purchased up to $50,000 on 03/05.
• REPRESENTATIVE BRUCE WESTERMAN purchased up to $15,000 on 03/03.
• SENATOR DAVID MCCORMICK sold up to $5,000,000 on 02/28.
• REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 1 purchase worth up to $15,000 on 12/30 and 1 sale worth up to $15,000 on 02/28.
• REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 2 purchases worth up to $30,000 on 02/24, 01/24 and 0 sales.
• SENATOR MARKWAYNE MULLIN has traded it 5 times. They made 3 purchases worth up to $115,000 on 02/03, 01/02 and 2 sales worth up to $65,000 on 12/18.
• REPRESENTATIVE JARED MOSKOWITZ has traded it 3 times. They made 3 purchases worth up to $45,000 on 01/15 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

GS Insider Trading Activity

GS insiders have traded $GS stock on the open market 66 times in the past 6 months. Of those trades, 10 have been purchases and 56 have been sales.

Here’s a breakdown of recent trading of $GS stock by insiders over the last 6 months:

• THOMAS K. MONTAG has made 0 purchases and 17 sales selling 20,000 shares for an estimated $11,899,207.
• DENIS P. COLEMAN (Chief Financial Officer) sold 12,929 shares for an estimated $7,667,284
• JOHN F.W. ROGERS (Executive Vice President) has made 0 purchases and 6 sales selling 11,391 shares for an estimated $6,823,219.
• DAVID M SOLOMON (Chairman of the Board and CEO) has made 0 purchases and 2 sales selling 8,965 shares for an estimated $5,503,952.
• KATHRYN H. RUEMMLER (Chief Legal Officer, GC) sold 7,498 shares for an estimated $4,758,905
• ALEX S GOLTEN (CHIEF RISK OFFICER) has made 0 purchases and 2 sales selling 5,208 shares for an estimated $3,313,567.
• CAREY HALIO (Global Treasurer) has made 0 purchases and 16 sales selling 5,185 shares for an estimated $3,282,853.
• DAVID A VINIAR sold 5,000 shares for an estimated $3,060,400
• SHEARA J FREDMAN (Chief Accounting Officer) has made 0 purchases and 10 sales selling 5,008 shares for an estimated $3,043,401.
• JOHN B HESS has made 9 purchases buying 3,904 shares for an estimated $1,997,583 and 0 sales.
• KEVIN R JOHNSON purchased 2,400 shares for an estimated $1,485,648

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

GS Hedge Fund Activity

We have seen 1,134 institutional investors add shares of GS stock to their portfolio, and 909 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• MIZUHO SECURITIES USA LLC removed 7,470,248 shares (-99.6%) from their portfolio in Q4 2024, for an estimated $4,277,613,409
• JPMORGAN CHASE & CO added 1,866,273 shares (+30.8%) to their portfolio in Q4 2024, for an estimated $1,068,665,245
• CASTLEKEEP INVESTMENT ADVISORS LLC added 1,646,071 shares (+53530.8%) to their portfolio in Q4 2024, for an estimated $942,573,176
• DODGE & COX removed 1,509,556 shares (-28.1%) from their portfolio in Q4 2024, for an estimated $864,401,956
• BANK OF AMERICA CORP /DE/ removed 1,121,427 shares (-27.5%) from their portfolio in Q4 2024, for an estimated $642,151,528
• PROFICIO CAPITAL PARTNERS LLC added 1,052,204 shares (+14007.0%) to their portfolio in Q4 2024, for an estimated $602,513,054
• DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 882,099 shares (+214.1%) to their portfolio in Q4 2024, for an estimated $505,107,529

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

GS Analyst Ratings

Wall Street analysts have issued reports on $GS in the last several months. We have seen 4 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Wells Fargo issued a "Overweight" rating on 04/15/2025
• Goldman Sachs issued a "Underperform" rating on 03/13/2025
• Barclays issued a "Overweight" rating on 01/27/2025
• Morgan Stanley issued a "Overweight" rating on 01/27/2025
• Evercore ISI issued a "Outperform" rating on 01/02/2025

To track analyst ratings and price targets for GS, check out Quiver Quantitative's $GS forecast page.

GS Price Targets

Multiple analysts have issued price targets for $GS recently. We have seen 5 analysts offer price targets for $GS in the last 6 months, with a median target of $625.0.

Here are some recent targets:

• Gerard Cassidy from RBC Capital set a target price of $560.0 on 04/15/2025
• Mike Mayo from Wells Fargo set a target price of $650.0 on 04/15/2025
• Betsy Graseck from Morgan Stanley set a target price of $558.0 on 04/07/2025
• An analyst from Goldman Sachs set a target price of $625.0 on 03/25/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,250,000 of AMERICAN AIRLINES INC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H.R. 2353 - Safer Skies Act of 2025: Provisions pertaining to commercial aviation. H.R. 1968 - Full-Year Continuing Appropriations and Extensions Act, 2025: Provisions pertaining to commercial aviation. Issues related to air traffic controller staffing. Issues related to sustainable aviation fuel. Issues related to the TSA Registered Traveler Program. H. Con Res 14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034: Provisions pertaining to DOT appropriations. Issues related to credit card interchange fees. Issues related to tax reform."

You can find more data on corporate lobbying on Quiver Quantitative.

AAL Congressional Stock Trading

Members of Congress have traded $AAL stock 5 times in the past 6 months. Of those trades, 4 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $AAL stock by members of Congress over the last 6 months:

• REPRESENTATIVE TIM MOORE has traded it 5 times. They made 4 purchases worth up to $300,000 on 03/31, 03/14, 03/13, 03/12 and 1 sale worth up to $250,000 on 03/20.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

AAL Insider Trading Activity

AAL insiders have traded $AAL stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $AAL stock by insiders over the last 6 months:

• ROBERT D JR ISOM (CEO and President) sold 102,441 shares for an estimated $1,763,511
• ANGELA OWENS (SVP Corporate Controller) sold 51,906 shares for an estimated $890,312

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

AAL Hedge Fund Activity

We have seen 251 institutional investors add shares of AAL stock to their portfolio, and 241 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS GROUP AG added 14,383,402 shares (+1390.7%) to their portfolio in Q4 2024, for an estimated $250,702,696
• VIKING GLOBAL INVESTORS LP added 13,539,994 shares (+inf%) to their portfolio in Q4 2024, for an estimated $236,002,095
• CITADEL ADVISORS LLC added 9,340,922 shares (+746.5%) to their portfolio in Q4 2024, for an estimated $162,812,270
• POINT72 ASSET MANAGEMENT, L.P. added 8,401,264 shares (+487.5%) to their portfolio in Q4 2024, for an estimated $146,434,031
• FMR LLC added 4,617,221 shares (+1129.0%) to their portfolio in Q4 2024, for an estimated $80,478,162
• ADAGE CAPITAL PARTNERS GP, L.L.C. removed 4,088,889 shares (-80.3%) from their portfolio in Q4 2024, for an estimated $71,269,335
• MILLENNIUM MANAGEMENT LLC removed 3,969,373 shares (-75.5%) from their portfolio in Q4 2024, for an estimated $69,186,171

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AAL Analyst Ratings

Wall Street analysts have issued reports on $AAL in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Raymond James issued a "Outperform" rating on 04/02/2025
• Citigroup issued a "Buy" rating on 03/12/2025
• Deutsche Bank issued a "Buy" rating on 01/24/2025
• TD Securities issued a "Buy" rating on 01/06/2025
• Seaport Global issued a "Buy" rating on 12/05/2024

To track analyst ratings and price targets for AAL, check out Quiver Quantitative's $AAL forecast page.

AAL Price Targets

Multiple analysts have issued price targets for $AAL recently. We have seen 5 analysts offer price targets for $AAL in the last 6 months, with a median target of $16.0.

Here are some recent targets:

• Savanthi Syth from Raymond James set a target price of $15.0 on 04/02/2025
• Conor Cunningham from Melius Research set a target price of $18.0 on 12/05/2024
• Daniel McKenzie from Seaport Global set a target price of $20.0 on 12/05/2024
• Catherine O'Brien from Goldman Sachs set a target price of $15.0 on 11/15/2024
• Brandon Oglenski from Barclays set a target price of $16.0 on 11/14/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$3,520,000 of COMCAST CORPORATION lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Reconciliation. Implementation of section 224 of the Communications Act, as amended, regarding pole attachments. Privacy, including the American Data Privacy and Protection Act (H.R.8152). Rural Broadband Deployment and Mapping. Broadband Adoption and Network. Infrastructure Investment and Jobs Act (Public Law No: 117-58). Online Video/Over the Top Video. Media reform, retrans, program carriage and diversity. Sports Programming. Media Diversity. Affordable Connectivity Program. 2024 National Defense Authorization Act. Provisions of the Consolidated Appropriations Act of 2023 re broadband and spectrum. Issues related to artificial intelligence. Media Regulation. Intellectual Property Issues. Legislation regarding COVID, privacy, data security and breach notification. Consumer data privacy. Childrens privacy (Kids Online Safety Act). Infrastructure Investment and Jobs Act (Public Law No: 117-58) and Build Back Better Act (H.R.5376). CARES Act - Tax Provisions. Inflation Reduction Act. Bonus depreciation. Corporate tax rate. Reconciliation. Tax Extenders. Legislation and regulation regarding a framework for cybersecurity, and mitigation and prevention of cyber threats. Infrastructure Investment and Jobs Act (Public Law No: 117-58). Spectrum, including unlicensed spectrum. Commerce, Justice, Science, and Related Agencies Appropriations Act, FY 2025. Legislative Branch Appropriations, FY 2025. Financial Services Appropriations, FY 2025. Judiciary Committee Issues. Commerce Committee Issues. Advertising issues. 2024 National Defense Authorization Act. Foreign distribution of U.S. films."

You can find more data on corporate lobbying on Quiver Quantitative.

CMCSA Congressional Stock Trading

Members of Congress have traded $CMCSA stock 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $CMCSA stock by members of Congress over the last 6 months:

• REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 1 purchase worth up to $50,000 on 03/31 and 1 sale worth up to $50,000 on 02/24.
• REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 02/25.
• SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 02/24.
• REPRESENTATIVE RICK LARSEN sold up to $15,000 on 01/07.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

CMCSA Insider Trading Activity

CMCSA insiders have traded $CMCSA stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $CMCSA stock by insiders over the last 6 months:

• BRIAN L ROBERTS (Chairman of Board & CEO) has made 0 purchases and 2 sales selling 469,515 shares for an estimated $20,063,802.
• MICHAEL J CAVANAGH (President) has made 0 purchases and 2 sales selling 133,159 shares for an estimated $5,664,712.
• JASON ARMSTRONG (CFO) has made 0 purchases and 2 sales selling 23,248 shares for an estimated $1,042,544.
• KENNETH J BACON sold 14,408 shares for an estimated $625,092

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CMCSA Hedge Fund Activity

We have seen 886 institutional investors add shares of CMCSA stock to their portfolio, and 1,294 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• NORGES BANK added 40,925,715 shares (+66.8%) to their portfolio in Q4 2024, for an estimated $1,535,942,083
• MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 17,065,980 shares (-39.3%) from their portfolio in Q4 2024, for an estimated $640,486,229
• VIKING GLOBAL INVESTORS LP added 16,726,300 shares (+540.8%) to their portfolio in Q4 2024, for an estimated $627,738,039
• AMUNDI added 14,369,056 shares (+147.9%) to their portfolio in Q4 2024, for an estimated $539,270,671
• EAGLE CAPITAL MANAGEMENT LLC added 12,279,836 shares (+66.0%) to their portfolio in Q4 2024, for an estimated $460,862,245
• CAPITAL WORLD INVESTORS added 11,255,683 shares (+8.6%) to their portfolio in Q4 2024, for an estimated $422,425,782
• BANK OF AMERICA CORP /DE/ removed 9,175,937 shares (-16.3%) from their portfolio in Q4 2024, for an estimated $344,372,915

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CMCSA Analyst Ratings

Wall Street analysts have issued reports on $CMCSA in the last several months. We have seen 5 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Wells Fargo issued a "Underweight" rating on 04/14/2025
• Cowen & Co. issued a "Buy" rating on 01/31/2025
• Citigroup issued a "Buy" rating on 01/31/2025
• Loop Capital Markets issued a "Buy" rating on 01/02/2025
• Seaport Global issued a "Buy" rating on 12/11/2024
• UBS issued a "Positive" rating on 10/31/2024

To track analyst ratings and price targets for CMCSA, check out Quiver Quantitative's $CMCSA forecast page.

CMCSA Price Targets

Multiple analysts have issued price targets for $CMCSA recently. We have seen 3 analysts offer price targets for $CMCSA in the last 6 months, with a median target of $38.0.

Here are some recent targets:

• Kannan Venkateshwar from Barclays set a target price of $37.0 on 02/03/2025
• Laurent Yoon from Bernstein set a target price of $38.0 on 01/31/2025
• David Joyce from Seaport Global set a target price of $46.0 on 12/11/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$9,940,000 of GENERAL MOTORS COMPANY lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Vehicle fuel economy; vehicle safety, autonomous vehicles, cybersecurity, connected vehicles, global competitiveness; S. 711, the Transportation Freedom Act, Protecting American Advanced Manufacturing Act; EV infrastructure and auto manufacturing supply chain; S. 154/H.R. 621, PART Act; Permitting Reform THUD Appropriations; Defense appropriations for Fiscal Year 2025; infantry squad vehicle funding, tactical electrification initiatives; Department of defense budget request for Fiscal Year 2025 Fuel economy/GHG rule/CAFE/ACC II; Safe II GHG reduction rule, Preserving Choice in Vehicle Purchases Act; calculation for EVs. Privacy and data breach, issues generally Tariffs, Non-tariff trade barriers, global market access Corporate governance and industrial loan charters, issues generally. H.R. 906, REPAIR Act, H.R. 1707 SMART Act; S. 2934/HR 8684 SHOP SAFE Act, S. 2220 PREVAIL Act and autonomous vehicle technology, issues generally. Issues related to OECD Pillar 2 negotiations and agreements on the taxation of global income, IRA sections 30D, 45X, 45W, expiring provisions of the Tax Cut and Jobs Act. Defense authorization for Fiscal Year 2025, hybrid propulsion programs, infantry squad vehicle authorization; Armored vehicle procurement, provisions related to LIDAR"

You can find more data on corporate lobbying on Quiver Quantitative.

GM Congressional Stock Trading

Members of Congress have traded $GM stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $GM stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 02/26.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

GM Insider Trading Activity

GM insiders have traded $GM stock on the open market 13 times in the past 6 months. Of those trades, 1 have been purchases and 12 have been sales.

Here’s a breakdown of recent trading of $GM stock by insiders over the last 6 months:

• MARY T BARRA (Chair & CEO) has made 0 purchases and 3 sales selling 713,648 shares for an estimated $38,942,692.
• CRAIG B. GLIDDEN (Executive Vice President & GC) has made 0 purchases and 5 sales selling 383,142 shares for an estimated $21,696,752.
• MARK L REUSS (President) sold 122,283 shares for an estimated $6,745,130
• RORY HARVEY (Executive Vice President) has made 0 purchases and 3 sales selling 18,226 shares for an estimated $1,037,900.
• ALFRED F JR KELLY purchased 12,000 shares for an estimated $607,920

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

GM Hedge Fund Activity

We have seen 559 institutional investors add shares of GM stock to their portfolio, and 623 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL WORLD INVESTORS removed 22,218,452 shares (-46.0%) from their portfolio in Q4 2024, for an estimated $1,183,576,938
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 8,347,526 shares (-27.7%) from their portfolio in Q4 2024, for an estimated $444,672,710
• CAPITAL INTERNATIONAL INVESTORS removed 7,196,697 shares (-71.7%) from their portfolio in Q4 2024, for an estimated $383,368,049
• HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC removed 6,366,002 shares (-36.8%) from their portfolio in Q4 2024, for an estimated $339,116,926
• BLACKROCK, INC. removed 6,009,772 shares (-5.7%) from their portfolio in Q4 2024, for an estimated $320,140,554
• BARCLAYS PLC removed 5,419,215 shares (-70.0%) from their portfolio in Q4 2024, for an estimated $288,681,583
• FMR LLC removed 4,217,131 shares (-21.9%) from their portfolio in Q4 2024, for an estimated $224,646,568

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

GM Analyst Ratings

Wall Street analysts have issued reports on $GM in the last several months. We have seen 4 firms issue buy ratings on the stock, and 3 firms issue sell ratings.

Here are some recent analyst ratings:

• Barclays issued a "Negative" rating on 04/15/2025
• Bernstein issued a "Underperform" rating on 04/07/2025
• Cowen & Co. issued a "Buy" rating on 03/06/2025
• UBS issued a "Buy" rating on 02/03/2025
• Wells Fargo issued a "Underweight" rating on 02/03/2025
• Evercore ISI issued a "Outperform" rating on 12/13/2024
• Bank of America Securities issued a "Buy" rating on 12/04/2024

To track analyst ratings and price targets for GM, check out Quiver Quantitative's $GM forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$7,990,000 of META PLATFORMS INC. AND VARIOUS SUBSIDIARIES lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Education regarding internet security policy and internet privacy issues, federal privacy legislation, and freedom of expression on the internet, including connectivity, spectrum and access issues, local media issues Issues related to Digital Services Taxes (DSTs); Discussions regarding corporate tax issues and international tax policy Discussions regarding free trade agreements; Data localization and cross-border trade flows; Trade promotion authority and digital trade; Commerce export regulations - emerging technology; EU/US data flow; China; Intermediary liability; US-India trade negotiations; Export controls Discussions regarding cybersecurity, data security, encryption, platform integrity, election integrity, content policy, and terrorism; Issues related to voter suppression/interference, political ads and misinformation policies Issues and discussions related to technology and the Internet including privacy, security, competition, research, trademark counterfeiting and copyright piracy issues; online advertising, content and platform transparency efforts; technology and engineering; protecting children, bullying prevention and online safety; youth safety and federal parental approval; human trafficking issues; data portability and interoperability; data breach; connectivity and network usage issues; platform integrity and cybersecurity; storage and access to electronic communications and encryption; manipulated media; continued conversations on Artificial Intelligence; Section 230 of the Communications Decency Act; youth restrictions on social media; issues related to online platform content in the EU; Congressional Review Act and other activity related to the CFPBs rulemaking on payment system plans and nonbank larger participants"; Stop CSAM Act; EARN It Act; S. 146, TAKE IT DOWN Act Issues related to infrastructure and subsea cable systems in the US and globally Issues related to Meta's Community Standards; Update on civil rights issues related to advertising practices; Issues related to human rights Issues related to encryption; Issues related to EU/US data flow; India, Turkey, Bangladesh and other data localization issues; Issues related to intermediary liability both civil and criminal Discussions regarding temporary high-tech worker visas and employment based permanent residency Issues related to renewable energy policy"

You can find more data on corporate lobbying on Quiver Quantitative.

META Congressional Stock Trading

Members of Congress have traded $META stock 17 times in the past 6 months. Of those trades, 13 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $META stock by members of Congress over the last 6 months:

• SENATOR SHELLEY MOORE CAPITO purchased up to $15,000 on 03/26.
• REPRESENTATIVE KELLY MORRISON has traded it 3 times. They made 3 purchases worth up to $80,000 on 03/24 and 0 sales.
• REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 1 purchase worth up to $15,000 on 03/05 and 1 sale worth up to $15,000 on 01/16.
• REPRESENTATIVE ROBERT BRESNAHAN has traded it 4 times. They made 1 purchase worth up to $15,000 on 03/04 and 3 sales worth up to $45,000 on 02/20, 01/29.
• REPRESENTATIVE BRUCE WESTERMAN purchased up to $15,000 on 03/03.
• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 4 times. They made 4 purchases worth up to $60,000 on 02/12, 01/21, 12/24, 11/01 and 0 sales.
• REPRESENTATIVE JONATHAN L. JACKSON purchased up to $15,000 on 12/09.
• REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 11/08.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

META Insider Trading Activity

META insiders have traded $META stock on the open market 1343 times in the past 6 months. Of those trades, 0 have been purchases and 1343 have been sales.

Here’s a breakdown of recent trading of $META stock by insiders over the last 6 months:

• MARK ZUCKERBERG (COB and CEO) has made 0 purchases and 1222 sales selling 1,685,935 shares for an estimated $1,092,297,985.
• CHRISTOPHER K COX (Chief Product Officer) has made 0 purchases and 48 sales selling 60,000 shares for an estimated $39,908,564.
• SUSAN J LI (Chief Financial Officer) has made 0 purchases and 8 sales selling 36,148 shares for an estimated $21,787,268.
• ANDREW BOSWORTH (Chief Technology Officer) has made 0 purchases and 6 sales selling 24,863 shares for an estimated $14,808,665.
• JENNIFER NEWSTEAD (Chief Legal Officer) has made 0 purchases and 25 sales selling 22,762 shares for an estimated $13,951,145.
• JAVIER OLIVAN (Chief Operating Officer) has made 0 purchases and 26 sales selling 21,058 shares for an estimated $13,244,529.
• NICHOLAS CLEGG (President, Global Affairs) has made 0 purchases and 5 sales selling 8,427 shares for an estimated $4,690,970.
• PEGGY ALFORD has made 0 purchases and 2 sales selling 1,646 shares for an estimated $993,649.
• AARON ANDERSON (Chief Accounting Officer) sold 731 shares for an estimated $407,167

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

META Hedge Fund Activity

We have seen 2,206 institutional investors add shares of META stock to their portfolio, and 1,612 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PROFICIO CAPITAL PARTNERS LLC added 6,240,810 shares (+78471.1%) to their portfolio in Q4 2024, for an estimated $3,654,056,663
• LEGAL & GENERAL GROUP PLC removed 3,882,116 shares (-22.0%) from their portfolio in Q4 2024, for an estimated $2,273,017,739
• NORGES BANK added 3,610,287 shares (+11.9%) to their portfolio in Q4 2024, for an estimated $2,113,859,141
• NORTHERN TRUST CORP added 2,787,832 shares (+13.5%) to their portfolio in Q4 2024, for an estimated $1,632,303,514
• CAPITAL INTERNATIONAL INVESTORS removed 2,699,264 shares (-9.2%) from their portfolio in Q4 2024, for an estimated $1,580,446,064
• BLACKROCK, INC. added 2,543,790 shares (+1.6%) to their portfolio in Q4 2024, for an estimated $1,489,414,482
• ASSENAGON ASSET MANAGEMENT S.A. added 2,225,186 shares (+712.2%) to their portfolio in Q1 2025, for an estimated $1,282,508,202

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

META Analyst Ratings

Wall Street analysts have issued reports on $META in the last several months. We have seen 22 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Tigress Financial issued a "Strong Buy" rating on 02/11/2025
• Cowen & Co. issued a "Buy" rating on 01/30/2025
• UBS issued a "Buy" rating on 01/30/2025
• RBC Capital issued a "Outperform" rating on 01/30/2025
• Susquehanna issued a "Positive" rating on 01/30/2025
• Cantor Fitzgerald issued a "Overweight" rating on 01/30/2025
• Citigroup issued a "Buy" rating on 01/30/2025

To track analyst ratings and price targets for META, check out Quiver Quantitative's $META forecast page.

META Price Targets

Multiple analysts have issued price targets for $META recently. We have seen 11 analysts offer price targets for $META in the last 6 months, with a median target of $700.0.

Here are some recent targets:

• An analyst from Tigress Financial set a target price of $935.0 on 02/11/2025
• An analyst from Argus Research set a target price of $775.0 on 02/04/2025
• An analyst from Piper Sandler set a target price of $670.0 on 01/24/2025
• An analyst from RBC Capital set a target price of $700.0 on 01/24/2025
• An analyst from JMP Securities set a target price of $750.0 on 01/02/2025
• An analyst from Raymond James set a target price of $675.0 on 11/25/2024
• Nat Schindler from Scotiabank set a target price of $583.0 on 10/31/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,150,000 of CSX CORPORATION lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to upcoming transportation reauthorization bill; Issues related to modal equity, user fees, and Highway Trust Fund; Issues related to rail safety technology - including air brake testing, automated track inspections, train inspection portals, trip optimizer, and safety pilot programs; Issues related to cargo theft; Issues related to rail operations and service; Issues related to supply chain network; Issues related to at-grade crossings and crossing elimination/signals funding; Issues related to Amtrak and passenger rail; Issues related to rail labor; Issues related to railroad right of way, including safety, encroachments, and property rights; Issues related to storm impacted infrastructure projects - Blue Ridge Subdivision restoration; HR 853: Assistance for Local Heroes During Train Crises Act; HR 854: DERAIL Act; HR 971: RAIL Act; HR 341: Railroad Responsibility Act of 2025; HR 928: Railway Safety Act of 2025; Monitor HR 2569: Train Noise and Vibration Reduction Act; HR 2166: Safe Route Acts of 2025 - heavy trucks; Monitor HR1487: The Agricultural and Forestry Hauling Efficiency Act - heavy trucks; Monitor HR 2424: Modern, Clean and Safe Trucks Act - trucks subsidy; Monitor HR 2514: Trucker Bathroom Access Act; Continuing funding Resolution, related to DOT funding; Issues related to streamlining permits approvals; Issues related to government regulations; Monitor cabinet nominations; Issues relate to environmental and energy regulation; Issues related to CARB waiver on zero-emission locomotives; Issues related to cargo theft prosecution and deterrent; Issues related to tariff proposals; Issues related to USTR proposed China ship fee; Budget Reconciliation - bonus depreciation, corporate tax rate, business SALT, and 45V; S 187/HR 574 ALIGN Act - tax depreciation"

You can find more data on corporate lobbying on Quiver Quantitative.

CSX Congressional Stock Trading

Members of Congress have traded $CSX stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CSX stock by members of Congress over the last 6 months:

• REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 03/13.
• REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 02/25.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

CSX Insider Trading Activity

CSX insiders have traded $CSX stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CSX stock by insiders over the last 6 months:

• NATHAN D GOLDMAN (EVP & CLO) has made 0 purchases and 2 sales selling 118,588 shares for an estimated $4,197,315.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CSX Hedge Fund Activity

We have seen 648 institutional investors add shares of CSX stock to their portfolio, and 766 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JPMORGAN CHASE & CO added 16,687,596 shares (+18.4%) to their portfolio in Q4 2024, for an estimated $538,508,722
• AMERIPRISE FINANCIAL INC added 9,863,587 shares (+89.7%) to their portfolio in Q4 2024, for an estimated $318,297,952
• PRICE T ROWE ASSOCIATES INC /MD/ removed 7,961,244 shares (-13.7%) from their portfolio in Q4 2024, for an estimated $256,909,343
• BANK OF NEW YORK MELLON CORP added 6,730,316 shares (+40.5%) to their portfolio in Q4 2024, for an estimated $217,187,297
• CAPITAL WORLD INVESTORS removed 6,493,505 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $209,545,406
• MITSUBISHI UFJ TRUST & BANKING CORP added 5,568,624 shares (+471.9%) to their portfolio in Q4 2024, for an estimated $179,699,496
• FIDUCIARY MANAGEMENT INC /WI/ added 5,523,970 shares (+inf%) to their portfolio in Q4 2024, for an estimated $178,258,511

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CSX Analyst Ratings

Wall Street analysts have issued reports on $CSX in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Barclays issued a "Overweight" rating on 04/02/2025
• Susquehanna issued a "Positive" rating on 03/27/2025
• Citigroup issued a "Buy" rating on 01/24/2025
• Jefferies issued a "Buy" rating on 01/10/2025

To track analyst ratings and price targets for CSX, check out Quiver Quantitative's $CSX forecast page.

CSX Price Targets

Multiple analysts have issued price targets for $CSX recently. We have seen 3 analysts offer price targets for $CSX in the last 6 months, with a median target of $34.0.

Here are some recent targets:

• Bascome Majors from Susquehanna set a target price of $37.0 on 03/27/2025
• An analyst from Deutsche Bank set a target price of $34.0 on 03/07/2025
• Rick Paterson from Loop Capital Markets set a target price of $34.0 on 02/03/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,060,000 of SLM CORPORATION lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues pertaining to federal student loan programs; S. 308: Graduate Opportunity and Affordable Loans Act (all provisions); H.Con.Res.14 (issues pertaining to federal student loan programs); H.R. 1739/S. 801: Higher Education Reform and Opportunity Act (issues pertaining to federal student loans). Issues pertaining to the official accounting of federal student loan programs (no specific bills); H.Con.Res.14: Issues pertaining to federal student loan programs. Issues pertaining to industrial loan companies (no specific bills)"

You can find more data on corporate lobbying on Quiver Quantitative.

SLM Insider Trading Activity

SLM insiders have traded $SLM stock on the open market 7 times in the past 6 months. Of those trades, 1 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $SLM stock by insiders over the last 6 months:

• ROBERT S. STRONG has made 0 purchases and 4 sales selling 54,000 shares for an estimated $1,512,540.
• KERRI A. PALMER (EVP, Chief Operational Officer) sold 25,000 shares for an estimated $797,522
• DONNA F VIEIRA (EVP & Chief Commercial Officer) sold 13,717 shares for an estimated $446,037
• TED MANVITZ purchased 10,000 shares for an estimated $289,032

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

SLM Hedge Fund Activity

We have seen 170 institutional investors add shares of SLM stock to their portfolio, and 151 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL RESEARCH GLOBAL INVESTORS added 5,224,849 shares (+inf%) to their portfolio in Q4 2024, for an estimated $144,101,335
• BARROW HANLEY MEWHINNEY & STRAUSS LLC added 5,092,179 shares (+inf%) to their portfolio in Q4 2024, for an estimated $140,442,296
• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 2,768,741 shares (+inf%) to their portfolio in Q4 2024, for an estimated $76,361,876
• DUQUESNE FAMILY OFFICE LLC added 2,520,275 shares (+inf%) to their portfolio in Q4 2024, for an estimated $69,509,184
• VANGUARD GROUP INC removed 2,417,962 shares (-7.7%) from their portfolio in Q4 2024, for an estimated $66,687,391
• IMPACTIVE CAPITAL LP removed 2,192,253 shares (-12.5%) from their portfolio in Q4 2024, for an estimated $60,462,337
• FMR LLC added 2,111,699 shares (+39.0%) to their portfolio in Q4 2024, for an estimated $58,240,658

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

SLM Analyst Ratings

Wall Street analysts have issued reports on $SLM in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Deutsche Bank issued a "Buy" rating on 01/03/2025
• Morgan Stanley issued a "Overweight" rating on 12/19/2024

To track analyst ratings and price targets for SLM, check out Quiver Quantitative's $SLM forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,420,000 of CITIGROUP WASHINGTON INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Met with the House and Senate on preemption issues Met with the House and Senate on issues impacting large global banks Met with the House and Senate on digital assets Met with the House and Senate on sanctions legislation Met with the House and Senate on market regulations Met with the House and Senate on bank capital regulations Met with the House and Senate on credit card pricing Met with the House and Senate on AML regulations Met with the House and Senate on geopolitical issues impacting the global economy, including China Met with the House and Senate on proposals related to outbound investment Met with the House and Senate on artificial intelligence Met with the House and Senate on fair access to banking issues and legislative proposals Met with the House and Senate on cybersecurity issues Met with the House and Senate on interchange issues/previously introduced Credit Card Competition Act Met with the House and Senate on bank supervision issues H.R.2392, the Stablecoin Transparency and Accountability for a Better Ledger Economy Act of 2025 - all provisions S.401/H.R.987, Fair Access to Banking Act - all provisions S.875/H.R.2702, Financial Integrity and Regulation Management (FIRM) Act - all provisions S.919, Guiding and Establishing National Innovation for U.S. Stablecoins (GENIUS) Act - all provisions S.1053/H.R.2246, Foreign Investment Guardrails to Help Thwart (FIGHT) China Act of 2025 - all provisions S.2381/H.R.1944, the 10 Percent Credit Card Interest Rate Cap Act - all provisions Met with House and Senate on issues related to the Inflation Reduction Act Met with House on issues related to H.C.Res.14 Met with House and Senate on issues related to corporate and international tax Met with House and Senate on tax incentives for renewable/clean energy Met with White House and Treasury on trade and tariffs S. 1053/ H.R. 2246, Foreign Investment Guardrails to Help Thwart (FIGHT) China Act of 2025 - all provisions"

You can find more data on corporate lobbying on Quiver Quantitative.

C Congressional Stock Trading

Members of Congress have traded $C stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $C stock by members of Congress over the last 6 months:

• REPRESENTATIVE BRUCE WESTERMAN purchased up to $15,000 on 03/03.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

C Insider Trading Activity

C insiders have traded $C stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.

Here’s a breakdown of recent trading of $C stock by insiders over the last 6 months:

• MARK MASON (Chief Financial Officer) sold 58,465 shares for an estimated $4,864,790
• EDWARD SKYLER (Hd of Ent Svc & Public Affairs) sold 35,545 shares for an estimated $2,929,263
• SYED SHAHMIR KHALIQ (Head of Services) has made 0 purchases and 5 sales selling 30,000 shares for an estimated $2,451,124.
• ANAND SELVAKESARI (Chief Operating Officer) has made 0 purchases and 2 sales selling 30,000 shares for an estimated $2,433,146.
• BRENT MCINTOSH (Chief Legal Off. & Corp. Sec'y) has made 0 purchases and 3 sales selling 20,000 shares for an estimated $1,624,453.
• SARA WECHTER (Chief Human Resources Officer) has made 0 purchases and 2 sales selling 15,125 shares for an estimated $1,225,284.
• PETER B. HENRY sold 13,000 shares for an estimated $909,674

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

C Hedge Fund Activity

We have seen 917 institutional investors add shares of C stock to their portfolio, and 778 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BERKSHIRE HATHAWAY INC removed 40,605,295 shares (-73.5%) from their portfolio in Q4 2024, for an estimated $2,858,206,715
• CAPITAL WORLD INVESTORS added 25,705,141 shares (+455.2%) to their portfolio in Q4 2024, for an estimated $1,809,384,874
• FMR LLC added 7,863,718 shares (+29.7%) to their portfolio in Q4 2024, for an estimated $553,527,110
• CITADEL ADVISORS LLC removed 6,831,969 shares (-85.2%) from their portfolio in Q4 2024, for an estimated $480,902,297
• NORGES BANK added 6,611,226 shares (+31.7%) to their portfolio in Q4 2024, for an estimated $465,364,198
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 6,433,746 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $452,871,380
• BARCLAYS PLC removed 4,010,301 shares (-43.1%) from their portfolio in Q4 2024, for an estimated $282,285,087

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

C Analyst Ratings

Wall Street analysts have issued reports on $C in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• RBC Capital issued a "Outperform" rating on 04/16/2025
• Morgan Stanley issued a "Overweight" rating on 01/07/2025
• Wolfe Research issued a "Outperform" rating on 01/03/2025
• Wells Fargo issued a "Overweight" rating on 01/03/2025
• Bank of America Securities issued a "Buy" rating on 12/02/2024

To track analyst ratings and price targets for C, check out Quiver Quantitative's $C forecast page.

C Price Targets

Multiple analysts have issued price targets for $C recently. We have seen 2 analysts offer price targets for $C in the last 6 months, with a median target of $81.0.

Here are some recent targets:

• Gerard Cassidy from RBC Capital set a target price of $78.0 on 04/16/2025
• An analyst from Truist Financial set a target price of $84.0 on 04/04/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,600,000 of CONSTELLATION ENERGY GENERATION LLC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"David Brown (House/Senate) H.R. 1968 - Making further continuing appropriations and other extensions for the fiscal year ending September 30, 2025, and for other purposes. H.Con.Res. 14 - Establishing the congressional budget for the United States Government for Fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. House Energy and Water appropriations FY 2026 Senate Energy and Water appropriations FY 2026 David Gilbert (House/Senate) H.R. 1968 - Making further continuing appropriations and other extensions for the fiscal year ending September 30, 2025, and for other purposes. H.Con.Res. 14 - Establishing the congressional budget for the United States Government for Fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. House Energy and Water FY 2025 Senate Energy and Water FY 2025 David Brown (House/Senate/White House/Department of Energy) Inflation Reduction Act of 2022 Implementation and preservation of nuclear tax credits Nuclear Fuel policy related to uranium, conversion, and enrichment Energy regulatory reform ADVANCE Act implementation Data Center policy Artificial Intelligence and Energy Use Eddystone Marine Terminal Litigation HR 1047- GRID Power Act David Gilbert (House/Senate) Inflation Reduction Act of 2022 Implementation and preservation of nuclear tax credits Nuclear Fuel policy related to uranium, conversion, and enrichment Energy regulatory reform ADVANCE Act Data Center policy Artificial Intelligence and Energy Use Eddystone Marine Terminal Litigation HR 1047- GRID Power Act Andrew Malcolm (House/Senate/White House) Inflation Reduction Act of 2022 Implementation and preservation of nuclear tax credits Nuclear Fuel policy related to uranium, conversion, and enrichment Energy regulatory reform ADVANCE Act Data Center policy Artificial Intelligence and Energy Use Eddystone Marine Terminal Litigation HR 1047- GRID Power Act Jacqueline Carney (House/Senate) Inflation Reduction Act of 2022 Implementation and preservation of nuclear tax credits Nuclear Fuel policy related to uranium, conversion, and enrichment Energy regulatory reform ADVANCE Act Data Center policy Artificial Intelligence and Energy Use Eddystone Marine Terminal Litigation HR 1047- GRID Power Act Sally McAllister (House) Nuclear Fuel policy related to uranium, conversion, and enrichment Nuclear fuel imports Used fuel management Electrification/Demand Growth Policy David Brown (House/Senate/White House/Department of Energy) Global climate change issues Permitting Reform David Gilbert (House/Senate) Global climate change issues Permitting Reform Andrew Malcolm (House/Senate) Global climate change issues Permitting Reform Jacqueline Carney (House/Senate) Global climate change issues Permitting Reform David Brown (House/Senate/White House/Department of Energy) Inflation Reduction Act of 2022 Implementation and preservation of nuclear tax credits Tariff policy David Gilbert (House/Senate) Inflation Reduction Act of 2022 Implementation and preservation of nuclear tax credits Andrew Malcolm (House/Senate/White House) Inflation Reduction Act of 2022 Implementation and preservation of nuclear tax credits Jacqueline Carney (House/Senate) Inflation Reduction Act of 2022 Implementation and preservation of nuclear tax credits Sally McAllister (House) Benefit of the IRAs 45U tax credit to the existing nuclear fleet. David Brown (House/Senate) Used fuel management West Lake Landfill Sally McAllister (House) West Lake Landfill"

You can find more data on corporate lobbying on Quiver Quantitative.

CEG Congressional Stock Trading

Members of Congress have traded $CEG stock 4 times in the past 6 months. Of those trades, 3 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $CEG stock by members of Congress over the last 6 months:

• REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 03/31.
• SENATOR SHELLEY MOORE CAPITO has traded it 2 times. They made 2 purchases worth up to $30,000 on 03/26, 02/04 and 0 sales.
• REPRESENTATIVE JULIE JOHNSON purchased up to $15,000 on 02/12.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

CEG Insider Trading Activity

CEG insiders have traded $CEG stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CEG stock by insiders over the last 6 months:

• MATTHEW N BAUER (SVP & Controller) has made 0 purchases and 2 sales selling 4,000 shares for an estimated $1,241,580.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CEG Hedge Fund Activity

We have seen 804 institutional investors add shares of CEG stock to their portfolio, and 548 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL WORLD INVESTORS removed 6,908,805 shares (-88.2%) from their portfolio in Q4 2024, for an estimated $1,545,568,766
• CAPITAL INTERNATIONAL INVESTORS added 2,672,712 shares (+10.6%) to their portfolio in Q4 2024, for an estimated $597,912,401
• FMR LLC removed 2,660,013 shares (-15.6%) from their portfolio in Q4 2024, for an estimated $595,071,508
• BLACKROCK, INC. added 1,814,081 shares (+8.3%) to their portfolio in Q4 2024, for an estimated $405,828,060
• VOYA INVESTMENT MANAGEMENT LLC added 1,298,993 shares (+244.8%) to their portfolio in Q4 2024, for an estimated $290,597,724
• MORGAN STANLEY added 1,196,954 shares (+19.1%) to their portfolio in Q4 2024, for an estimated $267,770,579
• D. E. SHAW & CO., INC. added 1,122,869 shares (+73.0%) to their portfolio in Q4 2024, for an estimated $251,197,023

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CEG Analyst Ratings

Wall Street analysts have issued reports on $CEG in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Guggenheim issued a "Buy" rating on 01/14/2025
• Wells Fargo issued a "Overweight" rating on 01/12/2025
• UBS issued a "Buy" rating on 01/08/2025
• Evercore ISI issued a "Outperform" rating on 01/02/2025
• BMO Capital issued a "Outperform" rating on 10/29/2024

To track analyst ratings and price targets for CEG, check out Quiver Quantitative's $CEG forecast page.

CEG Price Targets

Multiple analysts have issued price targets for $CEG recently. We have seen 3 analysts offer price targets for $CEG in the last 6 months, with a median target of $235.0.

Here are some recent targets:

• Durgesh Chopra from Evercore ISI set a target price of $258.0 on 01/02/2025
• Paul Zimbardo from Jefferies set a target price of $234.0 on 11/06/2024
• Paul Fremont from Mizuho Securities set a target price of $235.0 on 11/05/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,750,000 of ABBOTT LABORATORIES lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. Proposals related to telehealth implementation and remote monitoring. Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR). S. 1000/H.R. 1835 Saving Access to Laboratory Services Act. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to Medicare coverage of continuous glucose monitors. Proposals related to tariffs on products imported into the United States. Proposals regarding US-China trade negotiations. Proposals related to U.S. global health programs and pandemic preparedness. Proposals to advance global virus surveillance. H.R. 2300 To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. Proposals related to access to infant formula. Proposals to reform domestic and international tax structures. S. 3387 - Ensuring Safe and Toxic-Free Foods Act of 2023."

You can find more data on corporate lobbying on Quiver Quantitative.

ABT Congressional Stock Trading

Members of Congress have traded $ABT stock 15 times in the past 6 months. Of those trades, 7 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $ABT stock by members of Congress over the last 6 months:

• REPRESENTATIVE BYRON DONALDS has traded it 2 times. They made 2 purchases worth up to $30,000 on 03/20 and 0 sales.
• REPRESENTATIVE JOSH GOTTHEIMER has traded it 4 times. They made 3 purchases worth up to $45,000 on 02/13, 01/29, 01/28 and 1 sale worth up to $15,000 on 03/06.
• REPRESENTATIVE BRUCE WESTERMAN purchased up to $15,000 on 03/03.
• SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 02/24.
• REPRESENTATIVE JARED MOSKOWITZ has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 01/15.
• SENATOR MARKWAYNE MULLIN has traded it 2 times. They made 0 purchases and 2 sales worth up to $65,000 on 01/08, 12/11.
• REPRESENTATIVE EMILY RANDALL sold up to $15,000 on 01/06.
• REPRESENTATIVE THOMAS H. KEAN, JR. purchased up to $15,000 on 12/16.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

ABT Insider Trading Activity

ABT insiders have traded $ABT stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.

Here’s a breakdown of recent trading of $ABT stock by insiders over the last 6 months:

• HUBERT L ALLEN (EXECUTIVE VICE PRESIDENT) has made 0 purchases and 5 sales selling 347,209 shares for an estimated $42,766,602.
• ROBERT B FORD (CHAIRMAN AND CEO) sold 285,388 shares for an estimated $37,435,200
• LISA D EARNHARDT (EVP AND GROUP PRESIDENT) has made 0 purchases and 2 sales selling 91,367 shares for an estimated $12,227,296.
• DANIEL GESUA SIVE SALVADORI (EXECUTIVE VICE PRESIDENT) sold 23,771 shares for an estimated $3,054,573
• LOUIS H. MORRONE (EXECUTIVE VICE PRESIDENT) has made 0 purchases and 2 sales selling 3,755 shares for an estimated $490,326.
• ANDREA F WAINER (RETIRED EVP) sold 949 shares for an estimated $131,123
• MARY K MORELAND (EXECUTIVE VICE PRESIDENT) sold 791 shares for an estimated $109,292
• JOHN A. JR. MCCOY (VICE PRESIDENT AND CONTROLLER) sold 562 shares for an estimated $77,651
• ERIC SHROFF (Senior Vice President) sold 562 shares for an estimated $77,651

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

ABT Hedge Fund Activity

We have seen 1,221 institutional investors add shares of ABT stock to their portfolio, and 1,314 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BANK OF AMERICA CORP /DE/ added 7,379,093 shares (+64.7%) to their portfolio in Q4 2024, for an estimated $834,649,209
• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 6,628,310 shares (+383.1%) to their portfolio in Q4 2024, for an estimated $749,728,144
• JPMORGAN CHASE & CO added 6,262,503 shares (+21.7%) to their portfolio in Q4 2024, for an estimated $708,351,714
• BLACKROCK, INC. added 5,506,784 shares (+4.2%) to their portfolio in Q4 2024, for an estimated $622,872,338
• LEGAL & GENERAL GROUP PLC removed 2,727,869 shares (-19.1%) from their portfolio in Q4 2024, for an estimated $308,549,262
• TWO SIGMA ADVISERS, LP removed 2,515,118 shares (-64.4%) from their portfolio in Q4 2024, for an estimated $284,484,996
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 2,300,073 shares (-90.9%) from their portfolio in Q4 2024, for an estimated $260,161,257

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ABT Analyst Ratings

Wall Street analysts have issued reports on $ABT in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• RBC Capital issued a "Outperform" rating on 04/15/2025
• Barclays issued a "Overweight" rating on 01/27/2025
• UBS issued a "Buy" rating on 01/23/2025
• Bernstein issued a "Outperform" rating on 01/08/2025
• Evercore ISI issued a "Outperform" rating on 01/02/2025

To track analyst ratings and price targets for ABT, check out Quiver Quantitative's $ABT forecast page.

ABT Price Targets

Multiple analysts have issued price targets for $ABT recently. We have seen 2 analysts offer price targets for $ABT in the last 6 months, with a median target of $137.5.

Here are some recent targets:

• Shagun Singh from RBC Capital set a target price of $140.0 on 04/15/2025
• Lee Hambright from Bernstein set a target price of $135.0 on 01/08/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,940,000 of HONEYWELL INTERNATIONAL lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to classification of certain aerospace components for export licensing purposes Aircraft and helicopter cockpit and data voice recorders Helicopter terrain awareness warning systems Beyond Visual Line of Sight operations for Unmanned Aerial Vehicles (UAVs) Advanced and Urban Air Mobility (UAM/AAM) Department of Defense CyberSecurity FAR Changes Aviation safety related to Radar Altimeters and cockpit avionics and C-band spectrum interference and research and development Runway safety and mitigation technologies (Cockpit alerting systems) FY24 FAA Reauthorization Act FY24 and FY25 Defense Appropriations FY24 Transportation Appropriations (THUD) FY24 Interior and Environment Appropriations: EPA budget related to Significant New Alternatives Program and Montreal Protocol FY24 State Department, Foreign Operations and Related Appropriations: State Department budget related to Montreal Protocol FY24 Department ofEnergy Funding related to Quantum Computing Funding related to Cybersecurity programs Funding related to Artificial Intelligence programs Production Act Title III funding FY24 and FY25 National Defense Authorization Act FY24 and FY25 Defense Appropriations Department of Defense Cybersecurity Maturity Model Certification Issues regarding Buy American Act for the Department of Defense Issues related to US Army aviation and tracked combat vehicles Issues related to U.S. Air Force aviation fleet Issues related to U.S. Navy aviation fleet Issues related to navigation and guidance systems Issues related to rotary machines Issues related to hypersonics, directed energy, and phase change materials Issues related to critical rare earth elements Issues related to hydrogen fuel cells Issues related to FEDRAMP and Cloud Services Issues related to cybersecurity Issues concerning Superfund site cleanups (no pending legislation) Issues concerning energy conservation, energy research and development, low global warming offerings, FIFRA registration, and programsadministered by the EPA Issues related to mobile air conditioning, biofuels, fuel efficient and electric vehicles, FGas regulation, various EPA rules,climate change, and energy efficiency Cafe/GHG emissions standards Issues concerning Methane monitoring and detection, EPA methane monitoring regulation Issues related to plastics recycling Issues related to the production of lithium salts, electrolytes for electric batteries, including joint ventures to promote U.S. production. Issues related to Montreal Protocol Ratification NDAA Sect 889, Prohibition of Telecommunications and Video Surveillance Equipment Issues related to: privacy legislation, 5G legislation, and AI legislation DOE Industrial Base and Semiconductor Supply Chain Issues Related to Software Bill of Materials Joint Cyber Defense Collaborative IT-Sector Coordinating Council Issues related to FAA, FHA, and automotive technology programs Issues related to Corporate Average Fuel Economy and light duty vehicle greenhouse gas emissions Issues related to autonomous vehicles and advanced air mobility, including additional FAA certification personnel Issues related to TCJA including R&D tax expensing Issues related to temporary expiring tax provisions Clean Energy tax issues Issues related to energy efficiency in commercial and residential buildings, and advanced building controls Issues related to industrial technologies Issues related to carbon capture and sequestration technologies Issues related to nuclear energy Issues related to renewable energy (no pending legislation) Issues related to Smart Grid (no pending legislation) Issues related to natural gas Issues related to energy savings performance contracts Issues related to energy storage Issues relating to smart cities technologies Issues related to Hydrogen Issues related to biofuels, sustainable aviation fuels Issues related to energy storage Supply Chain Executive Order; DOE Industrial Base and Semiconductor Supply Chain Issues related to Export/Import Bank General issues related to existing trade policies Miscellaneous Tariff Bills Issues related to Sec. 301 tariffs on imports from China Issues related to Sec. 232 tariffs on steel and aluminum imports Issues related to US-Mexico-Canada Agreement (USMCA) Issues related to US-EU Commercial Aircraft Subsidies Dispute Issues related to US-Brazil bilateral trade negotiation Issues related to hydrofluorocarbons (HFCs) efforts/Environmental Issues related to the Export Control Reform Act of 2018 U.S. Department of Commerce Military End Use Rule U.S. Department of Commerce NPRM for Securing the Nations Information and Communications Technology and Services Supply Chain Issues related to Emerging and Foundational Technologies and Relevant Rules Additional tech and data related EOs and rules Issues related to semiconductors, outbound investment, and export requirements United States Innovation and Competition Act (S. 1260)/Competes/CHIPS Act Issues related to tariffs United States Innovation and Competition Act (S. 1260)/Competes/CHIPS Act"

You can find more data on corporate lobbying on Quiver Quantitative.

HON Congressional Stock Trading

Members of Congress have traded $HON stock 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $HON stock by members of Congress over the last 6 months:

• REPRESENTATIVE GREG LANDSMAN sold up to $15,000 on 03/27.
• REPRESENTATIVE CAROL D. MILLER purchased up to $15,000 on 03/10.
• SENATOR MARKWAYNE MULLIN sold up to $50,000 on 02/13.
• SENATOR SHELDON WHITEHOUSE sold up to $15,000 on 10/29.
• SENATOR TOMMY TUBERVILLE sold up to $50,000 on 10/29.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

HON Hedge Fund Activity

We have seen 1,110 institutional investors add shares of HON stock to their portfolio, and 1,158 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BARCLAYS PLC added 17,721,324 shares (+461.4%) to their portfolio in Q4 2024, for an estimated $4,003,069,878
• CAPITAL WORLD INVESTORS added 7,057,488 shares (+inf%) to their portfolio in Q4 2024, for an estimated $1,594,215,964
• WELLINGTON MANAGEMENT GROUP LLP removed 3,367,886 shares (-18.9%) from their portfolio in Q4 2024, for an estimated $760,771,768
• BLACKROCK, INC. added 3,091,541 shares (+7.4%) to their portfolio in Q4 2024, for an estimated $698,348,196
• JANUS HENDERSON GROUP PLC removed 2,977,576 shares (-74.8%) from their portfolio in Q4 2024, for an estimated $672,604,642
• UBS GROUP AG added 2,864,906 shares (+84.9%) to their portfolio in Q4 2024, for an estimated $647,153,616
• NATIONAL BANK OF CANADA /FI/ added 2,263,296 shares (+302.1%) to their portfolio in Q4 2024, for an estimated $511,255,933

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

HON Analyst Ratings

Wall Street analysts have issued reports on $HON in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Barclays issued a "Overweight" rating on 03/26/2025
• Wells Fargo issued a "Negative" rating on 01/07/2025
• Citigroup issued a "Buy" rating on 12/03/2024

To track analyst ratings and price targets for HON, check out Quiver Quantitative's $HON forecast page.

HON Price Targets

Multiple analysts have issued price targets for $HON recently. We have seen 3 analysts offer price targets for $HON in the last 6 months, with a median target of $240.0.

Here are some recent targets:

• Julian Mitchell from Barclays set a target price of $247.0 on 03/26/2025
• Joseph O'Dea from Wells Fargo set a target price of $240.0 on 01/07/2025
• Andrew Obin from Bank of America Securities set a target price of $230.0 on 10/24/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,690,000 of CHARTER COMMUNICATIONS INC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H.R. 651 - Spectrum Pipeline Act of 2025, all provisions. H.R. 791 - Foreign Anti-Digital Piracy Act, all provisions. S. 244 - ROUTERS Act, all provisions. H.R. 866 - ROUTERS Act, all provisions. S. 328 - Stop Sports Blackouts Act, all provisions. H.R. 888 - Stop Sports Blackouts Act of 2025, all provisions. S. 792 - Government Spectrum Valuation Act, all provisions. S. 794 - A bill to require the Assistant Secretary of Commerce for Communications and Information to audit Federal spectrum, all provisions. S. 725 - Enhancing First Response Act, all provisions. Issues related to Federal Communications Commission pole dispute bills. Issues related to digital goods."

You can find more data on corporate lobbying on Quiver Quantitative.

CHTR Hedge Fund Activity

We have seen 351 institutional investors add shares of CHTR stock to their portfolio, and 398 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• NORGES BANK added 2,326,301 shares (+339.5%) to their portfolio in Q4 2024, for an estimated $797,386,193
• PRICE T ROWE ASSOCIATES INC /MD/ added 1,126,783 shares (+822.8%) to their portfolio in Q4 2024, for an estimated $386,227,408
• BERKSHIRE HATHAWAY INC removed 830,120 shares (-29.4%) from their portfolio in Q4 2024, for an estimated $284,540,232
• HARRIS ASSOCIATES L P removed 767,801 shares (-15.0%) from their portfolio in Q4 2024, for an estimated $263,179,148
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 609,554 shares (+130.1%) to their portfolio in Q4 2024, for an estimated $208,936,824
• FRANKLIN RESOURCES INC removed 392,476 shares (-11.1%) from their portfolio in Q4 2024, for an estimated $134,528,998
• BARCLAYS PLC added 380,860 shares (+34.9%) to their portfolio in Q4 2024, for an estimated $130,547,382

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CHTR Analyst Ratings

Wall Street analysts have issued reports on $CHTR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

• Barclays issued a "Underweight" rating on 02/03/2025
• Bank of America Securities issued a "Buy" rating on 11/04/2024

To track analyst ratings and price targets for CHTR, check out Quiver Quantitative's $CHTR forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,110,000 of ABBVIE INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"S. 1096, Preserve Access to Affordable Generics and Biosimilars Act Patent litigation reform issues and issues related to post-grant proceedings at the USPTO Value of intellectual property S. 864, HELP Copays Act Drug cost and pricing policy issues Patient affordability issues Issues related to the 340B program Public Law 117-169 (formerly known as H.R. 5376, Inflation Reduction Act) Implementation regarding Medicare Part D drug negotiation program and smoothing out-of-pocket costs for patients Policy Proposals related to Medicare Part D and patient cost-sharing Department of Health and Human Services (HHS) drug policy issues and regulatory policy issues Issues related to HCV treatment H.R. 1328, Supply Chain Security and Growth Act of 2025 H.R. 1990, American Innovation and R&D Competitiveness Act of 2025 Public Law 115-97 (formerly known as H.R. 1, Tax Cuts and Jobs Act) Implementation Policy proposals relating to economic activity in Puerto Rico International tax issues, including OECD digital taxation work program Issues related to antitrust and competition policy"

You can find more data on corporate lobbying on Quiver Quantitative.

ABBV Congressional Stock Trading

Members of Congress have traded $ABBV stock 8 times in the past 6 months. Of those trades, 7 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $ABBV stock by members of Congress over the last 6 months:

• REPRESENTATIVE DWIGHT EVANS sold up to $15,000 on 04/03.
• REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 2 times. They made 2 purchases worth up to $30,000 on 03/17, 11/20 and 0 sales.
• REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 02/25.
• REPRESENTATIVE JEFFERSON SHREVE purchased up to $100,000 on 02/24.
• REPRESENTATIVE JARED MOSKOWITZ has traded it 2 times. They made 2 purchases worth up to $30,000 on 01/15 and 0 sales.
• REPRESENTATIVE VIRGINIA FOXX purchased up to $15,000 on 12/06.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

ABBV Insider Trading Activity

ABBV insiders have traded $ABBV stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.

Here’s a breakdown of recent trading of $ABBV stock by insiders over the last 6 months:

• TIMOTHY J. RICHMOND (EVP, CHIEF HR OFFICER) has made 0 purchases and 6 sales selling 29,917 shares for an estimated $6,070,036.
• KEVIN K BUCKBEE (SVP, CONTROLLER) has made 0 purchases and 3 sales selling 20,744 shares for an estimated $4,163,404.
• SCOTT T REENTS (EVP, CHIEF FINANCIAL OFFICER) sold 17,644 shares for an estimated $3,746,526
• PERRY C SIATIS (EVP, GC AND SECRETARY) has made 0 purchases and 2 sales selling 5,778 shares for an estimated $1,143,452.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

ABBV Hedge Fund Activity

We have seen 1,566 institutional investors add shares of ABBV stock to their portfolio, and 1,575 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• CAPITAL INTERNATIONAL INVESTORS removed 8,254,356 shares (-22.4%) from their portfolio in Q4 2024, for an estimated $1,466,799,061
• BLACKROCK, INC. added 6,062,998 shares (+4.5%) to their portfolio in Q4 2024, for an estimated $1,077,394,744
• JANUS HENDERSON GROUP PLC removed 5,800,981 shares (-57.7%) from their portfolio in Q4 2024, for an estimated $1,030,834,323
• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 4,661,205 shares (-99.9%) from their portfolio in Q4 2024, for an estimated $828,296,128
• FMR LLC added 4,466,971 shares (+32.8%) to their portfolio in Q4 2024, for an estimated $793,780,746
• BANK OF AMERICA CORP /DE/ added 4,383,302 shares (+20.9%) to their portfolio in Q4 2024, for an estimated $778,912,765
• DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN removed 4,142,655 shares (-75.1%) from their portfolio in Q4 2024, for an estimated $736,149,793

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ABBV Analyst Ratings

Wall Street analysts have issued reports on $ABBV in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• BMO Capital issued a "Outperform" rating on 02/03/2025
• Guggenheim issued a "Buy" rating on 02/03/2025
• Leerink Partners issued a "Outperform" rating on 11/22/2024
• Citigroup issued a "Buy" rating on 10/31/2024

To track analyst ratings and price targets for ABBV, check out Quiver Quantitative's $ABBV forecast page.

ABBV Price Targets

Multiple analysts have issued price targets for $ABBV recently. We have seen 5 analysts offer price targets for $ABBV in the last 6 months, with a median target of $215.0.

Here are some recent targets:

• Gary Nachman from Raymond James set a target price of $220.0 on 02/03/2025
• Evan Seigerman from BMO Capital set a target price of $215.0 on 02/03/2025
• Charlie Yang from Bank of America Securities set a target price of $210.0 on 10/31/2024
• Geoff Meacham from Citigroup set a target price of $226.0 on 10/31/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,620,000 of BOEING COMPANY lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Spectrum, to include 5G. Certification. Commercial aviation. Aviation quality and safety. Advanced aviation infrastructure, air mobility, innovation, technology, and unmanned aerial systems. Aeronautical charting and data. Aircraft, air safety, cockpit voice recorders, air traffic systems, and cybersecurity. Supply chain. Sustainable aviation fuel. Fire suppression. H.R.1968 - Full-Year Continuing Appropriations and Extension Act, 2025. H.Con.Res.14 & S.Con.Res.7 - Concurrent Resolution on the Budget for Fiscal Year 2025. FY26 Commerce, Justice, Science and Related Agencies appropriations. FY26 Transportation, Housing and Urban Development, and Related Agencies appropriations. NASA authorization legislation. Aerospace to include space and satellite programs. Acquisition policy. Science programs. Spectrum, to include 5G. Cybersecurity. Advanced aviation infrastructure, air mobility, and unmanned aerial systems. Civil aviation research and development. STEM education and workforce development. Human spaceflight issues. H.R.1968 - Full-Year Continuing Appropriations and Extension Act, 2025. H.Con.Res.14 & S.Con.Res.7 - Concurrent Resolution on the Budget for Fiscal Year 2025. FY26 Department of Defense appropriations. FY26 Commerce, Justice, Science and Related Agencies appropriations. FY26 State, Foreign Operations, and Related Programs appropriations. FY26 National Defense authorizations. Aerospace, weapons, missile defense, and military satellite & space programs. Communications science and technology. Manufacturing research and development. Acquisition policy, software development, and related topics. Data rights issues. Domestic sourcing. Systems modification, modernization, logistics, sustainment, and readiness. Intelligence surveillance and reconnaissance systems. DOD energy. STEM education, workforce training, and military to civilian job transition. Post-employment restrictions. Aeronautical charting and data. Critical minerals and rare earths. Defense industrial base cybersecurity, supply chain, and policy matters. H.R.1968 - Full-Year Continuing Appropriations and Extension Act, 2025. FY26 State, Foreign Operations, and Related Programs appropriations. International sales and service (commercial and military). International supply chain. China relations. Russia sanctions. AUKUS legislation. Foreign Military Financing. H.R.1026 - Primary Care Enhancement Act of 2025. H.R.1162 - Medicaid Primary Care Improvement Act. H.R.1650 & S.763 - Telehealth Expansion Act of 2025. General health care and employee benefits issues; health care coverage, regulatory implementation, transparency, delivery and payment reform, cost containment, and telehealth. Proposals related to ERISA preemption. FY26 Department of Homeland Security appropriations. Homeland security and border security. Bioterrorism. Immigration. Aviation security. Unmanned aerial vehicles. U.S. Coast Guard acquisitions. Cybersecurity policy. Artificial intelligence policy. FY26 Department of Defense appropriations. FY26 Intelligence authorizations. FY26 National Defense authorizations. Employment and labor issues, including labor relations and labor law. Workforce Innovation and Opportunity Act. Workplace safety - OSHA standards. Apprenticeships for credentials and employment. H.Con.Res.14 & S.Con.Res.7 - Concurrent Resolution on the Budget for Fiscal Year 2025. Corporate and aviation industry tax issues. Research & development audit procedures, enhancements, and experimentation expenses. Tax Cut and Jobs Act implementation. Foreign derived intangible income. Innovation and research & development competitiveness. Global minimum taxes. Energy tax. U.S. case at World Trade Organization regarding EU subsidies. International trade issues. African Growth and Opportunity Act. Tariffs and import duties imposed under authority of the International Emergency Economic Powers Act, Section 232 of the Trade Expansion Act of 1962, Section 301. Financial services issues. Export-Income Bank related issues. Securities and Exchange Commission, corporate governance, business conduct and related issues & standards. Sanctions legislation. STEM, workforce education and training. Apprenticeships for credentials and employment. Workforce innovation and opportunity issues. FY26 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations. Agriculture legislation with a nexus to aerospace issues. Clean air/CO2 emissions standards and related issues. Clean Water Act. Chemical manufacturing and use. Superfund and site remediation. Solid waste and recycling. Renewable energy, energy policy, and sustainable aviation fuel related issues. Implementation of P.L. 116-94 - Setting Every Community Up for Retirement Enhancement (Secure 1.0). Implementation of P.L. 117-328, Division T - Secure 2.0 Act of 2022. Single-employer pension premiums."

You can find more data on corporate lobbying on Quiver Quantitative.

BA Congressional Stock Trading

Members of Congress have traded $BA stock 8 times in the past 6 months. Of those trades, 4 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $BA stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 03/31 and 1 sale worth up to $15,000 on 01/24.
• REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $50,000 on 02/25 and 1 sale worth up to $50,000 on 01/13.
• REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 02/24.
• REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 2 purchases worth up to $30,000 on 02/12, 01/15 and 0 sales.
• REPRESENTATIVE THOMAS R. SUOZZI sold up to $15,000 on 10/24.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

BA Insider Trading Activity

BA insiders have traded $BA stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $BA stock by insiders over the last 6 months:

• UMA M AMULURU (EVP and Chief HR Officer) sold 3,158 shares for an estimated $570,759
• MICHAEL J CLEARY (Controller) sold 1,500 shares for an estimated $268,530

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

BA Hedge Fund Activity

We have seen 1,057 institutional investors add shares of BA stock to their portfolio, and 886 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BLACKROCK, INC. added 14,565,130 shares (+41.8%) to their portfolio in Q4 2024, for an estimated $2,578,028,010
• CAPITAL RESEARCH GLOBAL INVESTORS added 12,856,512 shares (+49.8%) to their portfolio in Q4 2024, for an estimated $2,275,602,624
• VANGUARD GROUP INC added 12,641,715 shares (+24.4%) to their portfolio in Q4 2024, for an estimated $2,237,583,555
• PRICE T ROWE ASSOCIATES INC /MD/ added 10,692,787 shares (+143.4%) to their portfolio in Q4 2024, for an estimated $1,892,623,299
• FMR LLC added 8,482,058 shares (+38.5%) to their portfolio in Q4 2024, for an estimated $1,501,324,266
• CAPITAL WORLD INVESTORS added 6,663,862 shares (+42.9%) to their portfolio in Q4 2024, for an estimated $1,179,503,574
• STATE STREET CORP added 6,147,043 shares (+22.1%) to their portfolio in Q4 2024, for an estimated $1,088,026,611

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

BA Analyst Ratings

Wall Street analysts have issued reports on $BA in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Susquehanna issued a "Positive" rating on 01/29/2025
• Deutsche Bank issued a "Buy" rating on 01/02/2025
• Cowen & Co. issued a "Buy" rating on 12/19/2024

To track analyst ratings and price targets for BA, check out Quiver Quantitative's $BA forecast page.

BA Price Targets

Multiple analysts have issued price targets for $BA recently. We have seen 4 analysts offer price targets for $BA in the last 6 months, with a median target of $200.0.

Here are some recent targets:

• Scott Deuschle from Deutsche Bank set a target price of $215.0 on 01/02/2025
• Douglas Harned from Bernstein set a target price of $169.0 on 10/29/2024
• Charles Minervino from Susquehanna set a target price of $200.0 on 10/24/2024
• Peter Arment from Robert W. Baird set a target price of $200.0 on 10/24/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$3,460,000 of THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"P.L. 117-169, the Inflation Reduction Act of 2022; H.R. 4189/S. 2016, The Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023. S. 864/H.R. 247, the Health Care Affordability Act of 2025 and issues relating to extension of Enhanced Advanced Premium Tax Credits (EAPTCs) included in the American Rescue Plan Act (ARPA) and the Inflation Reduction Act (IRA). Pharmacy issues related to the National Defense Authorization Act, FY2026. S. 1542/H.R.2214, the DRUG Act; H.R. 5378 Lower Costs, More Transparency Act; S. 1339, Pharmacy Benefit Manager Reform Act; S. 526, Pharmacy Benefit Manager Transparency Act; S. 1040, The Drug Competition and Enhancement Act; S. 1041, The Affordable Prescriptions for Patients Act. Issues related to H.Con.Res. 14/S.Con.Res. 7 (Establishing the congressional budget for the United States Government for fiscal year 2025) and budget reconciliation; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025."

You can find more data on corporate lobbying on Quiver Quantitative.

CI Congressional Stock Trading

Members of Congress have traded $CI stock 7 times in the past 6 months. Of those trades, 3 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $CI stock by members of Congress over the last 6 months:

• REPRESENTATIVE JULIE JOHNSON has traded it 3 times. They made 2 purchases worth up to $30,000 on 03/19, 01/15 and 1 sale worth up to $15,000 on 03/03.
• REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 02/25, 01/13.
• REPRESENTATIVE JEFFERSON SHREVE purchased up to $50,000 on 02/24.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 01/24.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

CI Insider Trading Activity

CI insiders have traded $CI stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $CI stock by insiders over the last 6 months:

• DAVID CORDANI (Chairman & CEO) sold 26,527 shares for an estimated $8,173,499
• NOELLE K EDER (See Remarks) sold 9,944 shares for an estimated $3,182,080
• NICOLE S JONES (See Remarks) sold 4,904 shares for an estimated $1,511,020
• ELDER GRANGER sold 2,376 shares for an estimated $737,391

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CI Hedge Fund Activity

We have seen 632 institutional investors add shares of CI stock to their portfolio, and 838 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 2,623,729 shares (+inf%) to their portfolio in Q4 2024, for an estimated $724,516,526
• FMR LLC removed 1,764,916 shares (-12.4%) from their portfolio in Q4 2024, for an estimated $487,363,904
• JPMORGAN CHASE & CO added 1,317,489 shares (+35.0%) to their portfolio in Q4 2024, for an estimated $363,811,412
• PRICE T ROWE ASSOCIATES INC /MD/ removed 1,117,751 shares (-9.3%) from their portfolio in Q4 2024, for an estimated $308,655,761
• BOSTON PARTNERS removed 1,080,728 shares (-62.7%) from their portfolio in Q4 2024, for an estimated $298,432,229
• BLACKROCK, INC. removed 751,711 shares (-3.1%) from their portfolio in Q4 2024, for an estimated $207,577,475
• GQG PARTNERS LLC added 737,099 shares (+22.4%) to their portfolio in Q4 2024, for an estimated $203,542,517

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CI Analyst Ratings

Wall Street analysts have issued reports on $CI in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Cowen & Co. issued a "Buy" rating on 02/03/2025
• Piper Sandler issued a "Overweight" rating on 02/03/2025
• Raymond James issued a "Strong Buy" rating on 01/31/2025
• Morgan Stanley issued a "Overweight" rating on 01/31/2025

To track analyst ratings and price targets for CI, check out Quiver Quantitative's $CI forecast page.

CI Price Targets

Multiple analysts have issued price targets for $CI recently. We have seen 5 analysts offer price targets for $CI in the last 6 months, with a median target of $355.0.

Here are some recent targets:

• Stephen Baxter from Wells Fargo set a target price of $341.0 on 02/04/2025
• Jessica Tassan from Piper Sandler set a target price of $348.0 on 02/03/2025
• John Ransom from Raymond James set a target price of $360.0 on 01/31/2025
• Erin Wright from Morgan Stanley set a target price of $379.0 on 01/31/2025
• Ben Hendrix from RBC Capital set a target price of $355.0 on 01/31/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$3,010,000 of GOOGLE CLIENT SERVICES LLC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Regulation of online advertising Privacy and competition issues in online advertising Intellectual property enforcement Intermediary liability for copyright infringing content generated by users Generative AI and copyright Generative AI and patents H.R. 2794 / S. 1367 - NO FAKES Act S. XXXX - Generative AI Copyright Disclosure Act of 2024 H.R. 791 -The Foreign Anti-Digital Piracy Act (FADPA) Privacy and data security issues Transparency related to the Foreign Intelligence Surveillance Act and national security orders General online consumer protection issues Online child safety protection issues; COPPA Mobile location privacy issues Cybersecurity Electronic communications privacy Data breach issues Policies on online controversial, inciting, and manipulative content Digital wellbeing Generative AI safety and privacy issues Age assurance H.R. 859 / S. 28 Informing Consumers About Smart Devices Act S. XXXX - Kids Online Safety Act S. 836 - Children and Teens' Online Privacy Protection Act S. 278 - Kids Off Social Media Act H.R. XXXX / S. XXX - App Store Accountability Act H.R. XXX - Preventing Deepfakes of Intimate Images Act H.R. XXX - Verifying Kids' Online Privacy Act S. 737 - Shielding Children's Retinas from Egregious Exposure on the Net Connected education Rolling Study Halls Digital skilling/Workforce development AI tools for education Freedom of expression and free flow of information Global trade issues Ukraine Response Israel Response Global connectivity/subsea cables/foreign data centers Health IT Health data policy Opioid and fentanyl crisis Public health information Mental health Health and fitness issues in the National Defense Authorization Act Health & AI Cybersecurity issues Online content moderation Cybersecurity workforce S. 438 / H.R. 1000 - Cyber PIVOTT Act H.R. 872 - Federal Contractor Cybersecurity Vulnerability Reduction Act High-skilled immigration and job creation STEM and innovation DACA H-1B visa reform Openness and competition in online services and devices Workplace policies; diversity and inclusion Future of work Competition regulation and antitrust law, domestically and internationally Interoperability/messaging standard issues affecting mobile handsets S. 1073 - Advertising Middlemen Endangering Rigorous Internet Competition Accountability Act (AMERICA) General issues related to Science, Technology, Engineering and Math (STEM) Open-source software Cloud computing Quantum computing AI principles R&D on artificial intelligence, machine learning, and quantum information science Semiconductor supply chain and domestic production Generative AI CHIPS and Science Act implementation Strengthening Agency Management and Oversight of Software Assets (SAMOSA) Act S. 1106 / H.R. 2321 - US Leadership in Immersive Technology S. XXX / H.R. XXX Expanding Partnerships for Innovation and Competitiveness Act (EPIC) Act S. XXX - AI Modernization of Veterans Benefits Act Benefits of online services for small businesses Grow with Google Small business advertising issues Small business competitive landscape Online video Competition in video programming Promoting broadband infrastructure deployment FCC regulation of privacy, broadband USF Reform MVPD Definition Freedom of expression, intermediary liability, and intellectual property in international trade agreements Data localization New trade agreement negotiations (e.g., USMCA) China tariffs Technology transfer, export administration and licensing, and supply chain security On-shoring the semiconductor supply chain DMA/DSA Anti-human trafficking efforts Internet intermediary liability Law enforcement access to data stored abroad Reporting of online terrorist activity Government access to electronic communications transactional records S. XXX - STOP CSAM Act H.R. 633 / S. 146 - Take It Down Act S. XXX - Protecting Children Over Profits Act H.R. 1623 / S. 737 - SCREEN Act International tax reform/OECD Digital services taxation On-shoring the semiconductor supply chain Tax Cuts and Jobs Act (TCJA)/foreign-derived intangible income (FDII) Permanency R&D Amortization Transmission development and deployment Sustainability efforts Energy Permitting Reform H.R. XXX / S. XXX - Advancing GETS Act H.R. 1077 / S. 456 STEAM Act H.R. 301 - GEO Act Continuing Appropriations for FY2025 Commercial Cloud Enterprise (C2E) and procurement National Defense Authorization Act for Fiscal Year 2025"

You can find more data on corporate lobbying on Quiver Quantitative.

GOOGL Congressional Stock Trading

Members of Congress have traded $GOOGL stock 8 times in the past 6 months. Of those trades, 5 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $GOOGL stock by members of Congress over the last 6 months:

• REPRESENTATIVE DWIGHT EVANS purchased up to $15,000 on 04/03.
• REPRESENTATIVE GREG LANDSMAN sold up to $50,000 on 03/27.
• REPRESENTATIVE BRUCE WESTERMAN has traded it 2 times. They made 1 purchase worth up to $50,000 on 03/03 and 1 sale worth up to $15,000 on 03/20.
• REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 03/03.
• SENATOR JOHN BOOZMAN purchased up to $15,000 on 02/13.
• REPRESENTATIVE RICK LARSEN purchased up to $15,000 on 01/07.
• REPRESENTATIVE WILLIAM R. KEATING purchased up to $15,000 on 10/31.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

GOOGL Insider Trading Activity

GOOGL insiders have traded $GOOGL stock on the open market 87 times in the past 6 months. Of those trades, 0 have been purchases and 87 have been sales.

Here’s a breakdown of recent trading of $GOOGL stock by insiders over the last 6 months:

• KAVITARK RAM SHRIRAM has made 0 purchases and 16 sales selling 190,566 shares for an estimated $35,538,992.
• SUNDAR PICHAI (Chief Executive Officer) has made 0 purchases and 17 sales selling 110,000 shares for an estimated $18,194,003.
• JOHN KENT WALKER (President, Global Affairs, CLO) has made 0 purchases and 9 sales selling 46,274 shares for an estimated $8,484,299.
• AMIE THUENER O'TOOLE (VP, Chief Accounting Officer) has made 0 purchases and 14 sales selling 18,816 shares for an estimated $3,481,412.
• RUTH PORAT (President, Chief Invs. Officer) has made 0 purchases and 6 sales selling 17,690 shares for an estimated $3,245,778.
• JOHN L. HENNESSY has made 0 purchases and 19 sales selling 4,900 shares for an estimated $912,638.
• FRANCES ARNOLD has made 0 purchases and 6 sales selling 1,005 shares for an estimated $176,306.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

GOOGL Hedge Fund Activity

We have seen 2,207 institutional investors add shares of GOOGL stock to their portfolio, and 1,986 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FMR LLC added 22,100,902 shares (+9.8%) to their portfolio in Q4 2024, for an estimated $4,183,700,748
• NORGES BANK added 21,327,831 shares (+19.8%) to their portfolio in Q4 2024, for an estimated $4,037,358,408
• BARCLAYS PLC removed 10,481,148 shares (-35.3%) from their portfolio in Q4 2024, for an estimated $1,984,081,316
• NORTHERN TRUST CORP added 10,135,430 shares (+17.0%) to their portfolio in Q4 2024, for an estimated $1,918,636,899
• CAPITAL RESEARCH GLOBAL INVESTORS added 10,037,685 shares (+16.2%) to their portfolio in Q4 2024, for an estimated $1,900,133,770
• LEGAL & GENERAL GROUP PLC removed 9,810,827 shares (-20.0%) from their portfolio in Q4 2024, for an estimated $1,857,189,551
• CANADA PENSION PLAN INVESTMENT BOARD removed 9,793,221 shares (-47.7%) from their portfolio in Q4 2024, for an estimated $1,853,856,735

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

GOOGL Analyst Ratings

Wall Street analysts have issued reports on $GOOGL in the last several months. We have seen 14 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Wedbush issued a "Outperform" rating on 04/15/2025
• KeyBanc issued a "Overweight" rating on 01/10/2025
• Wolfe Research issued a "Outperform" rating on 01/03/2025
• Needham issued a "Buy" rating on 10/30/2024
• Seaport Global issued a "Buy" rating on 10/30/2024
• BMO Capital issued a "Outperform" rating on 10/30/2024
• Jefferies issued a "Buy" rating on 10/30/2024

To track analyst ratings and price targets for GOOGL, check out Quiver Quantitative's $GOOGL forecast page.

GOOGL Price Targets

Multiple analysts have issued price targets for $GOOGL recently. We have seen 15 analysts offer price targets for $GOOGL in the last 6 months, with a median target of $202.0.

Here are some recent targets:

• Scott Devitt from Wedbush set a target price of $190.0 on 04/15/2025
• Gil Luria from D.A. Davidson set a target price of $160.0 on 04/14/2025
• An analyst from UBS set a target price of $190.0 on 03/27/2025
• An analyst from KeyBanc set a target price of $202.0 on 03/18/2025
• Mark Kelley from Stifel Nicolaus set a target price of $200.0 on 11/21/2024
• Aaron Kessler from Seaport Global set a target price of $200.0 on 10/30/2024
• Brian Nowak from Morgan Stanley set a target price of $205.0 on 10/30/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,800,000 of MERCK & CO INC lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"H.R. 3, (117th Cong.) Elijah E. Cummings Lower Drug Costs Now Act H.R. 19, (117th Cong.) Lower Costs, More Cures Act of 2021 H.R. 830, Help Ensure Lower Patient (HELP) Copays Act H.R. 1503/S. 2916, Prescription Information Modernization Act of 2023 H.R. 2679, Pharmacy Benefits Manager Accountability Act H.R. 2691, Transparent Prices Required to Inform Consumer and Employers (Transparent PRICE) Act H.R. 2816, Pharmacy Benefit Manager Sunshine and Accountability Act H.R. 2880, Protecting Patients Against PBM Abuses Act H.R. 2940/S. 1355, Pioneering Antimicrobial Subscriptions to End Upsurging Resistance Act (PASTEUR) Act of 2023 H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program H.R. 3285, Fairness for Patient Medications Act H.R. 3633, PREVENT HPV Cancers Act of 2023 H.R. 4368/S. 2131, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 4895, Lowering Drug Costs for American Families Act H.R. 5376/S. 2474, Share the Savings with Seniors Act H.R. 6283, Delinking Revenue from Unfair Gouging (DRUG) Act H.R. 7174, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 7635, The 340B PATIENTS Act of 2024 H.R. 8467, Farm, Food, and National Security Act of 2024 S. 150, Affordable Prescriptions for Patients Act of 2023 S. 1339, Pharmacy Benefit Manager Reform Act S. 1895 (116th Congress) Lower Health Care Costs Act S. 2333, Pandemic and All-Hazards Preparedness and Response Act S. 2543 (116th Congress) Prescription Drug Pricing Reduction Act of 2019 S. 4229, Reducing Drug Prices for Seniors Act. Issues relating to, 340B program integrity; 340B of the Public Health Services Act; 340B issues; 340B drug pricing program; Drug pricing; Drug pricing and reimbursement issues; Anti-microbial Resistance; Cost and value of medicines; Respiratory Syncytial Virus (RSV) immunization; Vaccines catch up; Vaccines issues; Package inserts, labeling issues, and E-Labeling authorization legislation; Pharmaceutical Supply Channel issues; Drug shortage issues; Inflation Reduction Act (P.L. 117-169), issues relating to drug pricing provisions; Issues related to the Patent and Trademark Law Amendments Act (PL 96-517); FY-2024 Budget and Appropriations Legislation; Intellectual property protection and trade issues; WTO IP Waiver for COVID therapeutics Animal Health; Animal Health Technology Issues; National Institute of Standards and Technology (NIST) draft Interagency Guidance Framework for Considering the Exercise of March-In Rights Animal Health Policy Issues: ADUFA & Funding for Electronic Animal Traceability; One Health Issues; General pharmaceutical issues; Vaccine Injury Compensation Program (VICP); Diversity in clinical trials; Accelerated approval reform; Pharmacy Benefit Manager (PBM) policy issues; Pharmacy Benefit Manager reforms; Food and Drug Administration issues; Public Health Issues. H.R. 1613, Drug Price Transparency in Medicaid Act of 2023 H.R. 2666, Medicaid VBPs for Patients (MVP) Act H.R. 7174, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program H.R. 7635, The 340B PATIENTS Act of 2024 Issues relating to, Medicare; Medicare Part B and D drug pricing issues; 340B program integrity; 340B of the Public Health Services Act; 340B drug pricing program; Drug pricing; Drug pricing and reimbursement issues; FY-2024 Budget and Appropriations Legislation; Medicaid drug rebate program (MDRP); Medicare coverage of COVID antiviral medicines. Issues relating to, Tax reform and tax policy, generally; Tax Cuts and Jobs Act of 2017 (P.L. 115-97); Inflation Reduction Act (P.L. 117-169), provisions relating to budget reconciliation and taxes."

You can find more data on corporate lobbying on Quiver Quantitative.

MRK Congressional Stock Trading

Members of Congress have traded $MRK stock 15 times in the past 6 months. Of those trades, 6 have been purchases and 9 have been sales.

Here’s a breakdown of recent trading of $MRK stock by members of Congress over the last 6 months:

• REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 04/09.
• REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 1 purchase worth up to $50,000 on 02/26 and 2 sales worth up to $65,000 on 03/31, 01/24.
• REPRESENTATIVE KELLY MORRISON sold up to $15,000 on 03/20.
• REPRESENTATIVE BRUCE WESTERMAN purchased up to $15,000 on 03/03.
• REPRESENTATIVE ROBERT BRESNAHAN sold up to $50,000 on 02/25.
• REPRESENTATIVE JEFFERSON SHREVE purchased up to $50,000 on 02/24.
• REPRESENTATIVE JOSH GOTTHEIMER sold up to $50,000 on 01/27.
• REPRESENTATIVE JULIE JOHNSON purchased up to $15,000 on 01/17.
• REPRESENTATIVE BYRON DONALDS has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 01/16.
• REPRESENTATIVE JARED MOSKOWITZ has traded it 3 times. They made 1 purchase worth up to $15,000 on 11/08 and 2 sales worth up to $30,000 on 01/15.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

MRK Insider Trading Activity

MRK insiders have traded $MRK stock on the open market 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $MRK stock by insiders over the last 6 months:

• DOUGLAS M JR BAKER purchased 15,000 shares for an estimated $1,327,500
• DAVID MICHAEL WILLIAMS (EVP,Chief Info&Digital Officer) sold 6,000 shares for an estimated $512,056
• INGE G THULIN purchased 2,832 shares for an estimated $249,999
• CRISTAL N DOWNING (Chief Comm. & Public Afrs Ofcr) sold 2,361 shares for an estimated $209,550

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

MRK Hedge Fund Activity

We have seen 1,367 institutional investors add shares of MRK stock to their portfolio, and 1,816 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FMR LLC removed 12,345,732 shares (-24.8%) from their portfolio in Q4 2024, for an estimated $1,228,153,419
• BLACKROCK, INC. added 10,022,108 shares (+4.7%) to their portfolio in Q4 2024, for an estimated $996,999,303
• PRICE T ROWE ASSOCIATES INC /MD/ removed 9,961,069 shares (-44.3%) from their portfolio in Q4 2024, for an estimated $990,927,144
• CAPITAL WORLD INVESTORS removed 7,327,778 shares (-48.1%) from their portfolio in Q4 2024, for an estimated $728,967,355
• AMUNDI removed 6,533,203 shares (-40.7%) from their portfolio in Q4 2024, for an estimated $649,923,034
• BANK OF NEW YORK MELLON CORP added 5,550,824 shares (+29.7%) to their portfolio in Q4 2024, for an estimated $552,195,971
• WELLINGTON MANAGEMENT GROUP LLP added 4,932,647 shares (+6.5%) to their portfolio in Q4 2024, for an estimated $490,699,723

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

MRK Analyst Ratings

Wall Street analysts have issued reports on $MRK in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Goldman Sachs issued a "Buy" rating on 02/05/2025
• Bank of America Securities issued a "Buy" rating on 02/05/2025
• Jefferies issued a "Buy" rating on 11/15/2024
• Leerink Partners issued a "Outperform" rating on 11/01/2024

To track analyst ratings and price targets for MRK, check out Quiver Quantitative's $MRK forecast page.

MRK Price Targets

Multiple analysts have issued price targets for $MRK recently. We have seen 4 analysts offer price targets for $MRK in the last 6 months, with a median target of $123.0.

Here are some recent targets:

• Terence Flynn from Morgan Stanley set a target price of $106.0 on 02/05/2025
• Courtney Breen from Bernstein set a target price of $110.0 on 12/02/2024
• Akash Tewari from Jefferies set a target price of $148.0 on 11/15/2024
• Evan David Seigerman from BMO Capital set a target price of $136.0 on 11/01/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,600,000 of DISNEY WORLDWIDE SERVICES INC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Corporate Tax Issues Digital Trade Issues Streaming and Pay TV Issues; Privacy; Content Production Issues; S. 1409: Kids Online Safety Act; S. 1418: Children and Teens Online Privacy Protection Act; S. 836 Children and Teens Online Privacy Protection Act (COPPA 2.0) Intellectual Property Enforcement; General Copyright and Other IP Issues; International Intellectual Property Issues; Artificial Intelligence Issues; H.R. 791 The Foreign Anti-Digital Piracy Act"

You can find more data on corporate lobbying on Quiver Quantitative.

DIS Congressional Stock Trading

Members of Congress have traded $DIS stock 7 times in the past 6 months. Of those trades, 1 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $DIS stock by members of Congress over the last 6 months:

• REPRESENTATIVE GREG LANDSMAN sold up to $15,000 on 03/27.
• REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 03/05.
• SENATOR JOHN BOOZMAN sold up to $15,000 on 02/13.
• REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 0 purchases and 2 sales worth up to $65,000 on 01/21, 01/13.
• REPRESENTATIVE DEBBIE DINGELL purchased up to $15,000 on 01/15.
• SENATOR SHELDON WHITEHOUSE sold up to $15,000 on 10/29.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

DIS Insider Trading Activity

DIS insiders have traded $DIS stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $DIS stock by insiders over the last 6 months:

• ROBERT A IGER (Chief Executive Officer) has made 0 purchases and 2 sales selling 372,412 shares for an estimated $42,667,113.
• BRENT WOODFORD (EVP, Control, Fin Plan & Tax) has made 0 purchases and 3 sales selling 13,000 shares for an estimated $1,486,021.
• SONIA L COLEMAN (Sr. EVP and Chief HR Officer) has made 0 purchases and 3 sales selling 6,565 shares for an estimated $697,473.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

DIS Hedge Fund Activity

We have seen 1,182 institutional investors add shares of DIS stock to their portfolio, and 1,610 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JPMORGAN CHASE & CO added 21,138,220 shares (+286.8%) to their portfolio in Q4 2024, for an estimated $2,353,740,797
• ALLIANCEBERNSTEIN L.P. removed 7,571,147 shares (-43.0%) from their portfolio in Q4 2024, for an estimated $843,047,218
• DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 5,449,158 shares (+1900.0%) to their portfolio in Q4 2024, for an estimated $606,763,743
• AMUNDI removed 4,935,001 shares (-27.0%) from their portfolio in Q4 2024, for an estimated $549,512,361
• BLACKROCK, INC. added 4,759,580 shares (+3.8%) to their portfolio in Q4 2024, for an estimated $529,979,233
• CITADEL ADVISORS LLC added 4,711,147 shares (+1785.4%) to their portfolio in Q4 2024, for an estimated $524,586,218
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 4,680,930 shares (+75.8%) to their portfolio in Q4 2024, for an estimated $521,221,555

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

DIS Analyst Ratings

Wall Street analysts have issued reports on $DIS in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Morgan Stanley issued a "Overweight" rating on 12/18/2024
• Evercore ISI issued a "Outperform" rating on 11/18/2024
• Guggenheim issued a "Buy" rating on 11/15/2024
• Loop Capital Markets issued a "Buy" rating on 11/15/2024
• Deutsche Bank issued a "Buy" rating on 11/15/2024

To track analyst ratings and price targets for DIS, check out Quiver Quantitative's $DIS forecast page.

DIS Price Targets

Multiple analysts have issued price targets for $DIS recently. We have seen 5 analysts offer price targets for $DIS in the last 6 months, with a median target of $131.0.

Here are some recent targets:

• Hamilton Faber from Redburn Partners set a target price of $147.0 on 01/07/2025
• Vijay Jayant from Evercore ISI set a target price of $134.0 on 11/18/2024
• Michael Morris from Guggenheim set a target price of $130.0 on 11/15/2024
• Alan Gould from Loop Capital Markets set a target price of $125.0 on 11/15/2024
• Bryan Kraft from Deutsche Bank set a target price of $131.0 on 11/15/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$2,520,000 of ELEVANCE HEALTH INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"ACA Exchanges & Enrollment Enhanced Premium Tax Credits Prior Authorization Mental Health Parity Facilitating Accountability in Reimbursements Act (FAIR Act (118th Congress) Site-based Invoicing and Transparency Enhancement (SITE) Act (118th Congress) Lower Cost, More Transparency Act (118th Congress) AI Use in Healthcare Health Disparities, including Maternal Health and Rural Health Veterans Assuring Critical Care Expansions to Support Servicemembers (ACCESS) Act of 2025 (S. 275 and H.R. 740) Veterans Affairs Community Cares program Dept. of Defense Military OneSource Program Provider Directories Transparency in Coverage and Machine-Readable Files Change Healthcare Cyber Incident Telehealth Modernization Act of 2024 Addressing Anti-Competitive Contracting Clauses Act No Suprises Act Implementation Physician Led and Rural Access to Quality Care Act (H.R. 2191) Full-Year Continuing Appropriations and Extensions Act of 2025 (H.R.1968) ACA Exchanges & Enrollment Enhanced Premium Tax Credits Prior Authorization Mental Health Parity Facilitating Accountability in Reimbursements Act (FAIR Act (118th Congress) Site-based Invoicing and Transparency Enhancement (SITE) Act (118th Congress) Lower Cost, More Transparency Act (118th Congress) AI Use in Healthcare Health Disparities, including Maternal Health and Rural Health Veterans Assuring Critical Care Expansions to Support Servicemembers (ACCESS) Act of 2025 (S. 275 and H.R. 740) Veterans Affairs Community Cares program Dept. of Defense Military OneSource Program Provider Directories Transparency in Coverage and Machine-Readable Files Change Healthcare Cyber Incident Telehealth Modernization Act of 2024 Addressing Anti-Competitive Contracting Clauses Act No Suprises Act Implementation Physician Led and Rural Access to Quality Care Act (H.R. 2191) Full-Year Continuing Appropriations and Extensions Act of 2025 (H.R.1968) Medicare Advantage Supplemental Benefits In-Home Health Risk Assessments Coverage Determination Clarity Act of 2023 (H.R. 5396) Puerto Rico Medicaid Program Funding - Federal Matching Assistance Percentage (FMAP) Puerto Rico Medicare Program Funding Medicare Advantage & Medicare Part D Prescription Drug Program Medicaid Managed Care Medicaid Eligibility and Redetermination Medicare Site Neutrality Medicare & Medicaid Social Determinants of Health (SDOH) Medicare Advantage - 2026 CMS Advance Rate Notice for MA and Parts D.s program Drug Patent Reform Pharmacy Benefit Manager (PBM) operations and practices, Spread Pricing, Rebates, Delinking Protecting Patients Against PBM Abuses Act (118th Congress) Drug Act (H.R. 2214) Robinson-Patman Act Reform Modernizing and Ensuring PBM Accountability (MEPA) Act (118th Congress) Pharmacy Benefit Manager Transparency Act of 2025 (S. 526) Pharmacy Benefit Manager Reform Act (118th Congress) Patients Before Middlemen Act (S.882) Prescription Drug Transparency and Affordability Act (H.R. 2450) Pharmacists Fight Back Act (118th Congress) Lower Cost, More Transparency Act (118th Congress) Full-Year Continuing Appropriations and Extensions Act of 2025 (H.R.1968)"

You can find more data on corporate lobbying on Quiver Quantitative.

ELV Congressional Stock Trading

Members of Congress have traded $ELV stock 6 times in the past 6 months. Of those trades, 2 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $ELV stock by members of Congress over the last 6 months:

• REPRESENTATIVE JARED MOSKOWITZ has traded it 4 times. They made 1 purchase worth up to $15,000 on 11/08 and 3 sales worth up to $45,000 on 03/10.
• REPRESENTATIVE JEFFERSON SHREVE purchased up to $50,000 on 02/24.
• REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 01/13.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

ELV Insider Trading Activity

ELV insiders have traded $ELV stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $ELV stock by insiders over the last 6 months:

• CHARLES MORGAN JR KENDRICK (EVP & President, Commercial) sold 3,504 shares for an estimated $1,388,635
• RONALD W PENCZEK (CAO & Controller) sold 443 shares for an estimated $183,902

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

ELV Hedge Fund Activity

We have seen 641 institutional investors add shares of ELV stock to their portfolio, and 935 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FMR LLC removed 2,426,019 shares (-52.5%) from their portfolio in Q4 2024, for an estimated $894,958,409
• WELLINGTON MANAGEMENT GROUP LLP added 1,893,947 shares (+42.5%) to their portfolio in Q4 2024, for an estimated $698,677,048
• AMERIPRISE FINANCIAL INC removed 1,872,364 shares (-49.4%) from their portfolio in Q4 2024, for an estimated $690,715,079
• HARRIS ASSOCIATES L P added 1,821,284 shares (+inf%) to their portfolio in Q4 2024, for an estimated $671,871,667
• ORBIS ALLAN GRAY LTD added 1,264,048 shares (+139.7%) to their portfolio in Q4 2024, for an estimated $466,307,307
• FIRST EAGLE INVESTMENT MANAGEMENT, LLC added 1,039,612 shares (+47.6%) to their portfolio in Q4 2024, for an estimated $383,512,866
• JPMORGAN CHASE & CO removed 942,104 shares (-37.3%) from their portfolio in Q4 2024, for an estimated $347,542,165

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ELV Analyst Ratings

Wall Street analysts have issued reports on $ELV in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Bernstein issued a "Outperform" rating on 03/28/2025

To track analyst ratings and price targets for ELV, check out Quiver Quantitative's $ELV forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,740,000 of PHILLIPS 66 lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"S. 996, Preserving Choice in Vehicle Purchases Act of 2025; H.R. 1346, S. 593, Nationwide Consumer and Fuel Retailer Choice Act of 2025; H.J. Res. 87, Providing congressional disapproval of the rule submitted by the Environmental Protection Agency relating to California State Motor Vehicle and Engine Pollution Control Standards; Heavy-Duty Vehicle and Engine Emission Warranty and Maintenance Provisions; Advanced Clean Trucks; Waiver of Preemption; Notice of Decision; H.J. Res. 88 Providing congressional disapproval of the rule submitted by the Environmental Protection Agency relating to California State Motor Vehicle and Engine Pollution Control Standards; Advanced Clean Cars II; Waiver of Preemption; Notice of Decision; Renewable Fuels Standard RVO Annual Rule 2026 and 2027; Issues arising from the Midwest governors petition to remove the 1-psi waiver and the related EPA rulemaking Support for CO2 capture and storage projects, industrial decarbonization, hydrogen hub projects, 45Q tax credit, battery projects; Standards of Performance for New, Reconstructed, and Modified Sources and Emissions Guidelines for Existing Sources: Oil and Natural Gas Sector Climate Review; Pipeline Safety: Gas Pipeline Leak Detection and Repair; Greenhouse Gas Reporting Rule: Revisions and Confidentiality Determinations for Petroleum and Natural Gas Systems; Methane Emissions Reduction Program (MERP); H.J. Res 35, Providing for congressional disapproval under chapter 8 of title 5, USC, of the rule submitted by the Environmental Protection Agency relating to Waste Emissions Charge for Petroleum and Natural Gas Systems: Procedures for Facilitating Compliance, Including netting and exemptions. H. Con. Res. 14, Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. Con. Res. 7, an original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; S. 187, the ALIGN Act; S. 1422, a bill to amend the Internal Revenue Code of 1986 to prohibit the use of foreign feedstocks for purposes of the clean fuel production credit, and for other purposes; H.R. 1347, S. 559, American Investment in Manufacturing and Main Street Act; Issues pertaining to preserving the corporate tax rate (no legislation introduced) Draft legislation to reauthorize PHMSA; Regulatory improvements for pipeline safety; Support for offshore oil port permit application Executive actions pertaining to potential tariffs affecting imports from Canada, Mexico, and China, plus reciprocal tariffs (no formal legislation introduced); Proposed Action in Section 301 Investigation of Chinas Targeting of the Maritime, Logistics, and shipbuilding Sectors for Dominance; Executive action extending deadline on license to operate in Venezuela"

You can find more data on corporate lobbying on Quiver Quantitative.

PSX Congressional Stock Trading

Members of Congress have traded $PSX stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $PSX stock by members of Congress over the last 6 months:

• SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 01/17.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

PSX Hedge Fund Activity

We have seen 709 institutional investors add shares of PSX stock to their portfolio, and 827 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• UBS GROUP AG added 5,437,195 shares (+149.3%) to their portfolio in Q4 2024, for an estimated $619,459,626
• PRICE T ROWE ASSOCIATES INC /MD/ added 4,455,220 shares (+283.5%) to their portfolio in Q4 2024, for an estimated $507,583,214
• WELLINGTON MANAGEMENT GROUP LLP removed 3,589,374 shares (-85.9%) from their portfolio in Q4 2024, for an estimated $408,937,379
• MIZUHO SECURITIES USA LLC removed 2,460,858 shares (-98.4%) from their portfolio in Q4 2024, for an estimated $280,365,551
• HARRIS ASSOCIATES L P added 1,894,510 shares (+19.3%) to their portfolio in Q4 2024, for an estimated $215,841,524
• JPMORGAN CHASE & CO removed 1,496,095 shares (-46.4%) from their portfolio in Q4 2024, for an estimated $170,450,103
• STATE STREET CORP removed 1,326,304 shares (-4.8%) from their portfolio in Q4 2024, for an estimated $151,105,814

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

PSX Analyst Ratings

Wall Street analysts have issued reports on $PSX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Wolfe Research issued a "Outperform" rating on 01/02/2025

To track analyst ratings and price targets for PSX, check out Quiver Quantitative's $PSX forecast page.

PSX Price Targets

Multiple analysts have issued price targets for $PSX recently. We have seen 2 analysts offer price targets for $PSX in the last 6 months, with a median target of $127.5.

Here are some recent targets:

• Nitin Kumar from Mizuho Securities set a target price of $140.0 on 01/13/2025
• Theresa Chen from Barclays set a target price of $115.0 on 01/13/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

$1,662,000 of GILEAD SCIENCES INC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"International trade and protection of intellectual property; TRIPS Waiver; global supply chain issues, including the Medical Supply Chain Resiliency Act; compulsory licensing and other IP issues in multiple countries. Advocate on drug pricing proposals and proposals to expand access to HIV treatment and prevention therapies including: Ryan White Care Act reauthorization; PEPFAR reauthorization; HIV/AIDS access to care, research, testing and treatment. Hepatitis C screening and linkage to care programs; coverage and reimbursement policy for Hepatitis C, HIV and oncology portfolio. Issues related to triple negative breast cancer (TNBC) and early detection and screenings for breast cancer. Advocate in favor of 340B program reforms and changes to Notice of Benefit and Payment Parameters (NBPP). Highlight Gilead's efforts to ensure diversity in clinical trials. Issues related to developing treatments and therapies, including: manufacturing, clinical trials, reimbursement and coverage. Advocate for provisions modifying the Inflation Reduction Act. HCV testing, screening and linkage to care programs. Medicaid and Medicare coverage, access and reimbursement issues for Hepatitis C, HIV, oncology products, and COVID-19 therapies and prevention including Medicare Part B proposals, and Medicare Part D reform and benefit redesign. CMS rules related to hospital inpatient payments, Medicaid Drug Rebate Program, and Value-Based Purchasing arrangements including changes to best price. Issues related to pharmaceuticals and intellectual property protection including technology transfer, patent rights and funding. Funding for policies relating to domestic and international HIV, Hepatitis C, oncology, and public health activities via appropriations. Advocacy regarding drug pricing proposals, including provisions modifying the Inflation Reduction Act and government purchasing proposals. Legislative and regulatory proposals to change international and domestic corporate tax law and policy."

You can find more data on corporate lobbying on Quiver Quantitative.

GILD Congressional Stock Trading

Members of Congress have traded $GILD stock 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $GILD stock by members of Congress over the last 6 months:

• REPRESENTATIVE JEFFERSON SHREVE purchased up to $50,000 on 03/31.
• REPRESENTATIVE CAROL D. MILLER purchased up to $15,000 on 03/10.
• REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 03/07.
• REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 12/24.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

GILD Insider Trading Activity

GILD insiders have traded $GILD stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.

Here’s a breakdown of recent trading of $GILD stock by insiders over the last 6 months:

• ANDREW D DICKINSON (Chief Financial Officer) has made 0 purchases and 11 sales selling 564,930 shares for an estimated $54,892,531.
• MERDAD PARSEY (Chief Medical Officer) has made 0 purchases and 7 sales selling 189,801 shares for an estimated $17,435,498.
• JEFFREY BLUESTONE sold 6,788 shares for an estimated $620,355
• JOHANNA MERCIER (Chief Commercial Officer) sold 5,000 shares for an estimated $456,400

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

GILD Hedge Fund Activity

We have seen 803 institutional investors add shares of GILD stock to their portfolio, and 837 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• BANK OF AMERICA CORP /DE/ added 10,487,673 shares (+145.1%) to their portfolio in Q4 2024, for an estimated $968,746,355
• FMR LLC added 7,157,113 shares (+21.6%) to their portfolio in Q4 2024, for an estimated $661,102,527
• PACER ADVISORS, INC. added 5,653,075 shares (+723.3%) to their portfolio in Q4 2024, for an estimated $522,174,537
• CAPITAL WORLD INVESTORS removed 4,842,566 shares (-6.3%) from their portfolio in Q4 2024, for an estimated $447,307,821
• AMUNDI removed 4,596,188 shares (-33.8%) from their portfolio in Q4 2024, for an estimated $424,549,885
• CAPITAL RESEARCH GLOBAL INVESTORS removed 3,853,443 shares (-6.2%) from their portfolio in Q4 2024, for an estimated $355,942,529
• ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 2,857,063 shares (-95.3%) from their portfolio in Q4 2024, for an estimated $263,906,909

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

GILD Analyst Ratings

Wall Street analysts have issued reports on $GILD in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Morgan Stanley issued a "Overweight" rating on 03/11/2025
• Deutsche Bank issued a "Buy" rating on 02/18/2025
• Citigroup issued a "Buy" rating on 11/13/2024

To track analyst ratings and price targets for GILD, check out Quiver Quantitative's $GILD forecast page.

GILD Price Targets

Multiple analysts have issued price targets for $GILD recently. We have seen 5 analysts offer price targets for $GILD in the last 6 months, with a median target of $126.0.

Here are some recent targets:

• Terence Flynn from Morgan Stanley set a target price of $130.0 on 03/11/2025
• An analyst from Johnson Rice set a target price of $126.0 on 03/05/2025
• An analyst from Oppenheimer set a target price of $132.0 on 03/04/2025
• Brian Abrahams from RBC Capital set a target price of $83.0 on 01/07/2025
• Joseph Catanzaro from Piper Sandler set a target price of $105.0 on 11/07/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.